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TANKYRASE 1 INFLUENCES TELOMERE RECOMBINATION, STABILITY OF 
THE NHEJ PROTEIN DNA-PKCS AND GENOMIC INTEGRITY 
 
 
The Poly(ADP-ribosyl)ating Polymerase (PARP) family of enzymes has gained 
considerable attention recently due to the success of inhibiting their activities in breast 
cancers with BRCA 1/2 deficient backgrounds.  PARPs serve as key regulators of protein 
recruitment, stability and activity in specific intracellular pathways including DNA-
repair, telomere stability, transcription factor regulation and mitotic integrity.  The PARP 
family member, PARP-5a, otherwise known as tankyrase 1 is unique in that it lacks a 
DNA-binding domain and interacts with proteins specifically.  First found to regulate 
telomere length by promoting access to telomerase, tankyrase 1 has since become 
associated with a multitude of critical cellular processes.  
In our studies investigating the role of DNA-dependent Protein Kinase catalytic 
subunit (DNA-PKcs) and tankyrase 1 at telomeres, we find that tankyrase 1 is required 
for the suppression of sister chromatid recombination events at the telomere and that the 
leucine zipper domain of DNA-PKcs is necessary for accurate end-capping function.  
Interestingly, during our investigation we also identified a link between the stability of 
the DNA-PKcs protein and tankyrase 1.   
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We find that under conditions in which tankyrase 1 is depleted or catalytically 
inhibited, DNA-PKcs becomes a substrate for proteasome mediated degradation.  The 
depletion of tankyrase 1 by siRNA-mediated knockdown or PARP inhibition resulted in 
the failure of DNA-PKcs function in both telomere end-capping and the DNA damage 
response following exposure to ionizing radiation; i.e., increased sensitivity to ionizing 
radiation-induced cell killing, mutagenesis, chromosome aberrations and telomere 
fusions.  Further, we find that the loss of DNA-PKcs is not coupled with depletion of 
Ku70, Ku80 or the PI3-kinase ATM, illustrating that tankyrase 1 acts to regulate DNA-
PKcs specifically.  Taken together, we identify important and novel roles of tankyrase 1 
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1.1.0  Telomeres guard chromosomal stability 
Telomeres are hexameric-repeat sequences that exist at the terminal ends of 
eukaryotic chromosomes.  In vertebrates, leading-strand telomeric DNA is composed of a 
‘TTAGGG’ hexameric-repeat sequence ranging in size from approximately 2 - 15 
kilobases (kb) in length and is universally accepted as a ‘non-coding’, untranslated region 
of linear chromosomes [1].  Telomeres serve two critical functions at the terminal ends of 
the chromosome.  First, telomeres act as a buffer region safeguarding coding DNA and 
thereby solving the ‘end replication problem’; the chronic chromosomal shortening per 
replication phase of the cell cycle as a consequence of the inability of DNA polymerases 
to synthesize nucleotide polymers in the 3’ to 5’ direction.  Second, telomeres solve the 
end-protection problem by assuming a specific conformation that serves to preserve the 
integrity of linear chromosome ends and prevent them from being recognized as a double 
strand break (DSB) by DNA-repair machinery, protecting against chromosome fusions 
and genomic instability [2-4].   
1.1.1 Telomeres solve the end-replication problem 
Each round of cell division in organisms containing linear chromosomal DNA is 
coupled with the ‘end replication problem’ [5, 6].  Following each DNA replication phase 
of the cell cycle, the telomere is shortened due to the inability of DNA polymerases to 
replace the excised RNA primer with 3’ - 5’ DNA synthesis.  In addition, nuclease 
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activities further recesses 5’ terminal ends to generate a 3’ single-stranded overhang.  
Generation of the 3’ single-stranded overhang, which ranges from 50 – 500 bases in 
length and is crucial for effective telomere-end capping [7-9], but does pose a pitfall 
through the shortening of the chromosome [5].  However, telomeres serve as a ‘buffer 
region’ between essential coding DNA and the chronic chromosomal shortening per 
round of DNA replication, coding regions of the chromosomes DNA are not initially 
impacted.   
Telomere length maintenance/telomerase 
Cells that contain a ribonucleoprotein termed telomerase posses the ability to 
lengthen the 3’ single-stranded overhang de novo during each replication cycle, allowing 
for stable telomere length over multiple divisions.  Thus, cells that express the 
appropriate components of the telomerase nucleoprotein are able to divide without 
limitation [10, 11].  Telomerase positive cells express detectable levels of the protein 
component, a telomere-specific reverse transcriptase known as (hTERT) [12].  Using a 
telomere RNA component (hTERC) integrated within TERT, telomerase is able to extend 
the 3’ single stranded overhang on each end of the chromosome [12].   
Most somatic cells do not possess telomerase [13, 14] or a method for alternative 
lengthening of the telomere (ALT [15]).  The exceptions are germ line and adult stem 
cells which contain active telomerase [16-18].  However, the enzymatic activity detected 
within these telomerase positive cell-types is not robust enough to protect against gradual 
erosion of the telomeres over a life-time [12].  Thus, there is a finite number of divisions 
a cell can undergo before replication is no longer possible without invading coding DNA  
3 
 
[19, 20].  This limit is reached sooner in somatic, telomerase and ALT negative cells 
compared to germ line and adult stem cells.   
Consequences of critically short/dysfunctional telomeres 
The limited number of divisions that can be achieved by a cell lacking telomerase 
activity is termed the ‘Hayflick Limit’ that once reached, requires the cell to initiate a 
stable, non-dividing state termed senescence [19].  In cells lacking a method for telomere 
elongation, the Hayflick limit serves as an effective method to suppress the passage of 
mutations accumulated within a single cell to progeny daughter cells in subsequent 
divisions and increased carcinogenic potential.  The inactivation of key tumor suppressor 
genes which are tasked with the maintaining appropriate cell proliferation can result in 
failed senesce.  As a consequence, the cell enters ‘crisis’, where critically eroded 
telomeres result in unstable chromosome ends that react with adjacent chromosome ends 
forming rearrangements (dicentrics and translocations).  Cells that are to survive ‘crisis’ 
are required to engineer a method of telomere elongation by either, telomerase activation 
or ALT; posing a risk for carcinogenic development as most tumor cells have become 
immortalized, with an infinite capacity to divide [21-25]. 
1.1.2 Telomeres solve the end-protection problem 
Linear chromosomes require an end-capping mechanism  to avoid activation of 
the DNA-damage response (DDR) (reviewed in [26]).  Generally, the DDR works in 
conjunction with cell cycle checkpoints to ensure DNA-damage induced over the course 
of the cell cycle is accurately repaired and thus does not persist into replication and/or 
mitotic division.   DNA damage persisting throughout the cell cycle can result in 
increased mutation and genomic instability [27].   
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Shelterin prevents DDR 
The results of studies have demonstrated that the accurate formation of telomeres 
in a capped conformation is dependent on telomeric DNA in complex with a series of 
double and single-stranded DNA-binding protein complexes to avoid recognition by the 
DDR.  Protein complexes that bind telomeric DNA also interact with one another to form 
the telomere-protein core unit of ‘shelterin’.  Effective telomere end-capping is achieved 
by the combined efforts of shelterin components, six proteins that maintain the integrity 
of telomeric DNA in a ‘capped’ conformation [28].  The core of the shelterin complex is 
composed of two dimerized telomere duplex-binding proteins; the Telomere Repeat 
binding Factors 1 (TRF1) and TRF2 in homodimer conformations.  In addition to being 
the primary DNA-binding proteins of double-stranded telomeric DNA, the TRF1 and 
TRF2 homodimers are necessary for the recruitment of the remaining four shelterin 
components: TRF1 & TRF2 Interacting Nuclear Protein 2 (TIN2), Repressor/Activator 
Protein 1 (Rap1 (human ortholog)), Tripeptidyl-peptidase 1 (TPP1) and the single-
stranded 3’ overhang binding protein POT1 [29].  In association with these recruited 
proteins, the homodimers TRF1 and TRF2 are referred to as the TRF1 & TRF2 
complexes.  In complex, TRF1 and TRF2 are designated the generic roles of telomere 
length control and telomere maintenance, respectively (Figure 1B & 1C [30]) [31-34]. 
Shelterin shields the terminal chromosome ends from recognition by DDR-
associated protein machinery (reviewed in [35]).  The TRF1 & TRF2 complexes are 
essential for the integrity of the double-stranded ‘T-loop’ component of the ‘capped’ 
telomere.  Following a homologous recombination-like event, the single-stranded 
overhang invades the telomere duplex and binds to the complementary C-rich telomere 
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strand.  The resulting ‘capped’ telomere is composed of a telomere-loop (T-loop) bound 
by TRF1 & TRF2 and a triple stranded region at the site of the recombination event 
where a small stretch of single-stranded DNA is displaced, forming the displacement 
loop (D-loop) bound by the single-stranded-binding protein Protection Of Telomeres 1 
(POT1) (Figure 1A [30]).  The telomere-end cap comprised of the T- and D-loops 
protects the telomere from processing by DDR machinery [36].  Under conditions in 
which shelterin proteins are rendered dysfunctional, the telomere can become ‘uncapped’, 
recognized as a DSB by DDR machinery and processed as such, resulting in 
cytogenetically visible telomere-based fusion phenotypes (reviewed in [26]).  Telomere 
uncapping is associated with the misregulation of one or more shelterin protein 
components.  Telomere-based fusions can occur between different chromosomes and/or 
adjacent sister chromatids as a consequence of failed end-capping and thus, contribute to 
genomic instability [37-39].    
Other telomere associated proteins that interact with shelterin and play a 
regulatory role and/or aid in telomere stability include:  DNA-repair/signaling proteins  
ERCC1, Apollo, Ku70, Ku80/86, DNA-PKcs, Mre11, RAD51, the 9-1-1 complex, 
PARP1 and PARP2; replication associated helicases RecQ & WRN, chromatin modifier 
HP1  and regulatory proteins tankyrase 1 and tankyrase 2 [40-50].  By various methods, 
each of these ‘telomere-associated’ proteins aid in sustaining the appropriate function of 
POT1 and the TRF1 & TRF2 complexes in their telomeric duties (Figure 1B & 1C [30]). 
1.1.3 Tankyrase 1 functions as an accessory component of ‘Shelterin’ 
Tankyrase 1 is a ubiquitously expressed member of the poly(ADP-ribosyl)ating 
polymerase (PARP) family [51], first characterized as an accessory shelterin component 
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where is serves to remove TRF1 from the telomere, providing access to telomerase [52].  
Upon TRF1 poly(ADP-ribosyl)ation (pADPr/PARsylation) via tankyrase 1, TRF1 is 
released from the telomere, rapidly ubiquinated and subsequently degraded [52-54].  
Hence, tankyrase 1 is thought to be a negative regulator of TRF1 and therefore, a positive 
regulator of telomere length.  Studies have demonstrated the over expression of tankyrase 
1 results in telomere elongation in telomerase positive cells where no effect on telomere 
length was observed in telomerase negative backgrounds.  These findings illustrate the 
role of tankyrase 1 at the telomere is to catalytically modify TRF1 via PARsylation, 
thereby allowing access to the telomere by telomerase and elongation of the telomere 
[55].    
  Misregulation of the TRF1 telomere dissociation dynamics by tankyrase 1 has 
detrimental consequences.  Tankyrase 1 knockdown has been found to result in extensive 
sister chromatid fusions [39] and in some cell lines, mitotic arrest [39, 56, 57].  Sister 
chromatid fusions result from persistent association of cohesion complexes between sister 
chromatids, keeping the telomeric ends in close proximity throughout DNA replication 
and G2 phase of the cell cycle.   Depletion of tankyrase 1 results in failure of TRF1 
dissociation from the telomere, thus it is thought that the chromatid ends undergo 
recombination events, which ultimately result in covalent fusions between sister 
chromatids [39].  It has been shown the cell death phenotype associated with tankyrase 1 
knockdown is associated with anaphase bridge formation in HeLa cells and subsequent 




1.1.4 DNA-PKcs is required for telomere end-capping in mammalian cells 
Recognized as the catalytically active kinase subunit of the DNA-dependent 
Protein Kinase holoenzyme (DNA-PK), DNA-PKcs is essential for appropriate 
mammalian telomere capping, at the leading strand in particular [37].  Functionally null, 
truncated forms of the DNA-PKcs protein in the SCID mouse were found to contribute to 
telomere uncapping and abundant telomere-telomere and telomere-DSB fusion 
phenotypes [37, 38].  Though the exact biochemical role of DNA-PKcs at the telomere is 
not currently understood, it has been shown that polymorphic variants of the protein also 
results in mass telomere uncapping ([58, 59] , Chapter 2).   
BALB/c and SCID mice contain single-nucleotide polymorphisms (SNPs) in the 
protein kinase, DNA-activated, catalytic polypeptide (Prkdc) allele, resulting in variant 
forms of the translated DNA-dependent protein kinase catalytic subunit (DNA-PKcs) 
protein.  The SCID cell line contains a nonsense mutation (Y4045X) [60] that results in a 
truncated form of the protein in addition to the two SNPs identified within the BALB/c 
mouse:  one within the leucine zipper domain (R2140C) and the other within the 
phosphoinositol kinase 3-related kinase (PIKK) domain (M3844V) [61-63] (Figure 2, 
adapted from [64]).  In each case, the fibroblasts from SCID and BALB/c mice show 
significantly elevated frequencies of telomere-based fusions compared to fibroblasts from 
the C57BL/6 mouse containing the ‘common’ Prkdc allele.  Although the SCID mouse 
cell line provided the initial evidence for the dependence of accurate mammalian 
telomere capping on the DNA-PKcs protein [38], investigation of the BALB/c cell line 
suggests a full length, polymorphic variant of DNA-PKcs is insufficient for accurate 
telomere capping.  This is speculated to be the consequence of deficient function of the 
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domains possessing the SNPs, reducing the functional capacity of the DNA-PKcs protein.  
Taken together, it has been established that DNA-PKcs is required for telomere capping.  
Further, specific domains of DNA-PKcs are essential for DNA-PKcs-mediated telomere 
capping. 
1.1.5  Consequences of uncapped/dysfunctional telomeres 
Deficiency in core shelterin components results in telomere dysfunction, 
chromosomal aberrations and genomic instability (reviewed in [35]).   Exposed 
chromosome ends as a consequence of telomere uncapping activates DDR machinery and 
the telomere is processed as a DSB.  Thus, high frequencies of telomere-DSB and 
telomere-telomere fusions are recognized as a consequence of telomere uncapping [26].  
Of the Shelterin components, deficiency of TRF2 results in the processing of the telomere 
by classical non-homologous end-joining (C-NHEJ), resulting in increased frequencies of 
telomere-based fusions [34, 65, 66].  Therefore, TRF2 is thought to protect the telomere 
from recognition as a DSB via NHEJ machinery; when lost, end-joining repair is 
prominent and reflected in the telomere-based fusions [31, 34].    Additionally, TRF2 is 
thought to play a role in T-loop formation [67].  Failure to accurately reform the capped-
end following replication activates the DDR and NHEJ mediated repair results in 
telomere-based chromosome-chromosome fusions [34, 65, 66]       
The consequences of TRF2 inhibition or expression of a dominant negative form 
have been shown to result in multiple different phenotypes including apoptosis and 
cellular senescence.  In certain cell types, activation of DDR via ATM in response to 
exposed telomere ends activates the p53 mediated apoptotic pathway [31, 65, 68].  While 
in other cell types including human fibroblasts, TRF2 dysfunction results in cell 
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morphological characteristics that resemble shortened telomere induced cellular 
senescence [66].  Cumulatively, these studies demonstrate telomere integrity and 
protection from end fusions is largely dependent on TRF2 function at the telomere and its 
ability to block ATM-mediated DDR activation.   
In the case of TRF1 deficiency, the effects investigated thus far have been partial 
to the telomere length regulation and telomerase activity.  Recent evidence has 
demonstrated cell cycle arrest following the conditional deletion of TRF1 in mouse 
embryonic fibroblasts [69].  This study shows TRF1 deficiency activates the DDR in an 
ATM/ATR-dependent fashion, resulting in multitelomeric signals (duplicated telomeres) 
and telomere fusion phenotypes, particularly between sister chromatids.  In support of 
other studies that suggest telomeres are fragile sites for DNA-replication that lead to 
incomplete replication, breaks and gaps [70], these findings suggest the loss of TRF1 
leads to an increase of stalled replication forks, ATR association and DDR initiation.  
Interestingly, the induction of chromatid fusion phenotypes at the telomere as a 
consequence of TRF1 deletion mirrors the effect of tankyrase 1 knockdown, where 
persistant cohesion association of sister chromtids leads to telomere fusions between 
chromatids [39].  Thus, it is suspected the appropriate regulation of TRF1 with the 
telomere is critical in the downstream regulation of cohesion association with sister 
chromatids at the telomere. 
Deficiencies in the POT1/Pot1 protein has been shown to result in multiple 
telomere instability phenotypes.  In the mice, Pot1a and Pot1b are each expressed and 
play redundant roles; interestingly only Pot1a knockout results in embryonic lethality 
whereas Pot1b knockouts were viable.  Pot1a knockdown in leads to substantial increases 
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in telomeric recombination events between sister chromatids known as telomere-sister 
chromatid exchanges (T-SCEs), implying the 3’ telomeric-overhangs act as a potential 
substrate for homologous recombination in the absence of this single-stranded binding 
protein [71, 72].  Interestingly, depletion of POT1 can also lead to telomere-based 
fusions, but to a far less extent than those observed in TRF2 depletion [72].  The 
phenotype more frequently associated with POT1 depletion was the accumulation of 
telomere dysfunction-induced foci (TIFs) at the telomere during G1 of the cell cycle [73].  
TIFs are comprised of colocalized p53-binding protein 1 (BP531), the double strand-
break foci marker γ-H2AX and TRF1 at the telomere.  In this study, TIFs were shown to 
be stably carried throughout the cell cycle for multiple divisions without becoming 
substrates for end-joining repair machinery and telomere fusion phenotypes [73].  
Further, expression of POT1 defective in it’s ability to bind DNA has been shown to 
elongate telomeres in telomerase positive backgrounds suggesting a role in telomere 
length regulation along with TRF1 [74, 75].   
It is known that NHEJ proteins are required for appropriate telomere end-capping 
[38] and may be recruited to the telomere by POT1 [38, 73].  In the event of POT1 
depletion, NHEJ components are not recruited to the exposed DNA-ends and thus, fail to 
perform their function, which in turn results in persistent TIF formation [73].  POT1 may 
recruit NHEJ proteins and protect the 3’ overhang, facilitating the regression of the 5’ 
end to generate an adequate 3’ end for accurate D-loop formation.  Loss of the POT1 
protein results in the association of ATR with the exposed end and initiation of the DNA-
damage response [2].  On the other hand, TRF2 appears to serve a NHEJ repressing 
function by inhibiting ATM-dependent DDR initiation.  Therefore, when TRF2 is lost, 
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recruited NHEJ machinery performs its ‘full’ function, resulting in the telomere fusions 
observed under TRF2 knockdown conditions; when coupled with POT1 knockdown and 
the ATM and ATR pathways initiate the DDR concurrently resulting in elevated 
telomere-based fusions [73].     
Cumulatively, the resulting defects produced by deficiencies and/or misregulated 
Shelterin components will result in telomere reactivity and chromosomal instability by 
various fusion and recombination events.  Chromosome- and chromatid-type fusions 
create unstable anaphase bridges that are forcefully resolved via random breakage 
between the two fused chromosomes, resulting in the asymmetrical distribution of genetic 
material between daughter cells.  The recipient daughter cells no longer contain stable 
genomes and consequently become prone to carcinogeneic development.  Further, fusions 
occurring in the religation events following these anaphase bridge breaks are capable of 
forming small deletions and translocation of genetic material across chromosomes.  
Consistent with classical tumorigenic models, deletions of tumor suppressor genes serve 
as a means for inactivation of the tumor suppressor gene function.  Translocation events 
between chromosomes are also known to result in a wide array of fusion proteins, 
potentially activating proto-oncogenes (reviewed in [76]). 
1.2.0 Non-homologous end-joining (NHEJ) in genomic stability 
Seemingly contradictory, accurate end-capping of mammalian telomeres relies on 
the NHEJ protein DNA-PKcs, providing a role for DNA-PKcs in maintaining genomic 
stability beyond end-joining [37, 38].  While the role of DNA-PKcs in NHEJ has been 
well characterized; functioning to maintain genomic stability throughout the cell cycle as 
the catalytically active kinase component of DNA-PK in classical non-homologous end-
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joining (C-NHEJ) DSB-repair [77], the exact role of DNA-PKcs at the telomere is not 
understood. 
In the C-NHEJ pathway, DNA-PKcs is recruited to the Ku70/Ku80 heterodimeric 
complex, localized on each side of the DSB, where it phosphorlyates serine/theonine 
residues in a regulatory and auto-regulatory fashion.  Once DNA-PKcs is complexed with 
the Ku70/Ku80 heterodimer (Ku), the heterodimer translocates along the DNA-strand 
approximately one helical turn, allowing for the formation of the functional DNA-PK 
holoenzyme [78].  Formation of identical DNA-PK complexes directly opposed to one-
another, acts to ‘synapse’ the two ends of the DSB in close proximity, allowing for repair 
of the DSB following the completion of DSB end-processing (Reviewed in [79, 80].   
The DNA-PK holoenzyme recruits multiple accessory proteins, to do the work of 
end-processing and religation of the DSB ends.  Currently known DNA-PK accessory 
proteins include:  XRCC4, Ligase IV, DNA-Polymerase µ & λ, a poly-nucleotide kinase 
(PNK), Artemis (nuclease function) and XLF/Cernunnos (reviewed in [79]).  The 
mechanism of recruitment for each protein is not well understood but each contributes to 
DNA-PK/NHEJ function.  In the case of Artemis, it is speculated the DNA-PKcs:Artemis 
complex forms an active exo/endonuclease, capable of processing the complex DNA 
ends in preparation for religation [81, 82].  Further processing of the damaged ends are 
formed via DNA-polymerase, PNK and XLF/Cernunnos before the DNA-PK enzyme 
becomes phosphorylated via DNA-PKcs kinase activity.  Though the ‘initiating event’ is 
currently unknown, it is recognized that Ku70/80 phosphorylation and DNA-PKcs 
autophosporylation events are essential for appropriate DNA-PK regulation and 
dissociation from the DSB, allowing for end-joining to occur.  In this final, critical step, 
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DNA-PK-dependent NHEJ requires the activity of XRCC4/LigaseIV once the Ku and 
DNA-PKcs components dissociate.  Hence, C-NHEJ is referred to as a DNA-
PK/LigaseIV-dependent end-joining method of repair.  Barring extensive and 
complicated damage, C-NHEJ is an efficient, rapid method of DSB repair that operates 
throughout the cell cycle.  However, C-NHEJ is coupled with deletion events per end-
joining event, which can contribute to increased mutagenesis and genomic instability 
(reviewed in [79]).      
An alternative, DNA-PK/LigaseIV-independent method of DSB end-joining is 
known to exist in cells incapable of performing C-NHEJ [83].  Generally, this ‘back-up’ 
pathway operates when functional forms of Ku70/80, Ligase IV or DNA-PKcs are 
absent.  This alternative non-homologous end-joining (A-NHEJ) process is poorly 
characterized but is known to be PARP-1-dependent and function independently of 
DNA-PK and Ligase IV [84-87].  Recent evidence has illuminated PARP-1 and, 
potentially Ligase III as the primary, necessary players in the A-NHEJ pathway [83].  
Interestingly, PARP-1, Ligase III, XRCC1 and DNA-Polymerase β are known to be 
components involved in base excision repair and single-strand break repair.  Although 
capable of end-joining, A-NHEJ is slower in the end-joining process compared to C-
NHEJ.  Additionally, it is more prone to end-joining error (mis-joining) and either fails to 
achieve end-joining resulting in terminal deletions or results in chromosomal 
translocations/rearranges [88-90].    
1.3.0  PARPs in genomic stability 
PARPs are specific to higher eukaryotes, a family of Poly(ADP-ribosyl)ating 
Polymerases (PARP) that use NAD+ as a substrate to modify ‘self’ and recipient proteins 
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posttranslationally by the addition of several hundred ADP-ribose groups (pADPr)  in a 
highly branched fashion.  Each pADPr-monomer has a net  ‘negative-two’ charge and 
thus, is capable of inducing major conformational changes in recipient proteins, in many 
cases altering protein function [91, 92].  Further, the heavy negative charge imparted by 
this modification drives non-covalent, electrostatic protein-protein interactions and in 
some cases, electrostatic repulsion.  The ability of pADPr to facilitate of both attraction 
and repulsion requires close regulation to ensure the necessary and appropriate functions 
are achieved as a result of protein pADPr modification [93].  In the event that hypo-
PARsylation, or even complete dePARsylation of a modified protein is required to 
perform a specific function, the PARP counter enzyme, poly(ADP-ribos)yl glycohyrolase 
(PARG) activity is fundamental (reviewed in [94]).  In vitro studies have suggested 
PARG activity is rapid enough to dePARsylate all pADPr-modified proteins 
intracellularly within a 1-2 minute time frame [95].  It is important to recognize the 
dynamic nature of PARP-based protein modification and the effects of PARsylation in 
regulation of the recipient protein.    
The ‘original’ poly(ADP-ribosyl)ating polymerase (PARP), termed PARP-1, was 
identified as a nuclear DNA-binding protein with the capacity to recognize the chemical 
structure of nicks in single-stranded DNA (single-stranded breaks (SSB)) and modify 
histone structure around the damage site [96].  The innate catalytic function of all PARP 
family members is to modify substrate proteins posttranslationally, including itself, by 
the addition of several hundred poly(ADP-ribose) groups (pADPr).  However, additional 
domains possessed by PARPs are highly variable from one PARP to another, each with 
unique binding domain enabling interaction with a wide range of substrates [93].   
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Of the PARP family members, only a select few are capable of DNA-interaction 
(Figure 3 A [93]).  Others possess domains that function specifically in facilitating the 
PARPs interaction with particular target proteins for pADPr modification, thereby 
achieving some regulation of the pADPr-recipient function.  The result of the 
heterogeneity observed in the function domains across the PARP family is an indicator of 
the wide array of roles attributed to PARP activity.  Included in this unique family of 
pADPr posttranslational modifiers are PARP-1, PARP-2, PARP-3, vault (VPARP) and 
the tankyrases family including PARP-5a and PARP-5b [97].     
PARP-1 is a known chromatin modifier and plays a crucial role in DNA-repair.  
PARP-1 recognizes and binds to SSBs through its’ DNA-binding domain (DBD) and 
subsequent pADPr modification of histones H1-H2B relaxes the nucleosome to allow 
PARP-1 access to the damaged DNA.  Once stably interacting with the damage site, 
PARP-1 becomes hypo-PARsylated by the combination of auto-modification and 
poly(ADP-ribosyl) glycohydrolayse (PARG) activity ([97, 98]).  The hypo-
autoPARsylated state of PARP-1 at the SSB acts to recruit additional DNA-repair 
proteins necessary for SSB repair.  Amongst the first to be recruited to hypo-PARsylated 
PARP-1 is the XRCC1/LigaseIII complex [97], followed by DNA-polymerase β (Pol β) .  
It is has been reported that failure of PARP-1 to dissociate from the DNA-damage site in 
a timely manner blocks the association of Pol β with the break [98, 99].  It appears 
PARP-1 dissociation from the DNA is dependent on the activation of PARP-1 auto-
PARsylation.  Stimulated by DNA-binding, PARP-1 auto-modification results in a heavy 
negative charge imparted by each ADP-monomer [93, 97].  The modification drives an 
electrostatic repulsion between PARP-1 and the DNA-strand, allowing for access by Pol 
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β.  This event in its entirety is descriptive of the PARP-1 dependent process of base-
excision repair (BER) and potentially nucleotide excision repair (NER).  Furthermore, 
PARP-1 plays an essential role in mitotic integrity and DSB-repair via the A-NHEJ 
pathway as mentioned previously [93, 97]. 
PARP-2 is the only other family member that contains a DNA-binding domain 
(DBD), however its’ role in vivo is currently poorly characterized.  The model of PARP-2 
function is one of playing a ‘back-up’ or ‘accessory’ role to PARP-1.  In the event of 
PARP-1 depletion, residual PARP activity at sites of DNA-damage is due to PARP-2 
activity [100].  Further, double knockout of PARP-1/PARP-2 results in the intensification 
of PARP-1 depletion phenotypes.  Nonetheless, PARP-2 appears to play a role in DNA-
repair, both with and without PARP-1 activity.   
PARP-3 is unique in that it is recognized as a cytoplasmically active PARP.  
PARP-3 is thought to be a component of the centrosome [97] and appears to function, at 
least in part, with PARP-1.  Until very recently, the exact role of PARP-3 in any cellular 
process was entirely uncharacterized [93, 97].  A recent study demonstrated PARP-3 
automodification accelerates classical non-homologous end-joining DNA-repair via the 
recruitment of the pADPr binding protein, aprataxin and poly-nucleotide kinase-like 
factor (APLF) [101].  It is assumed that PARP-3 automodification (in a hypoPARsylated 
state) recruits APLF to the double-strand break.  This is suspected to be downstream of 
DNA-PK holoenzyme dissociation from the DSB and leads to rapid resolution of the 
lesion as APLF forms a complex with XRCC4 and Ligase IV, retaining the 
XRCC4/Ligase IV complex bilaterally at the DSB [101].  Thus, XRCC4-dependent 
alignment of the processed ends and Ligase IV resolution of the lesion is promoted by 
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APLF localization to the DSB via PARP-3 autoPARsylation activity [101].  This 
particular activity of a PARP family member is not novel in nature, as PARP-1 similarily 
uses automodification for protein recruitment in SSB-repair and potentially in the 
alternative NHEJ pathway.  However, it is the first characterized role of PARP-3 
intracellularly and provides additional evidence for the involvement of PARPs as 
‘accessory proteins’ in DNA-repair pathways.      
The vault particle-interacting PARP, termed PARP-4/VPARP is the largest of 
member of the PARP family.  The specific role of the ribonucleoprotein vault particles in 
cellular processes is not currently understood and thus, the function of PARP-4 is 
unknown.  Vault particles are known to interact with the major vault protein (MVP), 
telomerase-associated protein (TEP) and untranslated vault mRNA (VRNA).  The role of 
PARP-4 in association with vault complexes may be in the subcellular localization of the 
ribonucleoprotein in complex with either MVP, TEP and VRNA [93, 97].  
Tankyrases are the most distinguishable members of the PARP family, sharing no 
homology with other PARP family members, with the exception of their catalytic PARP 
domain.  These unique PARP family enzymes are further categorized into a subset of 
proteins: PARP-5a and PARP-5b, also termed tankyrase 1 and tankyrase 2 respectively.  
The difference between the two proteins is marginal; the N-terminus of tankyrase 1 
contains a Histidine-Proline-Serine repeat that is lacking entirely in tankyrase 2 [93, 97] 
(Figure 3 B [104]).  Aside from this difference, tankyrases share more than 85% amino 
acid homology, possessing equivalent functional domains [93].  Tankyrases lack DBDs 
but contains twenty-four ankyrin-like repeat domains (ANK) that are critical for 
interaction with substrate proteins.  Further, tankyrases are the only PARPs that posses a 
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sterile alpha motif domain (SAM), used for tankyrase-tankyrase multimerization 
(oligomerization) [102, 103] (Figure 3 [93, 104]).  It is due to these unique domains 
within the PARP-5 group of PARPs that tankyrases are recognized primarily as having a 
regulatory role via pADPr modification of specific receptor proteins.   
Of the two tankyrases, tankyrase 1 is the best characterized.  Initially identified as 
a nuclear, shelterin-associated protein, tankyrase 1 was first found to regulate TRF1 via 
PARsylation; inducing a change in the TFR1 homodimer affinity for telomeric DNA and 
facilitating dissociation presumably by electrostatic repulsion.  Once dissociated from the 
telomere, PARsylated TRF1 is subject to E3 ligase ubiquitination and subsequent 
degradation if not de-PARsylated via PARG.  Tankyrase 1-dependent dissociation of 
TRF1 from the telomere has two functional implications.  First, TRF1 must be removed 
from the telomere for the progression of the replication fork during DNA replication.  
Second, cells that contain active telomerase require access to the telomere to perform 
elongation of the telomere’s single-stranded 3’ overhang.  TRF1 release initiates t-loop 
destabilization and telomerase access/association with the telomere [33, 51]. 
Tankyrase 1 has now been found to play a functional role in a multitude of cell 
processes, other than at the telomere [104].  Tankyrase-dependent PARsylation of 
pADPr-acceptor proteins is required for accurate cellular function throughout the cell 
cycle.  Tankyase-dependent pADPr-modification of substrate proteins has been shown to 
play a role in protein stabilization, scaffolding and activation.  To briefly illustrate 
examples of these characteristics, tankyrase 1 pADPr modification is required for 
accurate  spindle pole formation by stabilization and scaffolding of the nuclear mitotic 
apparatus (NuMA) protein during mitosis [56, 105, 106]; whereas tankyrase 1 pADPr 
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modification is essential in the activation of the transcription factor β –catenin [107].  
Interestingly, NuMA is dependent on pADPr modification as a method for appropriate 
protein network organization and noncovalent scaffolding with the immediately adjacent 
NuMA and tankyrase proteins [104, 105].  Tankyrase 1 is responsible for the 
PARsylation of the β-catenin sequestering protein axin, resulting in subsequent 
ubiquitination and degradation of the axin-dependent sequestering complex [107].  
Hence, tankyrase 1 plays an indirect regulatory role in the level of intracellular β-catenin 
by negatively regulating the corresponding sequestering complex [107]. 
In addition to regulating intracellular proteins, tankyrase 1 plays an auto-
regulatory role via PARsylation.  Once the pADPr modification of an acceptor protein is 
initiated, tankyrases multimerize by interacting with the SAM domain of adjacent 
tankyrases to accelerate processivity of the growing pADPr chain.  To dissociate from the 
tankyrase oligimer, individual tankyrases auto-PARsylate, inducing a conformational 
change that disrupts the tankyrase-tankyrase SAM interaction.  If not de-PARsylated by 
the activity of PARG and APD-ribose lyase (removes the final ADP monomer), pADPr 
modified tankyrases dissociate and become a vulnerable substrate for E3 ligase-mediated 
ubiquitination and subsequent proteasome-mediated degradation [108].  Hence, tankyrase 
stability is regulated via auto-PARsyaltion. 
1.4.0  An unanticipated relationship: PARPs and DNA-PKcs 
Prior sections have provided evidence for roles of PARPs and DNA-PKcs at both 
DNA-damage sites and in telomere stability.  Thus, there are likely instances where both 
a PARP and DNA-PKcs co-localize to specific sites.  One of these sites is the telomere.  
In mammalian cells, DNA-PKcs is required to accurately cap the telomere [38].  
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Likewise, tankyrase 1 is required for the release of TRF1 from the telomere during 
replication.  The role of both tankyrase 1 and DNA-PKcs are essential to maintain 
appropriate length and function of telomeres [38, 51].   Beyond the telomere, DNA-PKcs 
plays a role in DNA-repair, as do a variety of PARP family members. 
In DNA-repair, PARP-1 and PARP-2 are speculated to have redundant roles in 
BER, possibly NER, as well as alternative NHEJ pathways.  Similarly, DNA-PKcs 
localizes to DNA-DSBs following the initial recruitment of the Ku 70/80 heterodimer, 
forming the active DNA-PK holoenzyme.  It is controversial as to whether or not PARP-
1 competes with the Ku heterodimer for double-strand break ends, or if they co-localize 
at sites to achieve a common goal.  A pivotal IP study suggested that PARP-1 and DNA-
PKcs have a brief period of interaction intracelluarlly [109].   
1.4.1 Evidence for DNA-PKcs dependence on PARP 
Following the identification of PARP-1 in complex with DNA-PKcs, further in 
vitro analysis revealed a potential functional attribute to this interaction.  In vitro 
combination of DNA-PKcs with PARP-1 showed a shift in DNA-PKcs molecular weight 
only when incubated with NAD+, the substrate for PARP catalytic activity.  Further, 
incubation with PARP-1 and NAD+ resulted in the up-regulation of DNA-PKcs kinase 
activity on itself and on a variety of substrates in vitro [109].  Interestingly, these findings 
strongly suggest that pADPr modification has a positive impact on the catalytic activity 
of DNA-PKcs.  This implication has not been verified by any other study to date.  In fact, 
the question has only become more convoluted as there is no evidence supporting the 
involvement of PARP-1 in DNA-PKcs function.  Further, PARP-1 and DNA-PKcs each 
act in what are believed to be independent, non-related end-joining processes.   
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Although a specific in vivo protein-protein interaction between PARP-1 and 
DNA-PKcs has not been revealed, the initial findings are relevant in broadening the 
scope of pAPDr influence and are suggestive of the mechanism by which DNA-PKcs 
protein is regulated.  Importantly, identification of DNA-PKcs pADPr modification in 
vitro demonstrated DNA-PKcs is capable of becoming PARsylated [109].  In addition, 
immunoprecipitation of pADPr residues (in whole cell lysate) identified DNA-PKcs as a 
PARsylated member of the proteaome [110], supporting the findings of Ruscetti and 
collegues [109].  Given the high rate of intracellular PARG activity, PARsylated proteins 
are short lived.  Literature has shown that PARsylated proteins are closely regulated, as 
the modification generally plays a functional role [92, 93, 97, 104].  Interestingly, DNA-
PKcs has been found to contain pADPr interacting motifs (non-covalent interactions with 
pADPr residues on modified proteins) in addition to covalent pADPr modification, 
allowing for non-covalent protein-protein interactions [111]; suggestive of a method for 
PARP-mediated protein-protein scaffolding, mirroring the mechanism for complex 
formation observed in the NuMA model [56, 105, 106].   
Here, we investigate the impact of single-nucleotide polymorphisms in the the 
leucine zipper domain and phophatidylinositol-3-kinase like-kinase (PIKK) domain of 
the murine Prkdc allele to determine their influence in DNA-PKcs end-capping 
capabilities.  Furthermore, we find that tankyrasse 1 is responsible for contributing to 
genome stability, playing a novel, though indirect role in NHEJ DNA-repair.  
Surprisingly, we find genomic instability phenotypes emerge as a consequence of 
tankyrase 1 depletion or catalytic inhibition that reflect  hallmarks of DNA-PKcs 
deficiencies at the telomere and in DNA-repair.  We are the first to report that DNA-PKcs 
22 
 
is regulated by the catalytic PARP activity of tankyrase 1.  The studies presented here 
investigate the mechanisms by which DNA-PKcs becomes PARsylated, and begin to 
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The role of DNA-PKcs in telomeric end-capping is dependent on the leucine zipper 
domain 
The following was published in: 
Fabre KM, Ramaiah L, Dregalla RC, Desaintes C, Weil MM, Bailey SM, Ullrich RL: 
Murine Prkdc Polymorphisms Impact DNA-PKcs Function. Radiat Res 2011. 
All figures in the following chapter are original  productions of the dissertation author. 
 
2.1.0 Introduction & Background 
 
Genomic stability is largely dependent on timely and accurate repair of DNA 
damage.  In mammalian cells, an important contribution to both classical non-
homologous end-joining (C-NHEJ) and telomere function is the DNA-dependent protein 
kinase catalytic subunit (DNA-PKcs) activity.  Although the general role of DNA-PKcs 
is well appreciated, the function and contribution of specific domains within the large 
(470 kDa protein) are not well characterized.  Deficiency of DNA-PKcs associated with 
specific polymorphic forms of the Prkdc allele, such as the functionally null form 
expressed in the severe combined inmmunodeficient mouse (SCID), have been shown to 
impact telomere end-capping function as well as NHEJ-mediated DNA-repair following 
exposure to ionizing radiation (IR) [1-4].  Cytogenetic studies have revealed hallmarks of 
DNA-PKcs protein deficiency, resulting in failed telomere end-capping and manifesting 
as telomere-telomere and telomere-DSB fusion events [2, 5].  Further, studies 
investigating radiation sensitivity and carcinogenic potential in mouse models possessing 
single-nucleotide polymorphisms (SNPs) in the Prkdc allele, such as BALB/c find them 
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to be more prone to lung and mammary adenocaricomas following low dose irradiation 
(≤ 0.5 Gy) with either low-linear energy transfer (LET) γ-rays or high LET neutrons [6].   
Chromosome aberrations & rearrangements can be detected with state-of-the-art 
cytogenetic techniques like Fluorescent in situ Hybridization (FISH) and Chromosome 
Orientation Fluorescent in situ Hybridization (CO-FISH) [7-9],  which are particularly 
useful in IR studies for characterizing chromosomal instability phenotypes in the form of 
chromosome aberrations (gaps, breaks, and fusions), indicating genomic instability 
within the cell population (excludes microsatellite instability).  FISH is a technique that is 
useful in labeling specific chromosomes and chromosome sequences through probe 
hybridization to particular genes, allowing for detection of chromosomal 
rearrangements/translocation events.  Further, FISH can be used to cytogenetically 
identify centromeres (CM-FISH) [10, 11] as well as telomere sequences at the terminal 
ends of the chromosome [12].  However, this particular cytogenetic technique is 
restricted by its ability to distinguish between chromatid-specific sequences.  
Modification of the FISH technique, where newly synthesized daughter strand 
incorporated bromo-deoxy-uridine (BrdU) in each round of the cell cycle provided a 
mechanism for strand-specific degradation, producing single-stranded chromatids that 
could be labeled based on the orientation of their sequence [9].  This modified version of 
FISH is sensitive to the detection of inversions [8, 13] and can distinguish between 
telomeres synthesized during either leading or lagging strand synthesis [1].  Using this 
technique, it is possible to identify telomere based fusions and differentiate between 
telomere-double-strand break fusions and telomere-telomere fusions, at end-points that 
were formerly impossible using traditional FISH [14].           
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Here, we investigate the roles played by specific SNPs within the Prkdc allele and 
appropriate DNA-PKcs function in conserving genomic stability.  The impact of variant 
forms of the Prkdc allele on DNA-PKcs protein function and therefore, chromosome 
stability, telomere-uncapping and NHEJ dysfunction was evaluated in a variety of mouse 
cell lines possessing different Prkdc allele variants.   
The C57BL/6 murine cell line was used as a positive control for the ‘wild-type’ 
Prkdc allele and genetic background.  The murine severe combined immunnodeficient 
(SCID) cell line served as a negative control for DNA-PKcs function (null).  The murine 
SCID cell line is homozygous for a functionally null form of the DNA-PKcs protein 
resulting from a T-to-A transversion mutation, creating an tyrosine to an ochre stop 
codon (UAA) conversion in the C-terminus (Y4045X) and the loss of the final 88 amino 
acids [15-17].  Although the SCID Prkdc allele is stably expressed and the essential 
phosphatidylinositol 3-related-kinase (PIKK) motifs are conserved, the translated protein 
is less abundant within SCID cells compared to the common C57BL/6 mouse [17].  This 
indicates the reduction in the level of DNA-PKcs protein in SCID cells is the result of a 
posttranscriptional or posttranslational defect.  The truncated form of DNA-PKcs is 
paired with reduced kinase activity, though it is not known whether it is a consequence of 
lowered protein levels or loss of kinase function. As a consequence, the truncated DNA-
PKcs variant in SCID cells is defective in NHEJ function and telomere end-capping, 
resulting in the significant increase of cytogenetically visible telomere-telomere and 
telomere-DSB fusions [2, 14].  
The BALB/c cell line contains two single-nucleotide polymorphisms (SNPs) 
within the Prkdc allele; one in the phosphatidylinositol 3’ kinase-related kinase domain 
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and the other in the protein-interacting leucine zipper domain [18-20].  The A-to-G 
transition creates a SNP within the Prkdc kinase domain in exon 81, codon 3844 results 
in an amino acid conversion from methionine to valine (M3844V), potentially impacting 
the kinase activity of the DNA-PKcs protein [20].  The leucine zipper domain possesses a 
SNP resulting from a C-to-T base transition in exon 48, codon 2140, resulting in an 
arginine to cysteine amino acid conversion (R2140C).  The leucine zipper domain 
influences protein interactions with DNA and protein substrates [21].  In regards to the 
BALB/c murine strain, it has been proposed the IR sensitivity and susceptibility to 
carcinogenesis may be connected to the SNP in the leucine zipper (R2140C) of the Prkdc 
allele; impacting its ability to interact with specific proteins, DNA and potentially 
accurate tertiary structure [20].  Cumulatively, the SNPs within the BALB/c cell line 
Prkdc gene results in the significant elevation in chromosome aberrations as the result of 
telomere and DSB-based fusions in response to low-doses of low LET γ-ray irradiation 
[14, 18-20, 22].  As in SCID cells, the expression level of the Prkdc allele in BALB/c 
cells is normal but levels of the DNA-PKcs protein is reduced along with the 
corresponding kinase function [20].   
In an effort to determine if the IR-induced instability phenotypes observed in the 
BALB/c mouse result from the SNPs in the Prkdc domains or more from the BALB/c 
background itself, we generated two congenic mouse strains containing the different 
Prkdc alleles on either a C57BL/6 (wild-type) or BALB/c background.  In the case of the 
C.B6-PrkdcB6 (C.B6) congenic mouse, the wild-type Prkdc allele (C57BL/6) control was 
crossed onto a BALB/c background [3].  Conversely, the B6.C-PrkdcBALB (B6.C) mouse 
contains the BALB/c Prkdc allele crossed onto the C57BL/6 background [3].  We also 
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utilized cells derived from the inbred LEWES/EiJ (LEWES) mouse strain, containing 
only the BALB/c SNP within the Prkdc alleles PIKK domain (M3844V) [23].  DNA-
repair capabilities and telomeric end-capping function in the various mouse cell lines 
possessing variant forms of the Prkdc allele were determined by CO-FISH analysis to 
identify the impact of the various SNPs and their corresponding domain(s) (Figure 1).  
We provide additional evidence that supports SNPs in specific Prkdc domains have 
consequences in telomere capping efficiency, opposed to the genetic background on 
which it exists.  Further, we provide the first evidence that suggests an essential role for 
the Prkdc leucine zipper domain in accurate DNA-PKcs-mediated end-capping.    
2.2.0 Results 
2.2.1 BALB/c and SCID mouse cell lines display major chromosome instability 
phenotypes. 
C57BL/6 mice possess the common Prkdc allele.  SCID mice contain a truncated, 
functionally ‘null’ form of DNA-PKcs (significantly lower protein levels and activity 
[18]), whereas BALB/c express a variant form of DNA-PKcs protein owing to Prkdc 
SNPs within the leucine zipper domain (R2140C) and the PIKK domain (M3844V).  CO-
FISH analysis of BALB/c and SCID cell lines following 0 and 1 Gy γ-ray irradiation 
showed a significant increase in telomere uncapping phenotypes (telomere-DSB fusions) 
compared to the C57BL/6 wild-type control (p < 0.05) (Figure 2).  These results are 
consistent with previous reports regarding telomere end-capping failure and DSB-repair 
via NHEJ in both cell lines as a result of the variant Prkdc allele present in each cell type 




2.2.2  Role of BALB/c Prkdc SNPs in dealing with DNA ends 
 
Congenic Mouse Strains and Telomere Integrity 
Following 1 Gy γ-ray irradiation and CO-FISH analysis, our control C57BL/6 cell 
line responded with statistically insignificant increases in DSB-telomere fusions over the 
unirradiated population of C57BL/6 cells (p > 0.05).  The implication of the control study 
is that the common Prkdc allele on the C57BL/6 background is sufficient for maintaining 
genomic stability by NHEJ function and telomere end-capping.  The congenic C.B6 cell 
line contains the common Prkdc allele (as in C57BL/6), on a BALB/c background.  
Under non-irradiated conditions, C.B6 telomere-based fusions resemble the C57BL/6 
background.   Following 1 Gy γ-ray irradiation, the frequency of telomere-DSB fusions 
did not significantly increase over the non-irradiated C.B6 population, resembling the 
frequency observed in C57BL/6 1 Gy irradiated cells (p > 0.05).  Based on these 
observations, we conclude that the C.B6 cell line responds to radiation-induced DSBs in 
similar fashion as the C57BL/6 cell line, suggesting it is the Prkdc allele, not the mouse 
background that influences the cells ability to maintain functional, capped telomeres and 
accurately repair DSBs. 
CO-FISH analysis of telomere stability and function in the B6.C congenic cell 
line (BALB/c Prkdc allele) showed a significant elevation in telomere-DSB fusion 
frequencies over the C57BL/6 controls (p > 0.05) (Figure 3).  The increased background 
frequency in the B6.C cell line is remarkably similar to that observed in the BALB/c cell 
line background.  In addition, 1 Gy γ-ray irradiation resulted in a significant increase in 
the frequency of telomere-DBS fusions over non-irradiated B6.C cells (p < 0.001).  
Interestingly, the frequency of telomere-DSB fusions in irradiated B6.C did not 
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significantly differ from that observed in irradiated BALB/c cells (Figure 3).  
Cumulatively, we conclude the Prkdc alleles in the congenic cell lines are the 
determining factor for DNA-PKcs-dependent telomere stability, not mouse genetic the 
background in which they reside (Figure 3).   
2.2.3  LEWES cell line efficiently repairs DSBs and maintains capped telomeres. 
Next, we questioned whether both of the BALB/c SNPs are responsible for the 
DNA-PKcs-dependent genome instability phenotypes, or, there is a separation of function 
between each.  The recently derived LEWES mouse (on a novel background) contains 
only the BALB/c SNP in the Prkdc PIKK domain (M3844V) and therefore, provided a 
practical means of addressing this question.   
CO-FISH analysis of the LEWES mouse  cell line (PIKK SNP (M3844V)) 
revealed a frequency of telomere-DSB fusions not significantly different from telomere-
DSB fusion frequencies observed in the C57BL/6 cell line, possessing the wild-type 
Prkdc allele (with or without IR (p > 0.05)) (Figure 4 [23]).  In addition, we observed no 
statistically significant difference in telomere-DSB fusions between LEWES cells treated 
with IR and those which were not (p > 0.05) (Figure 4 [23]).  Based on these findings, we 
conclude that the Prkdc SNP within the PI3-K domain (M3844V) does not play a critical 
role in telomere end-capping, suggesting that the SNP residing within the leucine zipper 
domain of the Prkdc allele (R2140C) is critical to the appropriate function of DNA-PKcs 
at the telomere.  However, we are not able to rule out the possibility that it is the 
combination of the PIKK and leucine zipper Prkdc SNPs that result in the telomere 




2.3.0  Discussion: 
2.3.1  The leucine zipper domain is essential for DNA-PKcs-dependent telomere end-
capping 
To investigate the role of DNA-PKcs in telomere end-capping and classical 
NHEJ-mediated DNA-repair, we analyzed multiple cell lines containing various Prkdc 
alleles crossed onto various mouse genomic backgrounds; distinguishing DNA-PKcs 
variants from the mouse cell background in telomere end-capping.  Further, we 
determined the impact of specific SNPs within the Prkdc allele have on DNA-PKcs 
function in telomere end-capping.  CO-FISH analysis facilitated accurate identification of 
telomere-DSB fusions in each cell line, both in non-irradiated populations and those 
exposed to 1 Gy γ-rays. 
Over the course of our investigation, murine C57BL/6 cell line was used as the 
‘wild-type’ regarding both the Prkdc allele and cell background for comparison.  Other 
cell lines that were generated and/or selected contained a unique variant of the Prkdc 
allele, in order to improve understanding of the role played by each functional domain 
within the DNA-PKcs protein.  The murine cell lines investigated included:  SCID, which 
harbors an early stop codon at amino acid position 4045 in the Prkdc allele rendering a 
functionally null DNA-PKcs phenotype [15-17]; BALB/c, which has two SNPs within 
Prkdc (PIKK domain (M3844V)) and the leucine zipper domain (R2140C)) [18-20]; 
congenics C.B6 and B6.C with the common C57BL/6 Prkdc allele on a BALB/c 
background and the BALB/c Prkdc allele on the common C57BL/6 background 
respectively [3]; LEWES containing only one of the BALB/c Prkdc SNPs, M3844V in 
the PIKK domain [23].   
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Consistent with prior findings, SCID and BALB/c cell lines each maintained a 
high background level of chromosome aberrations, specifically telomere-based fusions.  
In addition to high background levels of telomere-telomere fusions following IR 
exposure [2], uncapped telomeres in SCID cells experienced inappropriate fusion with 
DSBs (telomere-DSB fusions) as observed in previous studies [2, 14].  For this reason, 
SCID cells serve as an appropriate positive control for DNA-PKcs protein deficiency 
phenotypes.  Although BALB/c cells do not maintain a telomere instability phenotype as 
robust in nature as SCID, the dual SNPs within the BALB/c Prkdc allele produces 
reduced levels of a variant form of the DNA-PKcs protein (compared to the C57BL/6 
control) resulting in significantly elevated telomere-DSB chromosome fusion frequencies 
compared to the common C57BL/6 Prkdc allele under irradiated and non-irradiated 
conditions.  The purpose of the current study was to investigate individual domains of the 
Prkdc allele that are critical for the expression of a functional DNA-PKcs protein capable 
of effective telomere end-capping.  The BALB/c mouse model provides a valuable 
resource in this regard, as it possesses two SNPs in Prkdc, in separate domains, which are 
necessary for accurate DNA-PKcs-mediated end-joining of DSBs and telomere end-
capping; the PIKK domain (M3844V) and the leucine zipper domain (R2140C) [18-20]. 
To date, we have evidence that the Prkdc allele variant carried by BALB/c results 
in DNA-PKcs deficiency, contributing to the telomere uncapping and mis-joining of 
uncapped telomeres and DSBs generated by exposure to IR.  To further support this 
supposition, we used two recently generated congenic mice: one containing the BALB/c 
Prkdc allele on the common C57BL/6 background (B6.C) in one case, or the converse, 
containing the common C57BL/6 allele on the BALB/c background (C.B6).  CO-FISH 
43 
 
analysis of metaphase spreads in each case paralleled the trends for chromosome fusions 
observed in the cell line containing the respective Prkdc allele.  This particular finding 
indicates it is in fact the Prkdc allele that impacts mammalian telomere stability, and 
therefore chromosome stability.  
The LEWES mouse carries only one of the SNPs within the BALB/c variant 
Prkdc allele, residing in the PIKK domain (M3844V) [23].  Interestingly, cells derived 
from the LEWES mouse did not show significantly elevated levels of telomere-DSB 
fusions whether exposed to IR or not, indicating that telomeres are accurately capped.  
These results suggest the presence of a functional form of DNA-PKcs despite the single 
Prkdc SNP in the LEWES mouse.  At the telomere end, only one molecule of DNA-PKcs 
is thought to be present and therefore, autophosphorylation in trans- as it likely occurs in 
NHEJ at DSB ends is not likely at the telomere [24].   
SNPs and DNA-PKcs Autophosphorylation at Telomere  
Importantly, our studies using the LEWES mouse demonstrates the SNP in the 
PIKK domain of the Prkdc allele (M3844V) alone is not responsible for the telomere 
end-capping dysfunction phenotypes observed in the BALB/c mouse.  However, it is 
important to recognize the extent to which this particular SNP impacts the kinase 
function of the variant DNA-PKcs produced is unknown [18, 20, 25]; i.e. reduced DNA-
PKcs kinase activity in BALB/c may be the consequence of the PIKK SNP (M3844V) 
and/or lower protein levels.  It has been previously shown that DNA-PKcs 
autophosphorylation at residue Thr-2609 is necessary for accurate telomere capping [22].  
We speculate that the SNP in the Prkdc PIKK domain (M3844V) does impact kinase 
activity, so autophosphoryation in cis- would be less frequent and result in less efficient 
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end-capping.  However, previous studies have demonstrated DNA-PKcs phosphorylation 
at the Thr-2609 residue can be performed by ATM following irradiation [26].  In 
C57BL/6 and BALB/c mice, Atm protein levels and kinase activity are readily 
detectable; whereas cells derived from SCID show little Atm protein and activity [27].  
Thus, the activity of Atm (not the intrinsic kinase activity of DNA-PKcs alone) may 
contribute to the phosphorylation of DNA-PKcs at Thr-2609 and enable DNA-PKcs end-
capping function.  This would explain the more severe telomere uncapping phenotypes 
observed in SCID mice compared to BALB/c despite reduced DNA-PKcs protein levels 
and kinase activity in each. However, it is doubtful that the SNP residing in the PIKK 
domain results in a kinase dead form of DNA-PKcs; if this were the case the LEWES cell 
line would be expected to resemble SCID phenotypes.  We therefore suggest the leucine 
zipper domain plays a critical role in the ability for DNA-PKcs to interact with relevant 
telomere components, perhaps by inducing conformational changes that are necessary to 
maintain an essential degree of autophosphorylation capability in cis-. 
At first glance, the generation of telomere-DSB fusions in cells derived from mice 
containing the Prkdc PIKK domain SNP (M3844V) seems counterintuitive, as it could 
inhibit DNA-PK-mediated NHEJ by influencing the kinase activity of DNA-PKcs and 
challenge the ability for the necessary autophosphorylation events to occur in trans- at 
the DSB synapse.  To explain this phenomenon, we examined SCID cells that are 
effectively ‘null’ for DNA-PKcs and experience significantly high frequencies of 
telomere-based fusions (compared to the C57BL/6 wild-type) [22].  Telomere-DSB 
fusions have been identified by prior reports that observe telomere fusions arising from 
DNA-PKcs deficient, uncapped telomeres, which require DNA-ligase IV for NHEJ [28].  
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In addition, it is not known to what extent, if at all, the PIKK SNP impacts kinase 
function in the respective cell lines; lowered kinase activity may be the consequence of 
lower DNA-PKcs protein expression levels in the LEWES cell line (compared to 
C57BL/6) (data not shown).  Previous reports show mRNA expression of the Prkdc allele 
does not significantly differ between BALB/c and C57BL/6 cell lines [18].  However, 
protein expression does differ significantly, indicating that either BALB/c Prkdc SNP 
(M3844V or R2140C) may lead to the destabilization of the DNA-PKcs protein 
following mRNA translation [18].   
Ultimately, we find that with and without IR exposure, the congenic mouse cells 
reflect the telomere end-capping phenotypes associated with the respective Prkdc donor 
allele (C57BL/6 or BALB/c).  Therefore, the telomere instability phenotype of BALB/c 
results from the variant DNA-PKcs, not the mouse genetic background.  Further, cells 
derived from the LEWES mouse reveal telomere-DSB fusions at frequencies similar to 
those observed in the C57BL/6 line, containing the wild-type Prkdc allele.  Based on 
these findings, we reason the BALB/c SNP within the PIKK domain does not affect 
DNA-PKcs-dependent telomere end-capping.  Rather, the SNP within the leucine zipper 
domain (R2140C) contributes to the reactive, uncapped telomere phenotype observed in 
the BALB/c mouse, indicating that this domain is required for effective DNA-PKcs-
mediated telomere end-capping.   
We speculate that the SNP within the PIKK domain maintains a degree of 
functionality and thus does not resemble the DNA-PKcs null SCID phenotype.  LEWES 
maintains a higher intracellular level of the DNA-PKcs protein and is more capable to 
perform telomere capping function as compared to BALB/c.  Perhaps the combination of 
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the SNPs in BALB/c results in a reduced DNA-PKcs protein half life, stemming from an 
unknown biochemical mechanism.  The increased level of DNA-PKcs protein in LEWES 
as compared to BALB/c argues the LEWES DNA-PKcs variant possessing only the 
PIKK Prkdc SNP (M3844V) is more stable than the BALB/c DNA-PKcs variant 
containing Prkdc SNPs in both the PIKK domain (M3844V) and the leucine zipper 
domain (R2140C).  As the result of expressing a DNA-PKcs variant with a longer half-
life, LEWES maintains a higher capacity for DNA-PKcs-mediated telomere end-capping, 
less chromosomal instability and thus, resembles the wild-type C57BL/6 mouse.  
2.4.0  Materials and Methods            
Irradiations 
 Irradiations were performed at a dose rate of 3.9Gy/min using a sealed-source 
Mark I 137Cs -ray irradiator (J.L. Shepherd and Associates), located at Colorado State 
University, Department of Environmental and Radiological Health Sciences.       
Generation of the C.B6 and B6.C congenic strains by marker-assisted “speed” congenics  
Two novel strains of congenic mice were generated by a combination of 
conventional and marker-assisted backcrossing [29].  The C.B6-PrkdcB6 congenic strain 
(C.B6) possesses the common allele of Prkdc (PrkdcB6), introgressed onto a BALB/c 
background. Conversely, the B6.C-PrkdcBALB congenic strain (B6.C) contains the 
BALB/c allele (PrkdcBALB) introgressed onto a resistant strain background (C57BL/6) 
[23]. 
Genotyping 
The PCR restriction fragment length polymorphism (RFLP) method was used to 
genotype all mouse strains.  The R2140C SNP located downstream of the leucine zipper 
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abolishes a BsmB1 site while the M3844V SNP in the kinase domain creates a novel 
Hph1 site.  PCR primers were designed to flank the SNP loci and sequences amplified 
using Taq polymerase (Invitrogen; Taq DNA polymerase, Recombinant 10342-020).  
Primer sequences used are: exon48 (PKF-GCCTAAGGTAAGGTGCTGTA & PKR-
GCCATGATCCTTAGCAAGTG) and exon81 (81F-ATGTTCTTTGCCATGCAGT 
AND 81R-TTCTTCCCTCCCTTCTCAGTA).  The PCR products were digested with 
BsmB1 or Hph1 and were compared against known size samples by electrophoresis 
through a 2% or 3% agarose gel [23].     
Sequencing 
 The entire coding region of the LEWES Prkdc gene was sequenced and compared 
to C57BL/6 and BALB/c sequences obtained from the Ensemble and NCBI databases 
(http://www.ensembl.org/index.html and 
http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccoreandid=124517705).  A total 
of 19 PCR primer sets were designed using the Primer3 website 
(http://frodo.wi.mit.edu/cgi-bin/primer3/primer3_www.cgi) (sequences to primers in 
supplementary methods).  The amplified products were purified and sequenced [23].   
Chromosome-Orientation Fluorescence in situ hybridization (CO-FISH)    
Following irradiation, cell cultures were incubated for various times, trypinsized 
and sub-cultured into 5’-bromo-2’-deoxyuridine (BrdU) for one cell cycle; colcemid (0.1 
µg/ml; Gibco) was added during the final 3-4 hours to accumulate mitotic figures, which 
were collected and processed for telomere CO-FISH as previously described with some 
modification [7, 30].  Briefly, samples were fixed in 3:1 methanol/acetic acid and 
dropped onto microscope slides, which were dried and treated with RNase A (100 µg/ml; 
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Sigma, 10 min at 37oC), rinsed in PBS, fixed in 1% formaldehyde (10 minutes at room 
temperature), rinsed in PBS, then dehydrated through a cold ethanol series (75%, 85% 
and 100%).  Slides were air dried and stained with Hoechst 33258 (0.5ng/μl; Fischer) for 
15 minutes and exposed to 365 nm UV light (Stratalinker 2400) for 25 minutes.  
Following UV exposure, BrdU incorporated stands were digested with Exonuclease III 
(2U/μl in provided reaction buffer; Promega) at room temperature for 10 minutes.  Slides 
were rinsed and denatured briefly in 70% formamide at 75˚C for 1 minute and 15 
seconds.  Following an additional ethanol dehydration and air drying, a Cy-3 conjugated 
(TTAGGG)3 PNA telomere probe (0.2μg/ml; Applied Biosystems) was hybridized at 
37˚C for 1.5 hrs.  Slides were rinsed in 70% formamide at 32˚C for 10 minutes and 
dehydrated in ethanol series before re-probing at 37˚C for two hours.  Following the 
second hybridization, slides were rinsed with 70% formamide at 32˚C for 15 minutes 
followed by a 5 min rinse in PN Buffer.  Chromosomes were counterstained with DAPI 
(4,6-Diamidine-2-phenylindole dihydrochloride; Vectashield with DAPI, Vector 
Laboratories). 
Statistical Analysis 
 Metaphases were scored (n = 25) and statistical significance was determined via 
an unpaired t-test comparing to means to generate a p-value.  Results were considered to 
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3.1.0 Introduction: 
3.1.1 Telomeres are regulated by the Shelterin complex 
Mammalian telomere stability requires an impressive variety of proteins, the core 
members of which are referred to as ‘Shelterin’, and are involved in telomere length 
regulation and end-capping function (reviewed in [1]).  The Shelterin complex consists of 
the telomere repeat binding factors 1 and 2 (TRF1 and TRF2), TRF1 and TRF2 
Interacting Nuclear Protein 2 (TIN2), Repressor/Activator Protein 1 (Rap1 (human 
ortholog)), Tripeptidyl-peptidase 1 (TPP1) and Protection of Telomeres 1 POT1 [2]. 
TRF1 & TRF2 regulate telomere length and telomere stability respectively 
TRF and TRF2 directly bind double-stranded telomeric sequences (TTAGGG) as 
homodimers and form complexes with additional proteins to create the TRF1 and TRF2 
complexes [1].  Each telomere repeat factor complex (TRF1 and TRF2) has a particular 
role in preserving the function of the telomere in protecting the end of the chromosome.  
The primary role of TRF1 is in telomere length regulation, whereas TRF2 is critical for 
telomere end-capping [3-7].  Prior studies have provided evidence of TRF1 involvement 
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in regulation of telomerase access in telomerase positive cell lines.  TRF1 dissociation 
from the telomere is linked to providing accessibility to telomerase for telomere 
elongation, therefore TRF1 is considered a negative regulator of telomere length [3].  
TRF2 is required to maintain end-capping, as depletion of TRF2 results in uncapped 
telomeres capable of fusing to each other or to double-stranded breaks (DSBs).  Such 
fusions are mediated by non-homologous end-joining (NHEJ) DNA-repair [7] and are 
cytogenetically visible as telomere-double strand break and telomere-telomere fusions [8, 
9].  Cumulatively, chromosome (and chromatid) fusions are hallmarks of instability and 
carcinogenic potential, resulting from errors in end-joining repair processes and/or 
telomere uncapping (reviewed in [10]).       
3.1.2 Tankyrase 1 negatively regulates TRF1 
TRF1 is recognized as a key regulator of telomere length and so, TRF1 
dysfunction results in the loss of appropriate telomere length regulation [5, 6].  TRF1 
function relies on ‘TRF1-associated’ proteins as well, which are vital in the appropriate 
regulation of TRF1 in complex with the telomere.  One of the ‘TRF1-associated’ 
shelterin accessory proteins is tankyrase 1, and more indirectly, tankyrase 2 [1, 11, 12].  
Tankyrase 1 plays a crucial role in the regulation of TRF1 by mediating the ability of 
TRF1 to interact with telomeric-DNA.  This is achieved by tankyrase 1-dependent 
poly(ADP-ribosyl)ation (pADPr/PAR) modification of TRF1, resulting in dissociation of 
the homodimer from the telomere [13, 14].  However, there are reports that telomere 
elongation can occur in the absence of fully functional tankyrase 1 and TRF1 
PARsylation [15].   Disruption of tankyrase 1 dynamics following siRNA-mediated 
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depletion of tankyrase 1 was shown to influence telomere stability and functionality, 
resulting in sister chromatid telomere fusions [16].   
In telomerase-positive cells, tankyrase 1-dependent release of TRF1 from the 
telomere facilitates telomerase access and telomere elongation [1, 17].  TRF1 dissociation 
occurs as the result of tankyrase 1-meidiated PARsylation of TRF1 at a RXXADG motif, 
a modification that causes the homodimer to dissociate from telomeric DNA [17, 18].  
Following PARsylation and dissociation from the telomere, TRF1 is tagged by an E3 
ligase for proteasome-mediated degradation, generally by the addition of ubiquitin[19].  
However, there is also evidence of TRF1 degradation occuring as the result of 
sumoylation and F-box protein, Fbx4 modifications [14, 20, 21].  Regardless of the 
mechanism by which TFR1 is degraded, tankyrase 1 is specifically tasked with removal 
of TRF1 from the telomere.  Thus, tankyrase 1 is regarded as a negative regulator of 
TRF1 regarding telomere interaction and so, is also recognized as a positive regulator of 
telomere length in telomerase positive cells.  Contradictory to this dogma, studies have 
shown that in some cell lines, failure to dissociate TRF1 from the telomere does not lead 
to critically shortened telomeres as would be expected [15].    
3.1.3  Tankyrase 1 dysfunction results in reactive telomeres 
Although the role of tankyrase 1 in TRF1 regulation inevitably has an impact on 
accurate telomere function, studies seek to further investigate the function of tankyrase 1 
at the telomere.  siRNA studies targeting tankrase 1 have yielded a wealth of interesting 
findings.  One such study found certain cell types, including HeLa, respond to the 
depletion of tankyrase 1 by arresting the cell cycle in mitosis and ultimately, cell death 
[22].  The conclusion was that cells fail to dissociate sister-chromatid telomeres in a 
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tankyrase 1-dependent fashion, either by failure to dissociate TRF1 or cohesion 
complexes.  These were amongst the first findings to identify tankyrase 1 as a critical 
protein in cell viability and a critical asset to appropriate cell cycle regulation.  Additional 
experiments have identified a potential explanation for the cell cycle arrest upon the loss 
of tankyrase 1 function.  In an effort to observe telomere malfunction beginning in S-
phase and persisting through G2 in tankyrase 1 knockdown cells, chromosomes were 
analyzed via fluorescent in situ Hybridization (FISH).  The result was a significant 
increase in cytogenetically visible sister chromatid-fusions of two varieties:  cohesion-
based protein interactions and sister chromatid telomere-fusions ([16]).  Cohesion 
complexes aid to reduce the need for persistent decatenation of the sister chromatids in S-
phase, throughout G2 and into mitosis [23].  Further, cohesion protein Smc1 has been 
shown to be necessary in the downstream signaling of the intra-S phase cell cycle 
checkpoint [24].  These results suggest that tankyrase 1, by an as yet unknown 
mechanism, is required for the dissociation of the Smc1/Scc1/Scc3 cohesion complex 
(SA1) between the newly replicated chromatids in late S/early G2 phase [16[25]; 
telomeres remain in close proximity in a TRF1/TIN2/SA1-dependent fashion following 
S-phase and ensuing end-joining events results in sister chromatid fusions between the 
uncapped telomeres.  Further, it is speculated tankyrase 1 cohesion release is necessary 
for exonuclease access for 3’-end resection and T-loop formation[16].   
Such observations provide supporting evidence for tankyrase 1-dependent 
telomere function in S-phase.  When lacking tankyrase 1, telomeres fail to become 
properly capped in G2 (following replication) and so serve as substrates for telomere-
telomere fusions via a Ligase IV-dependent NHEJ event.  The resulting anaphase bridges 
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are lethal in some cell lines (e.g., HeLa), whereas other cells progress through the cell 
cycle accumulating cytogenetically visible damage, possibly the result of anaphase bridge 
resolution by breakage.  Therefore, loss of tankyrase 1 results in persistent chromatid 
association, and in telomere ends not being properly capped, resulting in NHEJ-mediated 
sister chromatid-fusions, subsequent anaphase bridges and ultimately, lethality [16].  
Here we report the identification of five key aspects of intracellular tankyrase 1 
function.  First, we find tankyrase 1 to be critical in preventing telomeric recombination 
between sister-chromatids (T-SCEs).  Second, tankyrase 1 depletion is associated with 
genomic instability phenotypes, resulting in increased cell killing and mutagenesis 
following ionizing radiation (IR) exposure.  Third, tankyrase 1 depletion mirrors DNA-
dependent Protein Kinase catalytic subunit (DNA-PKcs) deficiency phenotypes in that 
telomeres become uncapped and end-joining becomes impaired, significantly increasing 
the frequency of cytogenetically visible terminal deletions and telomere-DSB fusions 
following treatment with IR compared to controls.  Fourth, increased mutation 
frequencies following IR exposure under conditions of DNA-PKcs inhibition and 
tankyrase 1 knockdown positively correlate with one another.  Lastly, we demonstrated 
that DNA-PKcs protein stability is dependent on the tankyrase 1 protein.  Taken together, 
we establish the requirement for tankyrase 1 for the regulation of telomere stability, as 
well as provide the first evidence for an indirect role of tankyrase 1 in maintaining cell 
wide genomic stability as a regulator of the DNA-repair protein, DNA-dependent Protein 





3.2.1 Tankyrase 1 regulates telomere stability 
Tankyrase 1 depletion has been shown to result in dysfunctional, uncapped 
telomeres that are prone to sister chromatid-fusions [16].  We aim to determine the 
consequences of misregulated TRF1 under tankyrase 1 depleted conditions with regards 
to telomere stability during DNA replication.  Using Chromosome Orientation In Situ 
Hybridization (CO-FISH), we distinguished telomeres synthesized by leading strand vs. 
lagging strand  synthesis [26].  To rule out a role for telomerase under tankyrase 1 
knockdown conditions, we selected cell lines with a telomerase negative background:  Li 
Fraumani (ALT) and normal human fibroblasts (5C).  T-SCE frequencies were 
determined and compared to those of the telomerase positive BJ-hTERT cell line.  Using 
CO-FISH, we visualized telomeres in a strand specific manner.  This approach allows for 
detection of recombination events within/between telomeric repeats, specifically, we 
monitored telomere-sister chromatid exchanges (T-SCE) [26, 27]. 
Tankyrase 1 siRNA knockdown was achieved in each cell line with multiple 
siRNA constructs.  Of these, two siRNA constructs that effectively reduced tankyrase 1 
levels to <1% relative to the mock transfected control (detected by horseradish 
peroxidase) were selected (Figure 1 [25]).  All siRNA-mediated tankyrase 1 knockdown 
tankyrase 1 studies were performed using siRNA construct “siRNA1”.   
Tankyrase 1 depletion elevates T-SCE frequencies 
Following lipofectamine siRNA transfection and successful tankyrase 1 
knockdown, cells were incubated in bromodeoxyuridine (BrdU) for one cell cycle.  
Metaphases were collected from mitotic cells and analyzed by CO-FISH and scored for 
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T-SCEs.  Consistently, T-SCEs were significantly elevated in the telomerase negative 
background of Li Fraumeni and 5c fibroblasts (background T-SCE levels vary between 
cell lines).  However, the BJ-hTERT telomerase positive cell line did not show an 
increase in T-SCEs following tankyrase 1 knockdown (Figure 2 [28]).  These findings are 
in agreement with those showing increased T-SCE frequencies as the result of stalled 
replication-forks within the telomere in WRN and BLM helicase deficient cells under 
siRNA-depleted telomerase conditions, where no effect was observed in telomerase 
positive cell lines [29].   
Furthermore, tankyrase 1 knockdown did influence the frequency of genomic 
sister chromatid exchanges (G-SCE) compared to mock transfection controls, similar to 
the trend observed in WRN deficient, telomerase negative cells [29].  This finding further 
supports the notion of the critical and specific roles played by tankyrase 1 at the telomere, 
not in chromatin structure or modeling dynamics throughout the genome.  As a regulator 
of the association of TRF1 with telomeric DNA, tankyrase 1 is necessary for replication 
fork progression through the telomere, as TRF1 (and TRF2) have been shown to 
block/stall replication forks [6, 7, 30-32].  
3.2.2 Tankyrase 1 maintains genomic stability 
Tankyrase 1 knockdown results in increased IR sensitivity & mutagenesis. 
Given the prominent telomere instability phenotypes resulting from the depletion 
of tankyrase 1 (T-SCEs and sister chromatid telomere-fusions [16]), we next questioned 
whether tankyrase 1 plays a role in genomic stability.  To investigate the influence of 
tankyrase 1 on genome stability, we examined the impact of tankyrase 1 knockdown on 
cell survival and mutagenesis following exposure to ionizing radiation (IR).  Under 
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tankyrase 1 siRNA knockdown conditions, double-stranded breaks (DSBs) were induced 
using γ-ray irradiation with doses ranging from 0-8 Gy and cell survival was determined 
using clonogenic assays in human dermal fibroblasts (5C) and Li Fraumeni cell lines 
(Figure 3 [25]).  Somewhat to our surprise, tankyrase 1 depletion did in fact reduce cell 
survival following IR treatment over the range of doses (Figure 3 [28]).   
Human lymphoblasts (WTK1) were also treated with the broad-range PARP 
inhibitor 3-aminobenzamide (3-AB), tankyrase 1 siRNA or a combination of the 
treatments (3AB + siRNA) and irradiated with 1.5 Gy γ-ray IR at 18 hours post 
treatment.  An increase in mutation frequencies (MF) (measured at the thymidine kinase 
locus) under either tankyrase 1 knockdown conditions or 3-AB treatment would provide 
additional evidence for the role of tankyrase 1 in genomic stability. 
In non-irradiated cells, there was no significant impact on MF under conditions of 
tankyrase 1 knockdown (p = 0.24) (Figure 4 [28]).  Cells depleted of tankyrase 1 and 
irradiated with 1.5 Gy γ-rays resulted in a MF 1.5 times higher than that observed in the 
mock transfected irradiated control (p = .002); 3-AB treatment increased the MF 2.5 
times over the respective control (p < 0.001) (Figure 4 [28]).  The combination treatment 
of tankyrase 1 siRNA-mediated knockdown and 3-AB reflected the mutation frequency 
observed in the 3-AB treatment alone (p = 0.48) (Figure 4 [28]).  The increase in MFs as 
a consequence of tankyrase 1 knockdown suggests that the role of tankyrase 1 extends 
beyond the telomere and is perhaps fundamental to maintaining genomic stability.  
Interestingly, treatment with 3-AB resulted in a significant increase in MF (p = 0.004) in 
non-irradiated cells compared to the mock transfected cell population (Figure 4 [28]).  
This result suggests the possibility that tankyrase-specific PARP activity is a necessary 
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element contributing to genomic stability, not just the presence of the tankyrase 1 protein 
alone.  
Tankyrase 1 knockdown results in DNA-PKcs deficiency signatures 
Cytogenetic whole-chromosome analysis of human lymphoblasts (WTK1) with 
CO-FISH revealed a significant increase in terminal deletions in cells depleted of 
tankyrase 1 via siRNA-mediated knockdown and irradiated with 1 Gy low-linear energy 
transfer (LET) γ-rays or high-LET 56Fe ions (1 GeV/n) (compared to mock transfected 
controls) (p < 0.03) (Figure 5 [25]).  Interestingly, all terminal deletions were the product 
of chromosome-type aberrations, indicating the aberrations occurred as a result of 
unrepaired DSBs induced during G1 of the cell cycle.   
Though tankyrase 1 catalytic activity has been identified as a critical factor for the 
appropriate function of substrate proteins such as NuMA [33], identification of a 
tankyrase 1-dependent DNA-repair deficiency is a novel observation.  The nature of the 
chromosome aberration-type observed highlights several important points:  each terminal 
deletion was the product of unrepaired DSBs induced in G1 of the cell cycle, replicated in 
S-phase and is the consequence of deficient NHEJ.  Defective NHEJ processes during G1 
of the cell cycle will produce chromosome-type aberrations such as those observed here.  
These findings suggest defective NHEJ mediated by DNA-dependent Protein Kinase, 
likely resulting in the initiation of ligase IV-dependent NHEJ [34] or activation of the 
slower, error-prone PARP-1-mediated alternative-NHEJ pathway [35].   
The conclusions drawn from our CO-FISH analysis of tankyrase 1 depleted cells 
are suggestive of impaired NHEJ machinery.  To investigate this possibility, we targeted 
the core component of DNA-PK-mediated NHEJ, the DNA-dependent Protein Kinase 
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catalytic subunit (DNA-PKcs).  To achieve this, we blocked DNA-PKcs kinase function 
using the potent inhibitor Nu7026 (Figure 5, DNA-PKcs I [28]).  In support of our 
speculation regarding DNA-PK-mediated NHEJ deficiency as a possible mechanism  for 
the production of terminal deletions, Nu7026 inhibition coupled with 1 Gy γ-ray or 1 
GeV/n 56Fe ion irradiation produced chromosome-type terminal deletions; these 
frequencies did not significantly differ from those observed during tankyrase 1 
knockdown conditions (p>0.76) (Figure 5 [25]).  Further, the combination of Nu7026 and 
tankyrase 1 knockdown did not produce terminal deletion frequencies that significantly 
differed from tankyrase 1 knockdown alone (p >0.18) (Figure 5 [28]). 
Cytogenetic analysis revealed tankyrase 1 knockdown is coupled with additional 
chromosome-type aberrations that are generally the result of telomere uncapping, 
telomere-DSB fusions.  To date, tankyrase 1 is not known to have a role in telomere 
capping during G1 of the cell cycle.  CO-FISH analysis determined there was no 
significant change in telomere-DSB fusions with tankyrase 1 knockdown alone.  
However, γ-ray irradiated cells revealed a 3-fold increase in telomere-DSB fusions over 
mock transfected and unirradiated controls; whereas HZE 1 GeV/n 56Fe irradiation 
increased the frequency of telomere-DSB fusions 2 fold (p = .023 and p = 0.14 
respectively) (Figure 6 [25]).  Consistent with the terminal deletion data, the observed 
instability phenotypes are not typical of inadequate tankyrase 1 function at the telomere.  
Interestingly, both uncapped telomeres and chromosome-based aberrations resulting from 
ineffective NHEJ are each hallmarks of DNA-PKcs dysfunction [34, 36-40].  Supporting 
this supposition, treatment with the DNA-PK inhibitor NU7026 (DNA-PKcs I), resulted 
in telomere-DSB fusion frequencies that parallel those observed in tankyrase 1 
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knockdown, irradiated cells (p = 0.023).  The combination of tankyrase 1 knockdown and 
Nu7026 inhibition yielded telomere-DSB fusion frequencies similar to those seen in the 
Nu7026 treatment alone (p < 0.023) (Figure 6 [25]). 
The connection between tankyrase 1 deficiency and decreased cell survival, 
increased mutagenesis, combined with the cytogenetically visible phenotypes that 
resemble DNA-PKcs-deficiencies provides sufficient evidence to further investigate the 
tie between tankyrase 1 deficiency and mis-regulated end-joining DNA-repair 
phenotypes.  To achieve this goal, we ask whether MFs under conditions in which DNA-
PKcs is depleted or inhibited correlates with the MF during tankyrase 1 knockdown.  
Consistent with our prior studies, siRNA-mediated DNA-PKcs knockdown and DNA-
PKcs inhibition (via Nu7026) resulted in MFs that positively correlate with those 
observed in tankyrase 1 knockdown (Figure 7 [28]).  Having consistently established a 
positive correlation between tankyrase 1 deficiency and DNA-PKcs depletion across 
multiple cell lines and multiple genomic instability end-points, we speculate tankyrase 1 
was not directly inducing genomic instability.  Rather, tankyrase 1 may be indirectly 
involved in DNA-repair as a regulator of the key end-joining protein DNA-PKcs. 
3.2.3 DNA-PKcs stability requires tankyrase 1  
Cytogenetic evidence that both DNA-repair and telomere end-capping 
deficiencies are consequences of tankyrase 1 knockdown, suggests a role for tankyrase 1 
in DNA-repair.  We postulate tankyrase 1 is not directly involved in DNA-repair but 





Tankyrase 1 depletion is coupled with DNA-PKcs protein loss 
To provide evidence for this supposition, we determined the relative level of 
DNA-PK holoenzyme proteins Ku80 and DNA-PKcs at 12, 24 and 48 hours time points 
following tankyrase 1 knockdown (Figure 8 [28]).  Western blot analysis and 
quantification verified knockdown of the tankyrase 1 protein to < 1% of the mock 
transfected control (Figure 8 [28]).  Interestingly, DNA-PKcs was reduced to < 10% 
relative to the mock treatment 12 hours following transfection with tankyrase 1 siRNA.  
Further, the time course of tankyrase 1 protein depletion was coupled with the significant 
reduction of the DNA-PKcs protein (Figure 8 [28]).  Illustrating the intimate relationship, 
tankyrase 1 protein recovery was accompanied by the rapid rebound of DNA-PKcs 
protein levels (data not shown).   
Reciprocal knockdown has no effect on tankyrase 1 
In the interest of determining dynamics of the tankyrase 1-DNA-PKcs protein 
relationship, we preformed the reciprocal knockdown to determine if tankyrase 1 protein 
stability requires the DNA-PKcs protein.  Supporting prior reports [41], DNA-PKcs 
siRNA-mediated knockdown does not result in a reduction of DNA-PKcs protein levels 
until approximately 48 hours (with maximal effect at 72 hours) post siRNA induction 
(Figure 9 [41]).  This finding in itself suggests tankyrase 1 is playing a regulatory role in 
DNA-PKcs protein stability; tankyrase 1 knockdown depletes DNA-PKcs protein levels 
several fold faster than DNA-PKcs targeted siRNA knockdown.  Furthermore, over the 
course of 122 hours following DNA-PKcs siRNA transfection, no negative impact on 
tankyrase 1 protein levels was observed (Figure 9 [28]).  Therefore, we conclude that 
tankyrase 1 regulates DNA-PKcs protein stability by an unknown mechanism.  
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DNA-PKcs related PI3-kinase superfamily members are not impacted by tankyrase 1 
depletion 
Destabilization of phosphatidylinositol 3-kinase-related protein (PIKK) has been 
shown to negatively impact the level of related proteins on a transcriptional level [41].  A 
prime example is the relationship between the PIKK DNA-PKcs and ataxia telangiectasia 
mutated (ATM).  Here, siRNA knockdown of the DNA-PKcs protein was coupled with 
ATM protein depletion.  Further investigation of this relationship demonstrated that 
siRNA-mediated knockdown of DNA-PKcs transcript and subsequent DNA-PKcs protein 
depletion was coupled with down-regulation of ATM gene transcription [41].  Hence, the 
level of the ATM protein was dependent upon the stability of the DNA-PKcs protein 
which appears to regulate the rate of ATM transcription [41].  Due to this relationship, 
we were obligated to investigate the relative mRNA levels of DNA-PKcs following 
tankyrase 1 siRNA-mediated knockdown.  The relative levels of DNA-PKcs and 
tankyrase 1 mRNA were determined via qRT-PCR at various time courses following 
transfection of tankyrase 1 siRNA.   
Concurring with our initial explanation of a posttranslational relationship, qRT-
PCR revealed normal and in some cases, elevated levels of DNA-PKcs mRNA levels in 
response to tankyrase 1 knockdown (Figure 10 [28]).  In addition, we used qRT-PCR 
analysis to validate the specificity of the tankyrase 1 siRNA construct by quantifying the 
relative mRNA levels of the closely related PARP, tankyrase 2; no significant reduction 
of tankyrase 2 mRNA was observed over 48 hours of tankyrase 1 knockdown (Figure 10 
[28]).  Supporting the exclusive nature of the tankyrase 1 and DNA-PKcs protein 
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relationship, ATM protein levels were not affected by tankyrase 1 knockdown and 
concurrent DNA-PKcs protein depletion over a 48 hour time period (Figure 11 [28]).  
Cumulatively these results support a post-translational relationship between 
tankyrase 1 protein levels and DNA-PKcs protein stability.  In an attempt to demonstrate 
a physical and perhaps stable protein-protein interaction, we performed a protein complex 
immunoprecipitation assay (Co-IP) against the DNA-PKcs protein.  Pending a successful 
pull-down of the DNA-PKcs protein in complex with tankyrase 1, this method would 
provide definitive evidence to identify tankyrase 1 as a DNA-PKcs binding partner.  
However, multiple Co-IP attempts failed to demonstrate the existence of a stable, 
physical DNA-PKcs-tankyrase 1 protein complex, suggesting a lack of physical 
interaction between the two.   
3.3.0 Discussion 
3.3.1 Tankyrase 1 depletion increases T-SCE frequencies 
TRF1 remains on telomeres & stalls replication 
Elevated T-SCE frequencies are representative of telomere instability and 
premature aging phenotypes (reviewed in [27]).  In our studies, tankyrase 1 knockdown 
in human cells was characterized by elevated T-SCE frequencies with no significant 
effect on the frequency of G-SCEs, indicating tankyrase 1 serves to regulate 
recombination specifically within telomeres but does not regulate global genomic 
recombination events between sister chromatids.  Telomere recombination in response to 
tankyrase 1 depletion is likely a result of inappropriate regulation of TRF1 association 
with the telomere.  TRF1 in complex with the telomere is required for telomere stability, 
length regulation and accurate formation of the shelterin complex [1, 42].  However, the 
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appropriate regulation of TRF1, including its release from the telomere, is required for 
appropriate function.  We speculate that the inability to dissociate TRF1 from the 
telomere during S-phase in order to facilitate replication, leads to the stalling of the 
replication fork [6, 32].  We propose the telomere engages a recombination mechanism 
between sister chromatids to ‘bypass’ this obstacle, allowing for recombination-
dependent advancement of the replication fork.  Consistent with this model, we find these 
sister chromatid-recombination events occur exclusively within the telomere and not 
within genomic regions of the chromosome (G-SCEs).   
Human lymphoblasts (WTK1) contain a heterogeneous thymidine kinase (TK) 
locus, allowing for a sensitive method for determining the mutation frequencies at the TK 
loci by the addition of aminopterin and trifluorothymidine to cell culture [43, 44].  Due to 
the fact that IR induced mutations are random and characterized by deletions (the product 
of two DSB events in close proximity), the probability of a mutation/deletion at any one 
location throughout the genome is equal.   Therefore, determining the mutation frequency 
of a specific gene is representative of the expected mutation frequency throughout the 
genome.  Carcinogenic potential increases with the accumulation of mutations in tumor 
suppressor genes and proto-oncogenes (reviewed in [45]), primary roles of which are to 
regulate the cell cycle and cellular proliferation.  We find that deficiency of the telomeric 
PARP family member tankyrase 1 increases IR-induced mutation frequencies, suggesting 
that variant forms of tankyrase 1 experiencing a loss of function would pose an increased 
risk for carcinogenesis.  
siRNA-mediated knockdown demonstrated that tankyrase 1 is required for 
accurate DNA-repair by DNA-PK-mediated NHEJ.  Inhibitor studies using the PARP-
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domain inhibitor 3AB mirrored the phenotypic consequences of tankyrase 1 siRNA 
knockdown, suggesting it is not simply the presence of tankyrase 1 that is necessary for 
genomic stability but rather, the requirement for tankyrase 1 catalytic activity 
specifically.  Furthermore, we observed an increase in IR sensitivity and cell killing in 
cells experiencing tankyrase 1 knockdown.  Taken together, our initial findings 
demonstrate that tankyrase 1 knockdown results in telomeres that are prone to hyper-
recombination, as well as increased mutation frequencies genome-wide and IR 
sensitivity.  These novel observations indicated that tankyrase 1 plays roles beyond the 
telomere, which appear to correlate with deficient DNA-repair phenotypes.    
3.3.2 Tankyrase 1 depletion or inhibition results in DNA-repair deficient phenotypes  
Complementing our assays that suggest tankyrase 1 is necessary for preserving 
genomic stability, cytogenetic analysis of Li Fraumeni and human fibroblasts (5C) via 
CO-FISH following 1 Gy γ-ray or HZE 56Fe revealed two instability phenotypes:  
elevated terminal deletions and telomere-DSB fusions.  Terminal deletions are the result 
of failed DNA-repair/end-joining and because the deletion is a chromosome type 
aberration, the break occurred in G1.  Telomere-DSB fusions result from successful end-
joining of a DSB, revealing that telomeres have become uncapped and are substrates for 
end-joining processes.  Therefore, the telomere is recognized as a DSB and a substrate for 
end-joining.  Having identified tankyrase 1 as a regulator of DNA-PKcs protein stability, 
we attributed the uncapped telomere phenotypes as a consequence of DNA-PKcs protein 
deficiency.  Likewise, the increase in terminal deletion frequencies resulting from 
irradiation during tankyrase 1 knockdown (lacking in the mock transfected irradiated 
controls) is likely the consequence of DNA-PKcs protein depletion and the inability to 
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perform optimal end-joining mediated by DNA-PK.  However, other methods of end-
joining, including DNA-Ligase IV/XRCC4-mediated NHEJ and PARP-1-mediated 
‘alternative NHEJ’ are independent of DNA-PKcs and are capable of DNA-repair, 
resulting in the fusions observed between telomere and DSB.  
Additionally, we observed that the quality of IR, i.e., high verses low linear 
energy transfer (LET), following tankyrase 1 knockdown impacted the frequency of 
terminal deletions & telomere-DSB fusions per metaphase.  Cells treated with high mass, 
charged, high energy (HZE) 56Fe ions following tankyrase 1 knockdown increased 
terminal deletion frequencies well above that observed in cells treated with low LET γ-
ray IR (Figure 5).  Conversly, exposure to low-LET IR (γ-rays) following tankyrase 1 
knockdown produced telomere-DSB fusions at a frequency noticeably higher than those 
observed in cells irradiated with HZE 56Fe ions (Figure 6). 
Though each IR type poses a DNA-repair challenge by the induction of DSBs, 
HZE IR specifically results in complex DNA-damage that requires longer periods of time 
for repair.  In many instances, the damage imparted by HZE IR is irreparable and results 
in cell death.  These characteristics of high-LET IR combined with the loss of DNA-PK-
mediated end-joining capability (DNA-PKcs depletion during tankyrase 1 knockdown) 
provides a plausible explanation for the high frequency of deletions observed following 
HZE 56Fe ion irradiation (during tankyrase 1 knockdown), as well as the less frequent 
telomere-DSB fusions seen in HZE 56Fe ion irradiated cells compared to γ-ray irradiated 




Likewise, the reduced frequency of terminal deletions and increased telomere-DSB 
fusions in tankyrase 1 knockdown, γ-ray irradiated cells compared to HZE tankyrase 1 
knockdown cells can be explained based on differences in radiation quality; i.e., low-LET 
γ-ray irradiation induces DSBs that are less complex in nature compared to those 
produced by HZE IR.  Though quantitatively the number of DSBs created by each IR 
type is approximately equal, increased frequencies of telomere-DSBs observed in low-
LET irradiated cells suggested increased end-joining repair capability compared to the 
HZE 56Fe ion irradiated cells.  We postulate this finding is due to the high degree of 
complexity of the damage induced by HZE IR, which resulted in reduced repair kinetics 
in tankyrase 1 knockdown, DNA-PKcs depleted cells.  Therefore, low-LET samples 
contain telomere-fusions generated by end-joining DNA-repair at a higher frequency 
compared to HZE irradiated cells, with fewer unrepaired terminal deletions.  
We found it intriguing that dysfunctional end-capping and end-joining phenotypes 
are hallmarks of classic DNA-PKcs deficiency.  We suspected tankyrase 1 perhaps may 
have an indirect role in regulating protein components of a DNA-repair pathway, as 
tankyrase 1 is not known to interact directly with DNA, nor recognize any chemical 
signature of damage.  Terminal deletions following IR (high- or low-LET) are 
chromosome-type aberrations produced during G1 phase of the cell cycle, where NHEJ is 
the primary DSB-break repair mechanism and DNA-PKcs is a critical component for 
accurate, efficient end-joining.  Therefore, we reasoned that tankyrase 1 was not directly 
responsible for the DNA-repair deficiencies and telomere uncapping but rather, played a 
role in regulating a NHEJ-repair protein, possibly DNA-PKcs.   
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Supporting this supposition, we investigated of multiple genome instability end-
points that positively correlated between tankyrase 1 & DNA-PKcs deficiencies.   Cells 
treated with the DNA-PKcs inhibitor Nu7026 resulted in outcomes similar to those 
observed in the tankyrase 1 knockdown conditions for cell survival (IR sensitivity), 
mutation frequencies, telomere deletions and telomere-DSB fusions end-points.  
Combination of tankyrase 1 knockdown and Nu7026 DNA-PKcs inhibition resulted in a 
cumulative effect, further elevating the frequencies of instability end-points such as DSB-
telomere fusions and terminal deletions following high- & low-LET irradiation types.  
This observation supports the idea that DNA-PKcs loss following tankyrase 1 
knockdown does not result in absolute abolishment of the protein, and so DNA-PKcs 
levels are not completely null.  Likewise, Nu7026 is not capable of 100% inhibition of 
DNA-PKcs activity (inhibitor studies are accepted to be effective to a threshold 90%).  
Therefore, it is not surprising that the combination of the two treatments amplified the 
frequencies of observed DNA-PKcs deficient phenotypes.   
The consistent positive correlation between tankyrase 1 knockdown and Nu7026 
end-points was critical in furthering our supposition that in each case, the end-points were 
not arising through independent mechanisms.  Rather, we suspect that tankyrase 1 plays a 
regulatory role for DNA-PKcs that when disrupted, results in the rapid loss of DNA-
PKcs, which would be expected to have phenotypes mirroring DNA-PKcs kinase 









3.3.3 Tankyrase 1 protein regulates DNA-PKcs protein stability  
 
DNA-PK Ku heterodimer is not impacted by tankyrase 1 knockdown 
To validate our speculation for an indirect role of tankyrase 1 in regulating DNA-
repair by regulating the stability of NHEJ protein components, specifically DNA-PKcs, 
we investigated DNA-PKcs protein levels at multiple time points following tankyrase 1 
siRNA-mediated knockdown.  We observed a significant reduction in DNA-PKcs protein 
levels 12 hours post-tankyrase 1 siRNA transfection.  However, the Ku80 component of 
the DNA-PK holoenzyme remained unaffected by tankyrase-1 knockdown.  These results 
indicate that the role of tankyrase 1 in the regulation of NHEJ components is specific for 
the stability of DNA-PKcs.  Thus, we validated our postulation that the genomic 
instability phenotypes observed as a result of tankyrase 1 protein depletion are the 
consequence of DNA-PKcs protein destabilization and loss.  
DNA-PKcs protein depletion does not impact tankyrase 1 protein stability  
Our investigation of the tankyrase 1-DNA-PKcs protein relationship repeatedly 
revealed that tankyrase 1-targeted siRNA transfection resulted in the significant and rapid 
reduction of DNA-PKcs protein levels as early as 12 hours after siRNA transfection.  Of 
relevance were studies that reported siRNA-mediated knockdown of DNA-PKcs requires 
approximately 48 hours post siRNA transfection before significant reduction in the DNA-
PKcs protein becomes evident [41].  Taken together, these studies suggest DNA-PKcs 
protein is in a stable, protected conformation in the presence of tankyrase 1 and hence, 
the extended time required for DNA-PKcs targeted siRNA to reduce DNA-PKcs protein 
levels.  Complementing this important finding, tankyrase 1 siRNA knockdown is coupled 
with the immediate reduction of DNA-PKcs with little, if any ‘lag’ time; indicating 
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DNA-PKcs protein stability is dependent upon the presence of the tankyrase 1 protein.  
These observations suggest that tankyrase 1 plays a role in regulation of DNA-PKcs 
protein stability.  In support of this notion, the reciprocal knockdown of DNA-PKcs does 
not reduce the levels of tankyrase 1, indicating there is no co-dependency in this model; 
tankyrase 1 is the ‘master regulator’ in this protein-protein relationship and tankyrase 1 
does not rely on DNA-PKcs protein for its own stability.  
Tankyrase 1 is required for DNA-PKcs protein stability on a posttranslational level 
Following tankyrase 1 siRNA knockdown, analysis of tankyrase 1, tankyrase 2 
and DNA-PKcs mRNA levels were determined via quantitative Real-Time PCR.  
Analysis revealed that only tankyrase 1 mRNA levels were depleted, indicating the 
efficiency and specificity of the siRNA construct to the respective target.  These results 
provide strong evidence that tankyrase 1, not the combined actions of the closely related 
tankyrases (1 & 2), is responsible for DNA-PKcs protein stability.  Furthermore, qRT-
PCR analysis demonstrates the depletion of the DNA-PKcs protein is not the result of an 
off target effect of the tankyrase 1 siRNA construct, nor is DNA-PKcs transcription 
impacted by the loss of the tankyrase 1 protein.  These findings are essential in 
supporting the notion that the DNA-PKcs-tankyrase 1 relationship is on the 
posttranslational level. 
3.3.4 The role of tankyrase 1 in DNA-PKcs stability is not the result of a stable protein 
complex.  
Multiple attempts at protein complex immunoprecipitation (Co-IP) of DNA-PKcs 
to identify tankyrase 1 as an interacting protein failed to produce evidence of a stable 
physical interaction between the two proteins.  The implication of this finding was that 
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the nature of this particular protein-protein relationship is not characterized by a 
persistent interaction.  Rather, the physical interaction between DNA-PKcs & tankyrase 1 
is likely transient in nature.  From a biochemical perspective, transient interactions are 
often used to facilitate posttranslational modification of a specific target protein to induce 
a change in protein function and/or conformation; e.g. phosphorylation.  In this case, it 
would be logical to speculate that the DNA-PKcs protein is dependent on tankyrase 1-
specific pADPr modification.  Thus, the ‘failure’ of the Co-IP is informative in 
determining the direction of additional studies investigating the relationship between our 
proteins of interest, as it is likely transient and serves a functional purpose in DNA-PKcs 
protein stabilization.  
3.4.0 Materials and Methods 
Cell lines 
Characterization of telomerase activity during spontaneous immortalization of Li-
Fraumeni syndrome skin fibroblasts [MDAH087 (087) telomerase negative (ALT) and 
MDAH041 (041) telomerase positive] has been described previously [46].  The mutant 
p53 status of these cell lines favored evaluation of telomere dysfunction and MDAH087 
provided an ALT background.  Telomerase negative (not ALT), normal neonatal 5C 
human dermal fibroblasts (HDFn; Cascade Biologics) were used at low passage, 
maintained in α-MEM medium (Hyclone) supplemented with 10% fetal calf serum 
(Sigma Aldrich) and 1% pen-strep (Hyclone), and incubated at 37oC in an atmosphere of 
95% air and 5% carbon dioxide.  A telomerase positive background was evaluated in the 
hTERT-immortalized human foreskin fibroblast cell line BJ-5ta (ATCC), which was 
sustained similarly [25]. 
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WTK1 human lymphoblastoid cells have a stable karyotype (47, X, Y 13+, 14q+) 
and were derived from the WI-L2 line [59]. WTK1 cells were used for mutation analyses 
as they are heterozygous at the thymidine kinase locus; they also have a single amino 
acid substitution in codon 237 at TP53. WTK1 cells were maintained in RPMI1640 
medium (Hyclone) supplemented with 10% heat-inactivated horse serum (Sigma-
Aldrich) and 1% pen-strep (Hyclone). 
Tankyrase 1 siRNA knockdown 
The following siRNA sequences were used for the targeted silencing of tankyrase 
1 (Dharmacon Research) and DNA-PKcs (Qiagen): tankyrase 1 siRNA1: 5’ AGG AAG 
GAG ACA CAG AUA UdTdT 3’; tankyrase 1 siRNA2: 5’ CCU GGA AGU AGC UGA 
AUA UdTdT 3’; DNA-PKcs siRNA: 5’-GAUCGCACCUUACUCUGUUdTdT-3’.  
WTK1 lymphoblasts were seeded in RPMI 1640 medium with 5% horse serum (no 
antibiotics), at a concentration of 5x105 cell/ml, 20 hr prior to transfection.  The 5C 
human dermal fibroblasts were seeded at 50-60% confluency in α-MEM medium with 
10% fetal bovine serum (no antibiotics), one day prior to transfection.  Cells were 
transfected with tankyrase 1 or DNA-PKcs siRNA (20nM) using Lipofectamine 2000 and 
OptiMEM (Invitrogen) serum free media; in some cases, a second transfection was done 
24 hr later to maintain knockdown.  The mock sample included in every experiment, 
contained only Lipofectamine 2000 with OptiMEM and no siRNA.  Cells were harvested 
at various times post siRNA transfection and processed for Western blot analysis, or used 
in experiments to assess radiation-induced effects [25]. 
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Western blot analysis 
Western blot analysis was always performed to confirm successful knockdown of 
target protein level before proceeding with evaluation of endpoints (representative blots 
shown in S1).  Cells were harvested, centrifuged and resuspended in cold PBS (without 
Mg+ Ca+) twice, then immersed in 1x RIPA buffer (1x TBS, 1% Nonidet P-40, 0.5% 
sodium deoxycholate, 0.1% SDS, 0.004% sodium azide) and protease inhibitor cocktail 
(Santa Cruz Biotechnology), incubated on ice for 5-10 min, then passed through a 25 
gauge syringe needle and centrifuged for 10 min at 140,000x g at 4°C. Protein in the 
supernatant was quantified using a BSA protein assay. Thirty five to 50μg of the 
supernatant proteins were fractionated by SDS-PAGE (Bio-Rad) and transferred to 
Immobilon-FL PVDF membranes (Millipore). Blots were blocked in 5% skim milk or 
5% BSA in TBS containing 0.1% Tween 20 and incubated overnight at 4°C with the 
following primary antibodies: rabbit polyclonal anti-tankyrase 1 (200 μg/ml; Santa Cruz 
Biotechnology); mouse monoclonal anti-actin (200 μg/ml; Santa Cruz Biotechnology); 
mouse monoclonal anti-PKcs Ab-4 (200 μg/ml; Neomarker); rabbit polyclonal anti-ATM 
(1mg/ml; Abcam). The blots were washed three times with TBS containing 0.1% Tween 
20 and incubated with secondary antibody 680IRDye-conjugated goat polyclonal anti-
rabbit IgG or IRDye 800CW-conjugated goat polyclonal anti-mouse IgG (1:15,000; LI-
COR Biosciences). Bound antibodies were detected and using an Odyssey fluorescent 
imaging system (LI-COR Biosciences); blots were quantified according to manufacturers 
instructions and normalized to independent actin loading controls [25]. 
Quantification of some blots was accomplished by importing images into 
Photoshop CS3 and analyzing as per a protocol adapted from the National Institutes of 
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Health (http:/rsb.info.nih.gov/ij/index.html).  Analysis involved first, multiplying the 
mean measured value by the number of pixels to obtain an “absolute intensity” value, an 
integrated measure of intensity and size of bands.  Next, the relative intensity for each 
sample band was calculated by dividing the absolute intensity of each band by the 
absolute intensity of the standard (the mock transfection sample) [25]. 
Chemical inhibition  
Nu7026 (Sigma-Aldrich), a competitive and highly selective inhibitor of DNA-
PKcs kinase activity, was added to WTK1 cultures after siRNA transfection at a final 
concentration of 9 M [47, 48], and remained on samples until collected for mutagenesis 
or cytogenetic analyses.  We have consistently found that this concentration of Nu7026 
yields similar results for these end points as does siRNA knockdown of DNA-PKcs. 
3-aminobenzamide (3-AB; Sigma-Aldrich) was used to inhibit global PARP 
activity at final concentrations ranging from 10 and 100 μM, to 10 and 20 mM.  3-AB 
was added to WTK1 cultures 24 hr prior to irradiation (or sham), which were then 
collected for mutation or western blot analyses [25].  
Co-immunoprecipitation (Co-IP) 
A Thermo Scientific Pierce Co-IP kit was used according to manufactures 
instructions to isolate native protein complexes from cell lysates by directly immobilizing 
purified antibody onto an agarose support.  The following primary antibodies were used; 
rabbit polyclonal anti-tankyrase 1 (Santa Cruz Biotechnology) and mouse monoclonal 




WTK1 lymphoblasts or 5C dermal fibroblasts were exposed to various doses of 
137Cs -rays in a Mark I irradiator (J.L. Shepherd) located at Colorado State University, or 
to 1 GeV/n 56Fe (high Z high energy; HZE) particles at the NASA Space Radiation 
Laboratory at Brookhaven National Laboratory (NSRL/BNL) [25].  
Mutation assay 
WTK1 lymphoblasts were treated with CHAT (10-5 M 2’-deoxycytidine, 2 x 10-4 
M hypoxanthine, 2 x 10-7 M aminopterin, 1.75 x 10-5 M thymidine; Sigma) for two 
days and CHT (CHAT without aminopterin) for one day to eliminate pre-existing TK- 
mutants.  Following CHAT treatment, cells were transfected with tankyrase 1 siRNA 
and/or treated with Nu7026 or 3-AB. Three days later, cells were irradiated with -rays or 
HZE particles. Two days after irradiation, when phenotypic expression of newly induced 
mutants was complete, the mutant fractions (MF) were determined by plating in 96 well 
dishes. For plating efficiency, one cell/well was seeded, or for scoring mutants, 2000 
cells/well were seeded in the presence of 2μg/ml trifluorothymidine (TFT; Sigma-
Aldrich). Fresh TFT was added 11 days after plating, and plates were scored for positive 
or negative wells after 20 days. The MFs were calculated using the Poisson distribution 
[49] and statistical analyses were done by t-tests using Sigma Stat 3.5 (Systat Software) 
[25]. 
Surviving fraction assay   
Two hours before exposure, exponentially growing cells were seeded into 60 mm 
dishes at various densities depending on the radiation dose to be delivered. After 
irradiation, plates were incubated at 37°C for 14-20 days in normal growth medium to 
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allow for colony formation. Plates were rinsed, fixed with methanol, and stained with 
methylene blue. Colonies with >50 cells were counted and absolute plating efficiencies 
calculated for each dose.  Surviving fractions represent the plating efficiency for the 
treated culture divided by the untreated control [25].   
Cytogenetic analyses 
Chromosome-Orientation Fluorescence in situ hybridization (CO-FISH) was 
performed as previously described [26, 50] with some modification.   Following 
irradiation, cell cultures were incubated for various times, trypsinized and sub-cultured 
into medium containing the thymidine analog 5-bromo-2-deoxyuridine (BrdU, 10µM; 
Sigma-Aldrich) for one cell cycle. Slides were air dried and stained with Hoechst 33258 
(0.50ng/µl; Sigma-Aldrich) for 15 minutes and exposed to 365 nm UV light (Stratalinker 
2400) for 25 minutes.  Following UV exposure, BrdU incorporated strands were digested 
with Exonuclease III (3U/μl in provided reaction buffer; Promega) at room temperature 
for 10 minutes.  A Cy-3 conjuated (TTAGGG)3 PNA telomere probe (0.2μg/ml; Applied 
Biosystems) was hybridized at 37˚C for 1.5 hr.  Slides were rinsed in 70% formamide at 
32˚C for 10 min and dehydrated in another ethanol series before re-probing at 37˚C for 
two hr.  Following the second hybridization, slides were rinsed with 70% formamide at 
32˚C for 15 min followed by 5 min rinse in PN Buffer.  Chromosomes were 
counterstained with DAPI (4,6-Diamidine-2-phenylindole dihydrochloride; Vectashield, 
Vector Laboratories).  Preparations were examined and images captured and analyzed 
using a Zeiss Axioskop2 Plus microscope equipped with a Photometrics Coolsnap ES2 




Scoring Criteria   
T-SCE were scored as a CO-FISH telomere signal split between the two 
chromatids of a metaphase chromosome, which were often of unequal intensity due to 
unequal SCE [51].  G-SCE were scored on cells that had progressed through two rounds 
of replication in the presence of the BrdU; characteristic FPG harlequin staining was 
visualized using a mouse monoclonal anti-BrdU conjugated to Alexafluor 488 (FITC; 
Invitrogen) after CO-FISH treatment [25]. 
Telomere fusion necessitates that telomeres of adjoining chromosomes/chromatids fuse 
into a single CO-FISH signal and the DAPI signal remain continuous [52]. Telomere-
DSB fusion appears as single-sided (on only one chromatid of a mitotic chromosome) 
interstitial blocks of CO-FISH telomere signal [34, 36].   Chromosome aberration 
frequencies (dicentrics, rings, terminal deletions, etc) were scored according to standard 
and accepted practice. Statistical analyses by Chi-square or Fisher’s exact test (Sigma 
Stat 3.5; Systat Software) was done to determine significance [25].  
Quantitative Real-Time PCR (RT-PCR) 
Alpha-MEM media (no antibiotics; Hyclone) was added to 5C human dermal 
fibroblasts (~50% confluent) 24 hrs prior to transfection of tankyrase 1 siRNA1 with 
Lipofectamine RNAiMAX Reagent (Invitrogen). Following transfection, -MEM (no 
FBS, no antibiotic) was added to the flasks. Cells were harvested at 4, 8, 12, 18, 24 and 
48 hours post transfection, and RNA was extracted using the RNeasy kit (Qiagen) with 
the optional on-column DNase treatment (Qiagen).  RNA was subjected to 
electrophoresis to affirm integrity and assure no genomic DNA contamination. A mock 
transfection (lipofectamine, no siRNA) was done for each time point [25].   
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Quantitative RT-PCR analysis was used to evaluate mRNA transcript levels of tankyrase 
1, tankyrase 2, and DNA-PKcs, relative to the housekeeping gene transferrin receptor C 
(TFRC).  Total RNA extracted for each time point was used for reverse transcription 
reactions using the Verso cDNA kit (Abgene).  The RT-PCR was performed using 
ABsolute SYBR Green Fluorescein mix (Abgene) with a total cDNA concentration of 
54ng/reaction.  The primers used to detect specific gene transcripts were as follows:   
tankyrase 1 forward, 5’-TTGCTCTTTCCAACACAAGC-3’;  
tankyrase 1 reverse, 5’-TACAGAACCACACGCTCCTC-3’;  
tankyrase 2 forward, 5’-TCTTCAGGTCCATCTAGCCC-3’;  
tankyrase 2 reverse, 5’-AAGCACCCTCTGTTCCACTT-3’;  
DNA-PKcs forward, 5’-AGCAAATGCACCGTTGTGGT-3’;  
DNA-PKcs reverse, 5’-TCCTTCTTCAGGAGCTTCCA-3’;  
TFRC forward, 5’-CGCTGGTCAGTTCGTGATTA-3’;  
TFRC reverse, 5’-GCATTCCCGAAATCTGTTGT-3’. 
Each sample was analyzed in triplicate for each transcript evaluated.  Relative 
transcript analyses were done using the delta-delta Ct method where expression is 
determined relative to the controls at each time point [53].  Three independent RT-PCR 
runs were evaluated for statistical significance via the SAS System MEANS Procedure to 
generate means, standard deviations and standard error of the means for comparisons of 
each gene at each time point.  Statistical analyses were performed using GraphPad Prism 
software. Figures containing three or more means were analyzed using ANOVA.  When 
means differed significantly (p<0.05), Tukey’s post hoc test was employed [25]. 
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DNA-PKcs protein stability is regulated by tankyrase 1-specific PARsylation 
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4.1.0 Introduction 
Our identification of genomic instability phenotypes that suggest deficient DNA-
repair in response to tankyrase 1 knockdown provided the first evidence for involvement 
of tankyrase 1 in DNA-repair [1].  Further investigation provided evidence that the 
instability phenotypes observed were the consequence of DNA-dependent Protein Kinase 
catalytic subunit (DNA-PKcs) protein destabilization as a consequence of tankyrase 1 
knockdown, suggesting tankyrase 1 is not directly involved in DNA-repair [1].  We 
speculated that tankyrase 1 may play a regulatory role in DNA-repair by stabilizing the 
DNA-PKcs protein, likely though a transient interaction.  Here, we investigate the 
mechanism by which tankyrase 1 stabilizes the DNA-PKcs protein.   
We found that the stability of the DNA-PKcs protein is dependent on tankyrase 1 
at the posttranscriptional level; tankyrase 2 and DNA-PKcs mRNA levels were not 
negatively influenced by siRNA-mediated tankyrase 1 knockdown.  Considering the 
converse siRNA knockdown of DNA-PKcs had no impact on tankyrase 1 protein levels, 
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we speculated that the stability of DNA-PKcs is dependent on the catalytic activity of 
tankyrase 1.  The pADPr modification of protein substrates has been shown to play a role 
in the negative regulation of proteins (TRF1) [2, 3], non-covalent scaffolding (NuMA) [4, 
5], protein recruitment (PARP-1-mediated single-stranded break-repair) [6, 7] and 
catalytic activation [8].  We aimed to uncover the mechanism underlying tankyrase 1-
dependent DNA-PKcs protein stability in order to provide valuable insight to the 
influences of poly(ADP-ribosyl)ation (pADPr/PARsylating) protein modification.   
4.1.1  Tankyrase-dependent protein regulation by poly(ADP-ribosyl)ation 
Tankyrase-dependent PARsylation of a substrate protein is coupled with 
tankyrase auto-pADPr modification in order to dissociate tankyrase monomers from the 
multimerized tankyrase complex formed via sterile-alpha motif (SAM) interactions [9, 
10].  Tankyrase multimerization (including tankyrases 1 & 2) is thought to optimize 
tankyrase catalytic addition of ADP-ribose [9]; longer pADPr additions prolong the half-
life of the modification before being removed by Poly(ADP-ribose) Glycohyrdolase 
(PARG) activity [9].  Tankyrase auto-modification disrupts SAM motif-dependent 
tankyrase complexes [9, 10].  Once auto-PARsylated, tankyrases become substrates for 
E3 Ub-ligase and subsequent proteasome degradation if the pADPr chain is not cleaved 
via PARG catalytic activity [11].  Thus, the tankyrases are auto-regulated by pADPr 
modification, which enhances their vulnerability to degradation. 
Poly(ADP-Ribose) Glycohydrolase (PARG) is the PARP counter enzyme that 
performs de-PARsylating activity at an extremely rapid rate; biochemical studies suggest 
that the cessation of all cellular PARP activity would result in the de-PARsylation of 
every acceptor protein within 60 seconds via PARG [12-14].  The random cleavages 
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between pADPr groups by PARG allows for tankyrase-dependent formation of a heavily 
branched pADPr chain that serve as an effective method to extend the receptor proteins 
half-life in a PARsylated form [15-18].  Appropriate regulation of tankyrase-dependent 
pADPr protein modification requires tankyrase multimerization in order to achieve rapid 
extension of branched pADPr chains and subsequent PARG activity.     
4.1.2 Tankyrase 1 modifies a broad spectrum of proteins with various effects  
Tankyrase 1 modification of pADPr-acceptor proteins has been shown to occur 
with a growing number of substrate proteins [19].  In addition to TRF1 regulation [2, 3], 
tankyrase 1-dependent pADPr protein modification is essential for accurate GLUT4 
storage vesicle (GSV) trafficking by the insulin responsive amino peptidase (IRAP) [11, 
20]; stabilization of the spindle-pole apparatus via modification of the nuclear mitotic 
apparatus complex (NuMA) [4, 5]; negative -regulation of the master beta-catenin 
sequestering protein, Axin [21] and autoregulation of  tankyrase 1 itself [11].  In each of 
these cases, pADPr modification of the acceptor protein alters the modified proteins 
function, ability to form protein complexes, stabilization, or affinity for additional 
modifications; e.g. ubiquitination (Ub).   
 GSVs containing the glucose transporter GLUT4 and the hormone 
protease IRAP are usually translocated from the golgi apparatus to the plasma membrane 
for glucose uptake.  Tankyrase 1 is an IRAP binding partner and tankyrase 1 knockdown 
results in ineffective, unorganized GSV trafficking.  Inhibition of tankyrase 1 activity has 
also been shown to interfere with appropriate GSV trafficking and function [20, 22].  
These studies demonstrate the role of tankyrase 1 pADPr-modification of IRAP, 
necessary for the appropriate function of IRAP in GSV orientation and trafficking to the 
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plasma membrane; the precise mechanism of this pADPr-dependent model is still under 
investigation. 
Tankyrase 1-specific pADPr additions have been shown to play a critical role in 
protein complex stability, forming a lattice-like scaffolding network for non-covalent 
protein-protein interactions [9, 10] as in the case of NuMA and spindle pole assembly [4, 
23].  The net negative charge of each ADP-ribose group provides an effective platform 
for stable, ionic-based protein-protein interactions, creating a temporary scaffolding 
structure between proteins [6, 7].  The integrity of the spindle pole apparatus during 
mitosis is dependent upon tankyrse 1 pAPDr-modification of NuMA monomers [4, 23]; 
pADPr-modified NuMA proteins associate non-covalently with one another (and 
tankyrases) to orient the microtubules in the spindle-pole apparatus assembly [4, 23-25].  
Tankyrase 1 deficiency results in the loss of pADPr-dependent scaffolding of the spindle 
pole apparatus and defective microtubule function (during mitosis) [4, 23].  Tankyrase 1 
dysfunction results in the random anchoring of microtubules in the cytoplasm, 
uncoordinated microtubule dynamics (extention and retraction) and failure to complete 
the mitotic process [4, 19, 23].   
Tankyrase 1 has also recently been identified as a positive regulator of the β-
catenin transcription factor by negatively regulating the master sequestering protein, Axin 
[21].  Activation of β-catenin is initiated via the Wnt signaling pathway [26].  When the 
appropriate cell signal is lacking, β-catenin remains in a sequestered, inactive state and 
eventually, becomes phosphorylated by casein kinase (CK1) or glycogen synthase kinase 
3B (GSK3b), ubiquitinated and degraded [27-30].  The CK1 and GSK3b kinases are kept 
in proximity with β-catenin by the formation of the Axin-dependent ‘β-catenin 
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destruction complex’.  Tankyrase 1 has been identified as the negative regulator of Axin, 
in which pADPr modification results in the degradation of Axin, disassembly of the ‘β-
catenin destruction complex’ and subsequent activation of β-catenin [21].  
4.1.3 The NHEJ protein DNA-PKcs as a substrate for tankyrase 1 PARsylation 
We have found that the stability of DNA-PKcs is dependent on tankyrase 1 
posttranslationally.  However, it is not known whether DNA-PKcs protein stability 
requires the physical presence of the tankyrase 1 protein or its catalytic activity 
(PARsylation).  Initial attempts to demonstrate tankyrase 1 and DNA-PKcs in complex 
via protein complex-immunoprecipitation (Co-IP) failed, suggesting that the interaction is 
transient in nature.  Most transient interactions are characterized by enzymatic 
modification of a target protein to alter the modified proteins function and/or 
conformation; e.g. phosphorylation.   
DNA-PKcs has been shown to be a pADPr-accepting protein and existing in a 
PARsylated state in vivo [31, 32].  However, the protein/s responsible for DNA-PKcs 
PARsylation and the functional implications of pADPr-modified DNA-PKcs have not 
been characterized.  In vitro studies with DNA-PKcs and PARP-1 demonstrate that 
DNA-PKcs is capable of accepting the pADPr-modification in the presence of ³²P-
adenylated NAD+ [8].  Additionally, PARsylated forms of DNA-PKcs have been 
reported to have up-regulated kinase activity, approximately 7-fold higher than 
unmodified forms of DNA-PKcs [8].  Collectively, these findings indicate tankyrase 1-
dependent pADPr modification of DNA-PKcs occurs in vivo and is a potential 
mechanism for catalytic activation of DNA-PKcs.  
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Evidence supporting a biochemical role for pADPr modified DNA-PKcs in vivo 
recently emerged, as DNA-PKcs was identified as a PARsylated member of the proteome 
in a pADPr immunoprecipatation assay.  However, the mechanism and function of DNA-
PKcs PARsylation was not determined [31].  This proteome-wide pADPr pull-down 
suggests that DNA-PKcs is covalently modified by a PARP family member, as opposed 
to a ‘pADPr interacting’ protein where pADPr is used as a scaffold to stabilize protein-
protein interactions [32].  These in vitro and in vivo studies demonstrate that DNA-PKcs 
is a substrate for one, or possibly several PARP family members, as PARsylated forms of 
DNA-PKcs have functional implications regarding activation of its kinase activity [8, 31, 
32].  
Here, we sought to uncover the mechanism by which tankyrase 1 contributes to 
DNA-PKcs protein stability.  Suspecting a transient interaction enzymatic in nature, we 
investigated tankyrase 1-dependent DNA-PKcs stability by inhibiting the catalytic 
activity of several proteins/complexes that participate in pADPr regulation.  We targeted 
broad-range PARP activity with 3-aminobenzamide (3-AB) [33, 34], tankyrase catalytic 
activity with XAV939 [21], proteasome-mediated degradation with MG132 [35] and 
PARG activity with ADP-Hydroxymethyl Pyrrolidinediol (ADP-HPD) [36].  Ultimately, 
we show that DNA-PKcs protein stabilization is acheived by tankyrase 1-specific 
pADPr-modification with no redundant function by other PARP family members.  When 
the tankyrase 1-dependent pADPr modification of DNA-PKcs is abrogated, DNA-PKcs 
is targeted for proteasome-mediated degradation. 
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4.2.0 Results 
4.2.1 Tankyrase PARP activity is required for DNA-PKcs protein stability 
To investigate a possible protein-protein interaction between tankyrase 1 and 
DNA-PKcs, multiple protein complex immuneprecipitation (Co-IP) experiments were 
performed, but failed to demonstrate tankyrase 1 and DNA-PKcs in complex.  A negative 
result via this assay does not rule out the possibility of the formation of a transient DNA-
PKcs-tankyrase-1 complex.  However, it does suggest that the interaction does not persist 
as a stable complex.  Often, transient protein interactions are enzymatic in nature and 
serve a regulatory function for a finite period of time [37].   
Initial support for pADPr modification of DNA-PKcs was provided by treatment 
with the general PARP inhibitor 3-AB, which demonstrated that PARP inhibition 
increases radiation-induced mutation frequencies [1].  Next, we question whether 3-AB 
treatment alone challenged the integrity of the DNA-PKcs protein.  Treatment with high 
concentrations of 3-AB (10 and 20 mM) were sufficient to induce an observable 
reduction of DNA-PKcs protein levels (Figure 1 [1]), suggesting that PARP catalytic 
activity is required for DNA-PKcs protein stability.  However, 3-AB has a higher affinity 
for PARP-1 and PARP-2 catalytic domains than for tankyrase 1; treatment with 3-AB at 
low concentrations inhibits the catalytic activity of PARP-1 and PARP-2, not tankyase 1 
or 2.  This is confounding in that PARP-1 has been shown to PARsylate DNA-PKcs in 
vitro [8] and thus, we cannot contribute the reduction in DNA-PKcs protein levels to 
tankyrase 1 PARP activity specifically.     
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4.2.2 Catalytic activity of tankyrase 1 stabilizes DNA-PKcs 
To determine the importance of tankyrase 1 catalytic activity in DNA-PKcs 
protein stability, we treated human lymphoblasts (WTK1) with the recently available 
small molecule inhibitor XAV939, a tankyrase-specific PARP domain inhibitor [21].   
XAV939 treatment (0.5 and 1.0 µM) rapidly and dramatically reduced DNA-PKcs 
protein levels (Figure 2 [1]).  This observation confirmed that DNA-PKcs protein 
stability is dependent on tankyrase-specific poly(ADP-ribosyl)ating activity, as XAV939 
does not bind the relevant interaction domains (i.e. ankyrin repeats, SAM).   
With respect to XAV939 concentrations used in culture, the catalytic activity 
tankyrase 1 & 2 are inhibited specifically, indicating the activity of no PARP family 
member (other than tankyrases) are responsible for DNA-PKcs protein stability [21].  
Biochemical characterization of XAV939 revealed that the inhibitor has a higher affinity 
for the tankyrase 2 PARP domain compared to tankyrse 1 (IC50 values for tankyrase 1 
and tankyrase 2 are 0.011 µM and 0.004 µM respectively) [21].  Therefore, we can 
assume that under conditions of XAV939-dependent inhibition of tankyrase 1, tankyrase 
2 will be inhibited as well.  However, following siRNA-mediated knockdown of 
tankyrase 1, qRT-PCR analysis of tankyrase 1 & tankyrase 2 mRNA levels showed the 
siRNA construct targeted tankyrase 1 mRNA specifically; tankyrase 2 was not affected.  
Therefore, DNA-PKcs stability is dependent on tankyrase 1 depletion specifically, 
excluding the involvement of tankyrase 2.  Building on this conclusion, we attribute the 
depletion of DNA-PKcs protein levels in the presence of XAV939 to tankyrase 1 PARP 
domain inhibition, not tankyrase 2.     
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Examination of various time points (2, 5, 8, 12, 18, 24 & 48 hours) and XAV939 
concentrations (0.1, 0.5 or 1.0μM) revealed a significant reduction of DNA-PKcs protein 
levels to ~50% (relative to the normal resting level) by 8 hours with both 0.5 µM or 1.0 
µM XAV939 (Figure 2 [1]).  The greatest reduction of DNA-PKcs protein levels (< 25% 
relative expression compared to DMSO treated controls) occurred at 12 hr with 1.0 µM 
XAV939 exposure.  Later time points (24 hr) showed recovery of DNA-PKcs protein 
levels relative to DMSO treated controls, likely due to loss of potency of the inhibitor in 
culture (data not shown).  Cumulatively, these results support tankyrase 1-specific 
PARsylating activity as a critical contributing factor to stabilization of the DNA-PKcs 
protein and provide preliminary evidence that DNA-PKcs protein stability relies on 
tankyrase 1 catalytic activity, as opposed to the physical presence of tankyrase 1 itself. 
4.2.3 Tankyrase 1 protein levels increase in response to tankyrase PARP inhibition 
Inhibition of the tankyrase PARP domain with XAV939 treatment did not 
diminish tankyrase 1 protein levels. To the contrary, treatment of human lymphoblasts 
with 1.0 µM XAV939 resulted in a significant increase of tankyrase 1 levels to ~150% 
relative to the DMSO treated controls (Figure 3 [1]).  This finding correlates with the the 
mechanism for the autoregulation of tankyrases through PARsylation [9-11].   
During PARsylation events, tankyrases “multimerize” for maximum catalytic 
efficiency [9, 10].  Tankyrase autoPARsylation allows tankyrase monomers to dissociate 
from multimerized complex [9].  PARsylated tankyrase is a potential substrate for E3-
Ligase dependent ubiquitination and proteasome-mediated degradation if the pADPr 
modification is not removed by PARG [11].  Therefore, XAV939 inhibition of tankyrase 
catalytic activity not only blocks tankyrase-dependent pADPr modification of substrate 
  109     
 
proteins, but also blocks the ability of tankyrase 1 to auto-PARsylate and thereby shields 
tankyrase 1 from potential ubiquitination and subsequent degradation. These findings 
further illustrate that DNA-PKcs stability is dependent on tankyrase 1-specific PARP 
activity, but also demonstrate that the physical presence of tankyrase 1 per se is not 
responsible for the integrity of the DNA-PKcs protein.  We speculated that tankyrase 1 
directly PARsylates DNA-PKcs, resulting in a dynamic, yet consistent pool of 
PARsylated DNA-PKcs. 
4.2.4 Tankyrase 1 stabilizes DNA-PKcs by protecting it from proteolytic degradation 
Our earlier studies showed that DNA-PKcs stability requires tankyrase 1 at a 
posttranslational level (qRT-PCR studies, Chapter 3).  To investigate the mechanism of 
DNA-PKcs protein depletion following tankyrase 1 inhibition or knockdown, we 
partially inhibited the proteasome by the addition of the chymotrypsin inhibitor MG132 
[38].  At various times following tankyrase 1 siRNA transfection (8, 12, and 24 hr), 
during the time that both tankyrase 1 and DNA-PKcs protein levels are depleted, cells 
were treated with MG132 for two hour time windows prior to cell culture harvest.  
Similarly, 12 hour treatments with XAV939 were combined with MG132 treatment for 
the final two hours and cells harvested.  
Although only a partial proteasome inhibitor (i.e. chymotrypsin-like activity, not 
trypsin-like or caspase-like activity), treatment with MG132 for 2 hours in combination 
with a 12 hour XAV939 treatment resulted in a detectable recovery of DNA-PKcs protein 
levels to ~10-15% above the steady-state DNA-PKcs levels in XAV939 treated cultures 
(Figure 4 [1]).  This result demonstrated that inhibition of proteasome-mediated protein 
degradation allowed cells to accumulate DNA-PKcs protein and so, provide support for 
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the notion that tankyrase 1 protects DNA-PKcs from proteolytic degradation.  This 
observation is also consistent with our qRT-PCR results demonstrating sufficient levels 
of DNA-PKcs mRNA following tankyrase 1 knockdown; i.e., ample DNA-PKcs message 
is available for translation.   That DNA-PKcs protein levels were only minimally restored 
upon proteasome inhibition, may reflect the short time window allowed for recovery, that 
MG132 does not completely inhibit the proteasome, and/or that it takes time to synthesize 
such a large and abundant protein. 
Taken together, the MG132 studies demonstrated that loss of DNA-PKcs occurs 
at the protein level and is degraded in a proteasome-mediated fashion.  Proteasome 
inhibition under tankyrase 1 siRNA knockdown conditions showed that loss of DNA-
PKcs via proteasome-mediated degradation is dependent upon the presence of the 
tankyrase 1 protein.  Furthermore, XAV939 results complement the MG132 studies in 
combination with siRNA knockdown, showing a ~15% increase of the DNA-PKcs 
protein over conditions lacking a 2 hour MG132 treatment.  From these observations we 
conclude that the PARsylating activity of tankyrase 1 protects DNA-PKcs from 
proteasome-mediated degradation, as opposed to functioning stoichiometrically at the 
protein level.  
4.2.5 DNA-PKcs protein levels decrease in response to PARG inhibition 
Hydrolysis and removal of ADP-ribose polymers from modified proteins is 
rapidly catalysed by poly(ADP-ribose) glycohydrolase (PARG)  [39].  To further explore 
tankyrase-dependent PARsylation of DNA-PKcs, we utilized the potent PARG inhibitor 
adenosine diphosphate (hydroxymethyl)pyrrolidinediol (ADP-HPD) [36].  We 
anticipated that inhibition of PARG activity without tankyrase inhibition would result in 
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increased DNA-PKcs protein levels, as DNA-PKcs would become stably and irreversibly 
PARsylated in a proteasome-resistant conformation.   
Unexpectedly, DNA-PKcs protein levels were rapidly and dramatically 
diminished under conditions in which lymphoblasts were treated with the ADP-HPD 
PARG inhibitor alone (1.2 µM), and in combination with XAV939 (1.0 µM).  Due to the 
unstable nature of hydrated ADP-HPD (from lyophilized form), we questioned whether 
the inhibitor was sustaining its structural integrity and function over the time course of 
the treatment when in combination with XAV939.  Therefore, we initiated addition of 
ADP-HPD (1.2 µM) to culture every 2.5 hours, resulting in a final concentration of 4.8 
µM (assuming each molecule remains active).  Consistent with 1.2 µM ADP-HPD 
treatments, treatment with 4.8 µM ADP-HPD alone and in combination with 1.0 µM 
XAV939 over a 10 hour time course resulted in the significant reduction of the DNA-
PKcs protein to ~55% and 40% expression respectively, relative to the DMSO treated 
control (Figure 5 [1]).  
4.2.6 PARG inhibition depletes tankyrase 1 protein levels 
 The lysate from cells treated with ADP-HPD was also probed for the 
tankyrase 1 protein by Western blot analysis, revealing that tankyrase 1 was reduced to 
an undetectable level in cells treated with ADP-HPD (Figure 6 [1]).  It became evident 
that PARG inhibition was interfering with the regulatory dynamics of the tankyrase 1 
protein in some way.  To dissociate from the multimerized tankyrase complex that forms 
during substrate protein PARsylation, tankyrases autoPARsylate, becoming a substrate 
for either E3 ubiquitin ligase or PARG.  We suspect that treatment with ADP-HPD 
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directly interferes with the ability of the autoPARsylated tankyrase 1 to become 
dePARsylated, as PARG activity is blocked.   
 ADP-HPD treatment in combination with XAV939 resulted in increased 
levels of tankyrase 1 (Figure 6 [1]).  We explain this as the consequence of treatment 
with XAV939, which alone, increases tankyrase 1 protein levels (relative to the DMSO 
treated controls).  Therefore, in combined treatments, the activity of the tankyrase 
inhibitor is epistatic, blocking autoPARsylation of tankyrase 1 and shielding tankyrase 1 
from becoming a substrate for PARG and/or E3 ubiquitin ligase activity, resulting in 
increased tankyrase 1 protein levels.   
4.2.7 PARG inhibition depletes tankyrase 1 and destabilizes DNA-PKcs 
 Treatment with the PARG inhibitor ADP-HPD (alone) parallels tankyrase 
1 siRNA knockdown in respect to the method of DNA-PKcs protein depletion.  In each 
case, tankyrase 1 protein is depleted (by protein destabilization verses transcript 
manipulation) and so it is not available to perform its catalytic function, consequentially 
depleting DNA-PKcs protein levels.  The ADP-HPD/XAV939 combined treatment 
resulted in increased levels of tankyrase 1, suggesting that the inability to auto-PARsylate 
predominates; i.e., there is little available to de-PARsylate.  Considering the evidence and 
implications provided by both PARG inhibition studies and tankyrase 1-specific PARP 
domain inhibition studies, we verified that tankyrase 1-specific PARsylation is required 
for DNA-PKcs protein stability.  
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4.2.8 Electrophoretic separation of PARsylated DNA-PKcs from unmodified pools of 
DNA-PKcs via SDS-PAGE     
 DNA-PKcs has been shown to be covalently modified by addition of 
pADPr via PARP1 in vitro, resulting in a significant increase in DNA-PKcs kinase 
activity, suggesting a functional effect for DNA-PKcs PARsylation beyond protein 
stability [40].  Considering that our inhibitor studies cumulatively suggested covalent 
modification of DNA-PKcs via tankyrase 1-dependent PARsylation as the mechanism of 
DNA-PKcs protein stability, we sought evidence of a high molecular weight pool of 
DNA-PKcs dependent upon tankyrase 1 catalytic PARP activity.    
 Initially, we sought to demonstrate that a pool of DNA-PKcs exists with a 
tankyrase-dependent pADPr modification.  Prior reports have demonstrated that DNA-
PKcs is capable of accepting pADPr groups in vitro, and that it exists as such to some 
extent intracellularly [8, 31].   We investigated whether the pADPr modification of DNA-
PKcs resulted from tankyrase 1-specific PARP activity.  Detection of pADPr at the 
molecular weight corresponding to DNA-PKcs failed despite multiple attempts (data not 
shown).  Due to the high variability in the number of pADPr groups that can exist on 
DNA-PKcs and the question of the effectiveness/sensitivity of the antibody, we moved 
toward a more progressive method for the detection of tankyrase 1-dependent 
PARsylated forms of DNA-PKcs.    
 Gel electrophoresis facilitated visualization (upon over exposure) of a high 
molecular weight pool of DNA-PKcs present in DMSO treated controls, much of which 
resided in the loaded well (Figure 7B [1]).  Further, treatment with XAV939, ADP-HPD 
and XAV939/ADP-HPD combined resulted in deterioration of this high molecular weight 
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pool of DNA-PKcs, as well as a corresponding increase in DNA-PKcs degradation 
products compared to the DMSO treated controls (Figure 7B [1]).  Due to the fact that the 
high molecular weight pool of DNA-PKcs was dependent on catalytically active 
tankyrase (the only experimental variable), the high molecular weight pool represented 
PARsylated forms of DNA-PKcs.   
 To further support this supposition, DMSO untreated controls and 
XAV939 treated samples (8 hr) were independently loaded every 2 hours in individual 
wells of a gradient gel (4-20%) over 6 hours (2, 4, and 6 hr total run times).  Here, our 
aim was to separate high molecular weight forms of DNA-PKcs from unmodified pools 
with time.  A significant reduction of the primary DNA-PKcs protein band was observed 
between the 2 and 4 hour run times (not over exposed); at 4 hours, DNA-PKcs levels in 
the DMSO treated control were reduced to ~50% relative to the DNA-PKcs levels 
detected in the 2 hour run; the 4 hour and 6 hours run times did not differ significantly in 
the levels of detected DNA-PKcs (Figure 7A [1]).  In contrast, the XAV939 treated 
samples lost little DNA-PKcs over the range of run times, indicating that a pool of 
tankyrase-dependent modified DNA-PKcs exists under normal conditions, which is not 
present under conditions of tankyrase PARP inhibition.  This result, in conjunction with 
detection of a high molecular weight pool of DNA-PKcs in DMSO treated controls, 
which is absent in XAV939 treated samples, supports the presence of a heterogeneous 
population of DNA-PKcs spanning a wide range of molecular weights, consistent with 
various levels of tankyrase 1-dependent PARsylated DNA-PKcs. 
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4.3.0 Discussion 
4.3.1 DNA-PKcs protein stability requires tankyrase 1 specific PARP catalytic activity 
Our tankyrase 1 siRNA studies first demonstrated the dependence of DNA-PKcs 
protein stability on tankyrase 1 specifically.  Evidence also indicated that the DNA-PKcs-
tankyrase 1 relationship occurred at the protein level, so we sought a mechanistic 
explanation.  Attempts to demonstrate that DNA-PKcs and tankyrase 1 physically 
associate by Co-IP revealed no such stable complex between the two proteins, suggesting 
the interaction is transient in nature.   
Transient interactions are often enzymatic and serve regulatory functions [37, 41].  
Fitting the description of pADPr modification, we addressed the role of tankyrase 1 
catalytic activity in the stability of DNA-PKcs.  Treatment with the broad-range PARP 
domain inhibitor 3-aminobenzamide (3-AB) [33, 34, 42] produced a prominent reduction 
in levels of the DNA-PKcs protein, indicating that PARsylating activity might be a key 
component of DNA-PKcs stability.  However, the non-specific nature of 3-AB does not 
provide solid evidence as to which of the PARP family member(s) specifically are 
involved in DNA-PKcs regulation via PARsylating activity.  Though our results 
suggested tankyrase 1 as a prime candidate, others have identified PARP-1 as a binding 
partner and potential modifier of DNA-PKcs [8, 43].  
4.3.2 DNA-PKcs protein stability requires tankyrase-specific catalytic activity 
The recent characterization of tankyrase-specific inhibition with the novel small 
molecule PARP inhibitor XAV939 [21] provided a valuable tool to investigate the role of 
tankyrase PARP activity in DNA-PKcs protein stability.  Use of XAV939 has also aided 
in the characterization of the role of tankyrases in the stability of the β-catenin master 
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sequestering protein, Axin [21].  It is important to note that XAV939 has a higher affinity 
for the tankyrase 2 PARP domain and thus, inhibition of tankyrase 1 with XAV939 will 
inevitably be coupled with tankyrase 2 inhibition.  Therefore, it could be argued that the 
reduction in DNA-PKcs protein levels is not consequence of tankyrase 1 inhibition alone.  
However, our earlier qRT-PCR studies revealed the loss of tankyrase 1 mRNA in 
tankyrase 1-siRNA mediated knockdown was not coupled with tankyrase 2 transcript 
depletion.   
Using a concentration of XAV939 in culture consistent with previous studies [21], 
we observed maximum depletion of DNA-PKcs protein levels over a surprisingly short 
time course of 12 hours, half the time used in tankyrase 1 siRNA studies (Figure 8).  We 
reason the difference in time courses results from the means of tankyrase 1 manipulation 
used in each case.  siRNA-mediated depletion requires successful transfection, 
degradation of the tankyrase 1 transcript, ubiquitination and degradation of the tankyrase 
1 protein before DNA-PKcs protein stability is influenced.  Inhibition of tankyrase PARP 
activity/domain with XAV939 is nearly instantaneous.  
Our results following tankyrase 1-specific catalytic inhibition address several 
important questions regarding the tankyrase 1-DNA-PKcs relationship.  First, they 
indicate that the catalytic activity of tankyrase 1 specifically is required for DNA-PKcs 
stability, involving no redundant function by other PARP family members.  Second, we 
find an explanation for the observation that DNA-PKcs siRNA knockdown, which 
requires 48 to 72 hours for maximum depletion [44], requires a longer time course 
compared to the siRNA knockdown of tankyrase 1, taking only 12-24 hours to deplete 
DNA-PKcs protein levels.  siRNA-mediated depletion of DNA-PKcs operates at the 
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mRNA/transcript level and so does not influence the regulatory dynamics of tankyrase 1 
in regards to DNA-PKcs protein stability, thus delaying the rate at which existing DNA-
PKcs protein is degraded.  Loss of tankyrase 1 via siRNA knockdown abrogates this 
regulatory role and therefore, results in the rapid depletion of DNA-PKcs.   
4.3.3 DNA-PKcs protein stability requires more than the physical presence of tankyrase 1 
Several lines of evidence suggested that it is the PARsylating activity of tankyrase 
1 that is important to DNA-PKcs protein stability, not the ability of tankyrase 1 to 
facilitate protein-protein interactions.  The ankyrin-like repeat domains in tankyrases 
allow tankyrases to interact with an array of target proteins, whereas the sterile alpha 
motif (SAM) is the functional domain responsible for tankyrase-based multimerization 
during PARsylation.  XAV939 does not bind to either the ankyrin-like repeat domain nor 
the SAM and thus, normal protein-protein interactions are not interfered with during 
XAV939 treatment.  This helps to rule out the formerly viable role for a stable DNA-
PKcs-tankyrase 1 complex in DNA-PKcs stability, functioning stoichiometrically.   
Interestingly, we also found that tankyrase 1 protein levels are increased with 
XAV939 treatment, supporting the mechanism of tankyrase 1 autoregulation proposed in 
prior studies [11] (Figure 9).  Tankyrase 1 automodification is used for tankyrase 
dissociation from multimerized tankyrase complexes that are created during PARsyaltion 
of a substrate protein [9, 10], which results in tankyrase ubiquitination and degradation if 
not dePARsylated by PARG [11].  In our studies, XAV939 blocks tankyrase 
autoPARsylation and because tankyrase 1 is ubiquitously expressed [45], tankyrase 1 
accumulates in an unPARsylated, proteasome resistant form (Figure 9).  This finding 
demonstrates that the level of tankyrase 1 protein is not critical to the stability of DNA-
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PKcs, as we find that even elevated levels of catalytically inhibited tankyrase 1 also 
results in the depletion of DNA-PKcs.   
4.3.4 Tankyrase 1 protects DNA-PKcs from proteasome-mediated degradation   
Depletion of DNA-PKcs protein levels was evident after both siRNA-mediated 
tankyrase 1 knockdown and XAV939-mediated catalytic inhibition of tankyrase 1.  For 
proteasome-mediated protein degradation, multiple posttranslational-modifications serve 
as a signal for protein degradation by the proteasome, i.e. Ub and small ubiquitin like 
modifier (SUMO) [46, 47].  In an effort to determine in DNA-PKcs protein degradation 
is mediated by selective ‘tagging’ (e.g. Ub, SUMO) or by vesicle trafficking (proteasome 
vs. lysosomal), we employed the partial proteasome inhibitor MG132.   Inhibition of the 
chymotrypsin proteolytic activity of the proteasome via MG132 under conditions 
optimized for DNA-PKcs depletion via tankyrase 1 siRNA knockdown and XAV939 
inhibition showed some recovery of the DNA-PKcs protein within a 2 hour time window.  
Although not an astounding return, DNA-PKcs protein recovery to 10-15% above the 
levels of DNA-PKcs in cell populations treated with siRNA or XAV939 alone, providing 
supporting evidence that degradation of the DNA-PKcs protein is mediated by the 
proteasome.  
4.3.5 Inhibition of PARG activity disrupts the dynamics of tankyrase autoregulation 
We anticipated that inhibition of the PARP counter-enzyme, poly(ADP-ribose) 
glycohydrolase (PARG) would preserve poly(ADP-ribose) residues on pADPr modified 
proteins, and therefore, maintain normal levels of DNA-PKcs.  However, inhibition of 
PARG activity with ADP-HPD alone and in combination with XAV939 resulted in the 
rapid, significant reduction of DNA-PKcs protein levels, supporting the notion that 
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PARG inhibition results in DNA-PKcs protein destabilization and degradation.  
Acknowledging the fact that ADP-HDP is extremely unstable once hydrated [48, 49] and 
considering the impact of cell culturing conditions on the potency of the inhibitor are 
poorly characterized, we speculated perhaps this observation was the result of ineffective 
ADP-HPD function.  Treatment with ADP-HPD also resulted in a dramatic reduction in 
tankyrase 1 protein levels, to such an extent that western blot analysis failed to detect any 
quantifiable tankyrase 1 protein.  We conclude that PARG inhibition disrupted the 
autoregulatory dynamics of the tankyrase 1 protein by inhibiting pADPr removal from 
tankyrase 1 following automodification, resulting in the ubiquitination and degradation of 
tankyrase 1.  ADP-HPD-mediated depletion of tankyrase 1 therefore, resulted in DNA-
PKcs depletion, similar to the mechanism by which siRNA knockdown of tankyrase 1 
depletes DNA-PKcs (by the depletion of tankyrase 1) (Figure 10).  
Our results from combining XAV939/ADP-HPD treatments reflected XAV939 
treatment alone (DNA-PKcs depleted).  Since XAV939 inhibits tankyrase 1 PARyslating 
activity, including autoPARsylation, tankyrase 1 did not accumulate in a pADPr-
modified state and therefore, did not become ubiquitinated & degraded.  Further, DNA-
PKcs cannot be PARsylated by tankyrase 1 in the combined treatment and so, PARG 
inhibition is irrelevant.  Hence, the reduction of DNA-PKcs protein levels in the 
combined XAV939/ADP-HPD treatment occurred by the same mechanism as treatment 
with XAV939 alone.  Supporting this explanation, we found that combined treatment also 
resulted in elevated levels of the tankyrase 1 protein compared to the DMSO treated 
controls.   
  120     
 
4.3.6 DNA-PKcs exists in a tankyrase-dependent, high molecular weight, PARsylated 
form 
Having determined the DNA-PKcs protein is dependent on the catalytic activity 
and regulatory dynamics of tankyrase 1, we sought to determine if DNA-PKcs is pADPr-
modified by tankyrase 1 or, if an intermediate effector protein might be involved in 
pADPr-dependent DNA-PKcs protein stability.  We were encouraged by recent studies 
that identified DNA-PKcs as a pADPr-modified member of the proteaome [31].  Further, 
in vitro studies had demonstrated DNA-PKcs is capable of accepting pADPr residues 
with functional implications in upregulating DNA-PKcs kinase activity (approximately 7 
fold over unmodified forms) [8].  It is important to recognize the highly variable nature of 
the pADPr posttranslational modification; pADPr groups can vary in length from 2 
groups through 200 [6, 7, 17, 50].  Therefore, pADPr modified forms of DNA-PKcs 
would be of various high-molecular weight sizes and smeared throughout a gel above the 
protein band (470kD).  
In an effort to determine if PARsylated forms of DNA-PKcs protein are in fact 
tankyrase 1 dependent, we sought to identify a high molecular weight group of DNA-
PKcs (above 470 kDa). Extended periods of incubation with the primary DNA-PKcs 
antibody coupled with overexposed development of the western blot (fluorescent 
detection) successfully detected a high molecular weight pool of DNA-PKcs, most of 
which failed to migrate far beyond the loaded well and represented hyper-PARsylated 
forms of DNA-PKcs.  Importantly, cell lysates from XAV939, ADP-HPD or combined 
XAV939/ADP-HPD treatments lacked the prominent high molecular weight pool of 
DNA-PKcs observed in the DMSO treated control.  Furthermore, a considerable level of 
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DNA-PKcs “degradation product” was noted below the DNA-PKcs band, a feature not 
present in the DMSO treated control.  Cumulatively, these observations demonstrate a 
high molecular weight pool of DNA-PKcs that is entirely dependent on tankyase 
1catalytic activity, and when disrupted, DNA-PKcs becomes dePARsyalted via PARG 
and targeted for proteasome degradation.  These findings further support the concept of a 
critical dynamic between pADPr-addition and removal that when challenged, resulted in 
destabilization of the DNA-PKcs protein.   
We speculate there may be a significant proportion of pADPr-modified DNA-
PKcs that contains few pADPr units (hypoPARsylated) that migrate with the DNA-PKcs 
band.  To investigate this possibility, we utilized gel electrophoretic filtration using 
extended run times (on a 4-20% gradient gel) to ‘filter out’ pADPr-modified, high 
molecular weight forms of DNA-PKcs (>470kD) from unmodified forms (470kD).  
Extended run-times through the gradient gel allows for greater resolution between the 
forms of DNA-PKcs that are ‘truly’ 470kD (no modification) and those that are modified 
(e.g. various numbers of pADPr residues and/or Ub/SUMO).  
In the DMSO treated controls, we observed a considerable reduction in the 
quantity of DNA-PKcs protein in the migrating band over longer run times.  Conversely, 
XAV939 treated samples showed only a modest reduction in the quantity of DNA-PKcs 
in the migrating band across all time points.  These findings demonstrate that the control 
sample possesses a considerable quantity of modified DNA-PKcs that is not present (to 
the same extent) in the XAV939 treated samples.  We suspect that in XAV939 inhibited 
samples, a small portion of the protein may contain pADPr residues added by 
incompletely inhibited tankyrase 1.  However, some proportion of DNA-PKcs that did 
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not migrate with unmodified forms of DNA-PKcs is likely to possess degradation signal 
residues (i.e., Ub or SUMO).  Interestingly, at the end of the time course, DMSO controls 
and XAV939 treated samples resulted in the same quantity of ‘unmodified’ DNA-PKcs 
relative to the 100% control (~36%).   
Taken together, our results demonstrate that DNA-PKcs exists in a wide-range of 
high molecular weight pools of both hypo- and hyperPARsylated forms that are 
dependent on tankyrase 1 cataytic activity.  Inhibition of tankyrase 1 PARP activity 
abolishes these variant high molecular weight forms (exceeding 470kD) of DNA-PKcs.        
4.3.7 DNA-PKcs is stabilized in a tankyrase-pADPr-dependent, proteasome-resistant 
form  
We have demonstrated that the DNA-PKcs protein is directly PARsylated by the 
catalytic activity of tankyrase 1 specifically, resulting in a proteasome resistant form of 
DNA-PKcs.  Further, we found that the extent of DNA-PKcs pADPr-modification has a 
considerable range.  Conditions that challenge the ability of tankyrase 1 to perform its 
catalytic PARP activity results in the dePARsylation of DNA-PKcs, proteasome-
mediated degradation and the rapid reduction of intracellular DNA-PKcs protein levels.  
Our results stress the importance of pADPr dynamics in the appropriate regulation of the 
modified target protein.  Taken together, our findings support a mechanistic model of 
tankyrase 1-dependent DNA-PKcs protein stabilization (Figure 11 [1]).  
We now speculate that the role of pADPr-modified DNA-PKcs goes beyond 
DNA-PKcs protein stability alone, possibly relevant in the function of DNA-PKcs in 
NHEJ DNA-repair.  Consistent with the findings of previous DNA-PKcs-pADPr kinase 
studies in vitro [8], we speculate that tankyrase 1-dependent pADPr-modification 
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enhances the kinase activity of DNA-PKcs in vivo [8]; perhaps a critical component in 
activation of the DNA-PK holoenzyme at double-stranded breaks.  In addition, pADPr 
may be necessary for DNA-PKcs recruitment to the DSB and scaffolding with the Ku 
heterodimer; Ku80 and DNA-PKcs have been shown to accept pADPr in vivo [31], 
whereas Ku70 and DNA-PKcs each possess pADPr interacting motifs (non-covalent 
interactions) [32]. 
4.4.0 Materials and Methods 
Cell lines 
WTK1 human lymphoblastoid cells have a stable karyotype (47, X, Y 13+, 14q+) 
and were derived from the WI-L2 line [51].  WTK1 cells are heterozygous at the 
thymidine kinase locus; they also have a single amino acid substitution in codon 237 at 
TP53.  WTK1 cells were maintained in RPMI1640 medium (Hyclone) supplemented 
with 10% heat-inactivated horse serum (Sigma-Aldrich) and 1% pen-strep (Hyclone. 
[25].  
Western blot analysis 
Western blot analysis was always performed to confirm successful knockdown of 
target protein level before proceeding with evaluation of endpoints.  Cells were 
harvested, centrifuged and resuspended in cold PBS (without Mg+ Ca+) twice, then 
immersed in 1x RIPA buffer (1x TBS, 1% Nonidet P-40, 0.5% sodium deoxycholate, 
0.1% SDS, 0.004% sodium azide) and protease inhibitor cocktail (Santa Cruz 
Biotechnology), incubated on ice for 5-10 min, then passed through a 25 gauge syringe 
needle and centrifuged for 10 min at 140,000x g at 4°C. Protein in the supernatant was 
quantified using a BSA protein assay. Thirty five to 50μg of the supernatant proteins 
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were fractionated by SDS-PAGE (Bio-Rad) and transferred to Immobilon-FL PVDF 
membranes (Millipore). Blots were blocked in 5% skim milk or 5% BSA in TBS 
containing 0.1% Tween 20 and incubated overnight at 4°C with the following primary 
antibodies: rabbit polyclonal anti-tankyrase 1 (200 μg/ml; Santa Cruz Biotechnology); 
mouse monoclonal anti-actin (200 μg/ml; Santa Cruz Biotechnology); mouse monoclonal 
anti-PKcs Ab-4 (200 μg/ml; Neomarker); rabbit polyclonal anti-ATM (1mg/ml; Abcam). 
The blots were washed three times with TBS containing 0.1% Tween 20 and incubated 
with secondary antibody 680IRDye-conjugated goat polyclonal anti-rabbit IgG or IRDye 
800CW-conjugated goat polyclonal anti-mouse IgG (1:15,000; LI-COR Biosciences). 
Bound antibodies were detected and using an Odyssey fluorescent imaging system (LI-
COR Biosciences); blots were quantified according to manufacturers’ instructions and 
normalized to independent actin loading controls [25]. 
Quantification of some blots was accomplished by importing images into 
Photoshop CS3 and analyzing as per a protocol adapted from the National Institutes of 
Health (http:/rsb.info.nih.gov/ij/index.html).  Analysis involved first, multiplying the 
mean measured value by the number of pixels to obtain an “absolute intensity” value, an 
integrated measure of intensity and size of bands.  Next, the relative intensity for each 
sample band was calculated by dividing the absolute intensity of each band by the 
absolute intensity of the standard (the mock transfection sample) [25]. 
Chemical inhibition  
Nu7026 (Sigma-Aldrich), a competitive and highly selective inhibitor of DNA-
PKcs kinase activity, was added to WTK1 cultures after siRNA transfection at a final 
concentration of 9 µM [52, 53], and remained on samples until collected for mutagenesis 
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or cytogenetic analyses.  We have consistently found that this concentration of Nu7026 
yields similar results for these end points as does siRNA knockdown of DNA-PKcs [25]. 
3-aminobenzamide (3-AB; Sigma-Aldrich) was used to inhibit global PARP 
activity at final concentrations ranging from 10 and 100 μM, to 10 and 20 mM.  3-AB 
was added to WTK1 cultures 24 hr prior to irradiation (or sham), which were then 
collected for mutation or western blot analyses [25].  
XAV939, the recently identified small molecule shown to specifically inhibit 
PARP activity of tankyrase 1 (and tankyrase 2 at higher concentrations) [21], was used 
here at much lower concentrations than 3-AB.  The tankyrase specific inhibitor XAV939 
(Tocris) was solubilized in DMSO at 55 ˚C to a stock concentration of 10mM, which was 
diluted to a working concentration of 100μM; final concentrations of 0.5μM or 1μM were 
well within the concentration parameters suggested for cell culture experiments to inhibit 
tankyrase specifically.  Cultures were maintained under these conditions for the duration 
of the designated time course.  Controls were exposed to DMSO alone [25].  
MG132.  WTK1 lymphoblasts were transfected with tankyrase 1 siRNA, or 
treated with 1.0 µM XAV939, then incubated with the proteosome inhibitor MG-132 
(12.5 μM; Sigma-Aldrich) for 2 hr time windows starting at 8, 10, 12 or 24 hours after 
transfection [54]. Cell samples were harvested 4 hours after treatment for western blot 
analysis [25]. 
ADP-HPD.  WTK1 lymphoblasts were treated with the PARG inhibitor ADP-
HPD [36] at 1.2 µM (EMD Chemicals) every 2.5 hours for a period of 10 hours, either 
alone or concurrently with XAV939 (1.0 µM final), at a final concentration of 4.8 µM 
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ADP-HPD. Samples were harvested at 10 hours following the respective treatment and 
lysates were prepared for western blot analysis [25].  
Electrophoretic separation of high molecular weight DNA-PKcs.  
WTK1 lymphoblasts treated with either DMSO or 1.0 µM XAV939 for 8 hours 
were loaded into independent wells of a 4-20% gradient SDS-PAGE every 2 hours over 
the course of 6 hours.  At each time point, DMSO and XAV939 samples were loaded into 
wells immediately adjacent to the prior time point.  The corresponding load times at 0, 2 
and 4 hours resulted in total run times of 2, 4 and 6 hours respectively.  Following 
completion of the final run time, the gel was analyzed via western blot for DNA-PKcs 
and actin loading controls, then quantified 25]. 
     
 

































































1. Dregalla RC, Zhou J, Idate RR, Battaglia CL, Liber HL, Bailey SM: Regulatory 
roles of tankyrase 1 at telomeres and in DNA repair: suppression of T-SCE 
and stabilization of DNA-PKcs. Aging (Albany NY) 2010, 2(10):691-708. 
2. Smith S, de Lange T: Tankyrase promotes telomere elongation in human cells. 
Curr Biol 2000, 10(20):1299-1302. 
3. Smith S, Giriat I, Schmitt A, de Lange T: Tankyrase, a poly(ADP-ribose) 
polymerase at human telomeres. Science 1998, 282(5393):1484-1487. 
4. Chang P, Coughlin M, Mitchison TJ: Interaction between Poly(ADP-ribose) 
and NuMA Contributes to Mitotic Spindle Pole Assembly. Mol Biol Cell 2009, 
20(21):4575-4585. 
5. Sbodio JI, Chi NW: Identification of a tankyrase-binding motif shared by 
IRAP, TAB182, and human TRF1 but not mouse TRF1. NuMA contains this 
RXXPDG motif and is a novel tankyrase partner. J Biol Chem 2002, 
277(35):31887-31892. 
6. Ame JC, Spenlehauer C, de Murcia G: The PARP superfamily. Bioessays 2004, 
26(8):882-893. 
7. Smith S: The world according to PARP. Trends Biochem Sci 2001, 26(3):174-
179. 
8. Ruscetti T, Lehnert BE, Halbrook J, Le Trong H, Hoekstra MF, Chen DJ, 
Peterson SR: Stimulation of the DNA-dependent protein kinase by poly(ADP-
ribose) polymerase. Journal of Biological Chemistry 1998, 273(23):14461-
14467. 
9. De Rycker M, Price CM: Tankyrase polymerization is controlled by its sterile 
alpha motif and poly(ADP-ribose) polymerase domains. Mol Cell Biol 2004, 
24(22):9802-9812. 
10. De Rycker M, Venkatesan RN, Wei C, Price CM: Vertebrate tankyrase domain 
structure and sterile alpha motif (SAM)-mediated multimerization. Biochem 
J 2003, 372(Pt 1):87-96. 
11. Yeh TY, Meyer TN, Schwesinger C, Tsun ZY, Lee RM, Chi NW: Tankyrase 
recruitment to the lateral membrane in polarized epithelial cells: regulation 
by cell-cell contact and protein poly(ADP-ribosyl)ation. Biochem J 2006, 
399(3):415-425. 
12. Juarez-Salinas H, Sims JL, Jacobson MK: Poly(ADP-ribose) levels in 
carcinogen-treated cells. Nature 1979, 282(5740):740-741. 
  139     
 
13. Alvarez-Gonzalez R, Jacobson MK: Characterization of polymers of adenosine 
diphosphate ribose generated in vitro and in vivo. Biochemistry 1987, 
26(11):3218-3224. 
14. Davidovic L, Vodenicharov M, Affar EB, Poirier GG: Importance of poly(ADP-
ribose) glycohydrolase in the control of poly(ADP-ribose) metabolism. Exp 
Cell Res 2001, 268(1):7-13. 
15. Jacobson EL, Antol KM, Juarez-Salinas H, Jacobson MK: Poly(ADP-ribose) 
metabolism in ultraviolet irradiated human fibroblasts. J Biol Chem 1983, 
258(1):103-107. 
16. Miwa M, Sugimura T: Splitting of the ribose-ribose linkage of poly(adenosine 
diphosphate-robose) by a calf thymus extract. J Biol Chem 1971, 
246(20):6362-6364. 
17. Ueda K, Hayaishi O: ADP-ribosylation. Annu Rev Biochem 1985, 54:73-100. 
18. Wielckens K, Schmidt A, George E, Bredehorst R, Hilz H: DNA fragmentation 
and NAD depletion. Their relation to the turnover of endogenous 
mono(ADP-ribosyl) and poly(ADP-ribosyl) proteins. J Biol Chem 1982, 
257(21):12872-12877. 
19. Hsiao SJ, Smith S: Tankyrase function at telomeres, spindle poles, and 
beyond. Biochimie 2008, 90(1):83-92. 
20. Chi NW, Lodish HF: Tankyrase is a golgi-associated mitogen-activated 
protein kinase substrate that interacts with IRAP in GLUT4 vesicles. J Biol 
Chem 2000, 275(49):38437-38444. 
21. Huang SM, Mishina YM, Liu S, Cheung A, Stegmeier F, Michaud GA, Charlat 
O, Wiellette E, Zhang Y, Wiessner S et al: Tankyrase inhibition stabilizes axin 
and antagonizes Wnt signalling. Nature 2009, 461(7264):614-620. 
22. Sbodio JI, Lodish HF, Chi NW: Tankyrase-2 oligomerizes with tankyrase-1 
and binds to both TRF1 (telomere-repeat-binding factor 1) and IRAP 
(insulin-responsive aminopeptidase). Biochem J 2002, 361(Pt 3):451-459. 
23. Chang P, Coughlin M, Mitchison TJ: Tankyrase-1 polymerization of 
poly(ADP-ribose) is required for spindle structure and function. Nat Cell Biol 
2005, 7(11):1133-1139. 
24. Gaglio T, Saredi A, Bingham JB, Hasbani MJ, Gill SR, Schroer TA, Compton 
DA: Opposing motor activities are required for the organization of the 
mammalian mitotic spindle pole. J Cell Biol 1996, 135(2):399-414. 
25. Merdes A, Ramyar K, Vechio JD, Cleveland DW: A complex of NuMA and 
cytoplasmic dynein is essential for mitotic spindle assembly. Cell 1996, 
87(3):447-458. 
26. Lade AG, Monga SP: Beta-catenin signaling in hepatic development and 
progenitors: Which way does the WNT blow? Dev Dyn 2011, 240(3):486-500. 
27. Dajani R, Fraser E, Roe SM, Yeo M, Good VM, Thompson V, Dale TC, Pearl 
LH: Structural basis for recruitment of glycogen synthase kinase 3beta to the 
axin-APC scaffold complex. Embo J 2003, 22(3):494-501. 
28. Ding Y, Dale T: Wnt signal transduction: kinase cogs in a nano-machine? 
Trends Biochem Sci 2002, 27(7):327-329. 
  140     
 
29. Liu C, Li Y, Semenov M, Han C, Baeg GH, Tan Y, Zhang Z, Lin X, He X: 
Control of beta-catenin phosphorylation/degradation by a dual-kinase 
mechanism. Cell 2002, 108(6):837-847. 
30. Xing Y, Clements WK, Kimelman D, Xu W: Crystal structure of a beta-
catenin/axin complex suggests a mechanism for the beta-catenin destruction 
complex. Genes Dev 2003, 17(22):2753-2764. 
31. Gagne JP, Isabelle M, Lo KS, Bourassa S, Hendzel MJ, Dawson VL, Dawson 
TM, Poirier GG: Proteome-wide identification of poly(ADP-ribose) binding 
proteins and poly(ADP-ribose)-associated protein complexes. Nucleic Acids 
Res 2008, 36(22):6959-6976. 
32. Pleschke JM, Kleczkowska HE, Strohm M, Althaus FR: Poly(ADP-ribose) binds 
to specific domains in DNA damage checkpoint proteins. J Biol Chem 2000, 
275(52):40974-40980. 
33. Milam KM, Thomas GH, Cleaver JE: Disturbances in DNA precursor 
metabolism associated with exposure to an inhibitor of poly(ADP-ribose) 
synthetase. Exp Cell Res 1986, 165(1):260-268. 
34. Purnell MR, Whish WJ: Novel inhibitors of poly(ADP-ribose) synthetase. 
Biochem J 1980, 185(3):775-777. 
35. Rock KL, Gramm C, Rothstein L, Clark K, Stein R, Dick L, Hwang D, Goldberg 
AL: Inhibitors of the proteasome block the degradation of most cell proteins 
and the generation of peptides presented on MHC class I molecules. Cell 
1994, 78(5):761-771. 
36. Okita N, Ashizawa D, Ohta R, Abe H, Tanuma S: Discovery of novel poly(ADP-
ribose) glycohydrolase inhibitors by a quantitative assay system using dot-
blot with anti-poly(ADP-ribose). Biochem Biophys Res Commun 2010, 
392(4):485-489. 
37. Nooren IM, Thornton JM: Structural characterisation and functional 
significance of transient protein-protein interactions. J Mol Biol 2003, 
325(5):991-1018. 
38. Dragovich PS, Zhou R, Skalitzky DJ, Fuhrman SA, Patick AK, Ford CE, Meador 
JW, 3rd, Worland ST: Solid-phase synthesis of irreversible human rhinovirus 
3C protease inhibitors. Part 1: Optimization of tripeptides incorporating N-
terminal amides. Bioorg Med Chem 1999, 7(4):589-598. 
39. Alvarez-Gonzalez R, Althaus FR: Poly(ADP-ribose) catabolism in mammalian 
cells exposed to DNA-damaging agents. Mutat Res 1989, 218(2):67-74. 
40. Ruscetti T, Lehnert BE, Halbrook J, LeTrong H, Hoekstra MF, Chen DJ, Peterson 
SR: Stimulation of the DNA-dependent protein kinase by poly(ADP-ribose) 
polymerase. Journal of Biological Chemistry 1998, 273(23):14461-14467. 
41. Nooren IM, Thornton JM: Diversity of protein-protein interactions. Embo J 
2003, 22(14):3486-3492. 
42. Kaminker PG, Kim SH, Taylor RD, Zebarjadian Y, Funk WD, Morin GB, 
Yaswen P, Campisi J: TANK2, a new TRF1-associated poly(ADP-ribose) 
polymerase, causes rapid induction of cell death upon overexpression. J Biol 
Chem 2001, 276(38):35891-35899. 
  141     
 
43. Galande S, Kohwi-Shigematsu T: Poly(ADP-ribose) polymerase and Ku 
autoantigen form a complex and synergistically bind to matrix attachment 
sequences. J Biol Chem 1999, 274(29):20521-20528. 
44. Peng Y, Woods RG, Beamish H, Ye R, Lees-Miller SP, Lavin MF, Bedford JS: 
Deficiency in the catalytic subunit of DNA-dependent protein kinase causes 
down-regulation of ATM. Cancer Res 2005, 65(5):1670-1677. 
45. Cook BD, Dynek JN, Chang W, Shostak G, Smith S: Role for the related 
poly(ADP-Ribose) polymerases tankyrase 1 and 2 at human telomeres. Mol 
Cell Biol 2002, 22(1):332-342. 
46. Rattan SI: Synthesis, modification and turnover of proteins during aging. Adv 
Exp Med Biol 2010, 694:1-13. 
47. Burger AM, Kona F, Amemiya Y, Gao Y, Bacopulos S, Seth AK: Role of the 
BCA2 ubiquitin E3 ligase in hormone responsive breast cancer. Open Cancer 
J 2010, 3(1):116-123. 
48. Slama JT, Aboul-Ela N, Goli DM, Cheesman BV, Simmons AM, Jacobson MK: 
Specific inhibition of poly(ADP-ribose) glycohydrolase by adenosine 
diphosphate (hydroxymethyl)pyrrolidinediol. J Med Chem 1995, 38(2):389-
393. 
49. Slama JT, Aboul-Ela N, Jacobson MK: Mechanism of inhibition of poly(ADP-
ribose) glycohydrolase by adenosine diphosphate 
(hydroxymethyl)pyrrolidinediol. J Med Chem 1995, 38(21):4332-4336. 
50. Althaus FR, Richter C: ADP-ribosylation of proteins. Enzymology and 
biological significance. Mol Biol Biochem Biophys 1987, 37:1-237. 
51. Levy JA, Virolainen M, Defendi V: Human lymphoblastoid lines from lymph 
node and spleen. Cancer 1968, 22(3):517-524. 
52. Veuger SJ, Curtin NJ, Richardson CJ, Smith GC, Durkacz BW: 
Radiosensitization and DNA repair inhibition by the combined use of novel 
inhibitors of DNA-dependent protein kinase and poly(ADP-ribose) 
polymerase-1. Cancer Res 2003, 63(18):6008-6015. 
53. Veuger SJ, Curtin NJ, Smith GC, Durkacz BW: Effects of novel inhibitors of 
poly(ADP-ribose) polymerase-1 and the DNA-dependent protein kinase on 
enzyme activities and DNA repair. Oncogene 2004, 23(44):7322-7329. 
54. Canudas S, Houghtaling BR, Kim JY, Dynek JN, Chang WG, Smith S: Protein 













Future Directions – Implications of poly(ADP-ribosyl)ation in Non-Homologous 
End-Joining pathways 
 
The following figures are original productions contributed by the author and are 
unpublished. 
 
5.1.0 pADPr is a diverse posttranslational protein modification with multiple 
functional implications 
We have found that the telomeric PARP family member PARP-5a, better known 
as tankyrase 1, operates as a key regulator of DNA-PKcs protein stability via poly(ADP-
ribosyl)ation (pADPr/PAR) modification [1].  In this modified form, DNA-PKcs 
maintains a proteasome-resistant conformation that is dynamically regulated by the 
contributions of tankyrase 1, poly(ADP-ribose) glycohydrolase (PARG) and the 
proteasome [1]. When tankyrase 1 is depleted or catalytically inhibited, intracellular 
DNA-PKcs is rapidly de-PARsylated (via PARG activity) and so becomes a substrate for 
proteasome-mediated degradation, resulting in the rapid and significant reduction of 
DNA-PKcs protein. 
Interestingly, there are examples of tankyrase-dependent pADPr protein 
modifications that result in destabilization and degradation of the modified protein [2-5].  
In the case of DNA-PKcs however, pADPr addition is a positive regulator of the protein, 
joining a select few other proteins which respond to PARsylation in a similar fashion [6, 
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7].  So, although not the first protein found to be stabilized via pADPr addition, the story 
regarding DNA-PKcs and pADPr -modification is just emerging and so, is incomplete. 
In a manner similar to phosphorylation, the addition of a pADPr chain to a protein 
is thought to initiate a conformational change in the acceptor protein via the net two 
negative charges of each APD-ribose monomer in the chain [8, 9]. Following pADPr 
addition, the fate of the pADPr-modified proteins have been shown to include: 
additional/secondary modification, recruitment of additional proteins, scaffolding 
between proteins and/or activation of the PARsylated protein [6-15]. 
Ubiquitination is one such possible secondary protein modification following 
pADPr-addition, as seen in the classic Telomere Repeat-binding Factor 1 (TRF1)-pADPr 
model [13].  Here, TRF1 is pADPr-modified by tankyrase 1 to release TRF1 from the 
telomere, allowing access to telomerase as well as progression of the replication fork 
through the telomere [13]. Once released, PARsyalted-TRF1 becomes a substrate for E3 
ubiquitin ligase and subsequent proteasome degradation if not dePARsyalted via PARG 
activity [13].   
A classic example of protein recruitment to a pADPr-modified protein is that of 
PARP-1 in the base-excision repair and single-strand break repair (BER/SSB) pathways, 
where, hypo-autoPARsylation is used to electrostatically recruit Ligase III and XRCC1 to 
the DNA-damage site (reviewed in [8]). Immediately following, hyper-autoPARsylation 
stimulates PARP-1 release from the DNA via heavy negative electrostatic repulsion 
between the pADPr groups and the negatively charged DNA (reviewed in [9]). Thus, 
PARP-1 utilizes pADPr as a mechanism for DNA-repair protein recruitment to the 
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damage site, releasing itself from the DNA once recruitment is completed, allowing for 
the appropriate repair proteins to access the damage site. 
A more recently described novel feature of pADPr addition is utilization of the 
electrostatic nature of the group to facilitate non-covalent scaffolding between adjacent 
proteins to maintain stable protein-protein interactions. The nuclear mitotic apparatus 
protein (NuMA) has been identified as a protein that requires tankyrase 1-dependent 
PARsylation for appropriate complex organization [6].  Each NuMA monomer recruited 
to the greater NuMA complex is PARsylated and interacts with the adjacent NuMA 
and/or associated tankyrase 1 monomers non-covalently through the pAPDr chain [6].  
When tankyrase 1 function is disrupted, the NuMA complex does not organize properly, 
leading to failure of spindle-pole organization and dynamics.  Earlier studies identified a 
variety of proteins that contain pADPr-interaction motifs, which are now recognized as 
potential players in protein complex scaffolding [16, 17].  Interestingly, amongst the 
proteins found to contain pADPr-interacting motifs are the non-homologous end-joining 
(NHEJ) proteins Ku70 and DNA-PKcs [17]. 
Protein modification by pADPr-addition has also been shown to activate some 
acceptor proteins. The transcription factor, nuclear factor of activated T-cells (NFAT), 
accepts pADPr via PARP-1 activity and is positively regulated as a result, increasing 
NFAT-dependent transcription [7].  Further, in vitro studies have demonstrated that 
DNA-PKcs is capable of pADPr-modification, and the corresponding functional 
consequence of this modification is increased DNA-PKcs kinase activity [12].   
It is clear that pADPr modification of proteins can have multiple purposes.  The 
addition of pADPr can result in subsequent protein modification by an additional 
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enzymes (i.e. E3 ubiquitin ligase) [3, 4, 13], recruitment of additional proteins 
electrostatically (i.e., PARP-1) [15, 18-20], non-covalent pADPr-dependent protein 
interactions (i.e. NuMA) [6, 11] or protein activation (i.e. NFAT & DNA-PKcs) [7, 12]. 
Thus, the role of DNA-PKcs PARsylation very likely extends beyond protein 
stabilization.  Currently, we understand that modification of DNA-PKcs via tankyrase 1-
dependent PARsylation has a dynamic, stabilizing role by protecting DNA-PKcs from 
proteasome-mediated degradation.  However, the functional implication of this 
modification has yet to be established.  
5.2.0 pADPr-modification in DNA-PK integrity 
5.2.1 DNA-PK components interact with pADPr and are PARP substrates  
Recruitment of the Ku70/Ku80 heterodimer to the site of a double-stranded break 
(DSB) is imperative for initiation of DNA-PK-mediated NHEJ [21]. The localization of 
the Ku70/80 heterodimer to a DSB results in the subsequent recruitment of DNA-PKcs, 
forming the DNA-PK holoenzyme (reviewed in 
[22]).  However, the means of DNA-PKcs recruitment to the Ku heterodimer, 
holoenzyme stabilization and mechanism of its activation is not currently understood.  
Studies have provided evidence of pADPr involvement in DNA-PK protein 
components [12, 16, 17].  Most recently, PARP-3 has been shown to be a key factor in 
recruitment and stabilization of XRCC4 & Ligase IV at the DSB following DNA-PK 
dissociation, possibly via pADPr-dependent processes [23].  Components of the DNA-PK 
holoenzyme have also been shown to accept pADPr in vivo [12, 16].  Additionally, Ku70 
and DNA-PKcs possess non-covalent pADPr-interacting motifs, suggesting a potential 
mechanism for DNA-PK scaffolding & stabilization [17].  Based on these findings and 
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our characterization of tankyrase 1-mediated DNA-PKcs pADPr modification, we 
hypothesize that pADPr modification of the DNA-PK proteins contributes to DNA-PK 
function in NHEJ-mediated DSB-repair from three perspectives: holoenzyme activation, 
protein recruitment and stabilization. 
5.2.2 DNA-PKcs kinase function in the DNA-PK holoenzyme requires tankyrase 1-
dependent pADPr-modification 
The first insight into a potential role for pADPr modified DNA-PKcs came from a 
previous study in vitro that demonstrated PARsylated DNA-PKcs possessed increased 
kinase activity compared to unmodified forms [12].  A protein complex 
immunoprecipitation (Co-IP) pull-down of PARP-1 identified DNA-PKcs as an 
intracellular binding partner, leading to an investigation as to the possible purpose of such 
a complex [12].  Analysis of PARP-1 catalytic activity revealed that DNA-PKcs is an 
acceptor of pADPr residues in a DNA-independent manner.  Further, pADPr-modified 
forms of DNA-PKcs demonstrated an up-regulation in kinase function of approximately 
7-fold over unmodified forms, regardless of the presence or absence of DNA in the 
reaction.  This study provided preliminary evidence in support of DNA-PKcs being a 
pADPr-modified member of the proteome with functional implications.   
Proteome-wide interrogation of pADPr-modified proteins has verified DNA-PKcs 
as a pADPr-modified protein [16].  We find that pADPr-modification is fundamental to 
maintaining DNA-PKcs protein stability, whereas in vitro studies submitted that there is a 
functional role for this modification in the regulation of DNA-PKcs kinase activity [12]. 
To date, evidence for the role of pADPr-modified DNA-PKcs from a functional 
biochemical perspective is lacking.   
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We postulate that tankyrase 1-dependent pADPr-modification of DNA-PKcs 
results in a proteasome resistant, kinase active form of the protein that is favored in 
DNA-PKcs-dependent biochemical processes, DNA-repair specifically.  Considering that 
the role of DNA-PKcs is to serve as the active kinase in DNA-PK-mediated NHEJ we 
speculate that pADPr-modified DNA-PKcs exists in a dynamic proteasome resistant 
pool, providing a readily available ‘reserve’ of catalytically active DNA-PKcs ‘primed’ 
for immediate response to the Ku heterodimer (at the DSB) and the initiation of DNA-
PK-mediated NHEJ.   
5.2.3 PARP-1 activity in the recruitment of DNA-PKcs to the Ku heterodimer 
The mechanism by which DNA-PKcs is recruited to the Ku heterodimer at the 
site of a DSB is not understood.  We postulate that the recruitment of DNA-PKcs to the 
Ku heterodimer is a pADPr dependent event on two separate fronts.  The first requisite is 
that DNA-PKcs exist in a pADPr-modified form.  Provided this, we suspect an additional 
pADPr-modified component of DNA-PK is necessary for appropriate holoenzyme 
assembly and stabilization.  We propose PARsylated Ku80 as a candidate to complete 
pADPr scaffolding within the DNA-PK holoenzyme, as it has also been shown to be a 
PARsylated member of the proteome [16].   
The Ku heterodimer and PARP-1 each recognize the chemical signatures of 
exposed DNA-ends and so, it has been proposed they compete for DSB-ends and 
determine pathway choice: classical NHEJ or alternative PARP-1-mediated NHEJ [21].  
Failure to assemble the DNA-PK holoenzyme is known to result in ligase IV-dependent 
NHEJ [24] and/or PARP-1-mediated ‘alternative NHEJ’ [25].  Consistent with such 
studies, we imagine that PARP-1 acts as an accessory protein to the DNA-PK 
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holoenzyme [26] by initiating recruitment of DNA-PKcs to the DNA-bound Ku 
heterodimer via pADPr-modification of Ku80.     
Although association of the Ku heterodimer with the DSB reduces the affinity of 
PARP-1 for the exposed-DNA ends [21], it does not necessarily completely inhibit the 
ability for PARP-1 to briefly bind DNA.  Once bound to the DSB, the Ku heterodimer 
translocates distal to the break [27], allowing restricted access of PARP-1 to the DSB.  
As a consequence, PARP-1 would form a short lived intermediate complex with the DSB 
and Ku80 and thus, the association of PARP-1 with the exposed ends of the break is not 
long enough to recruit PARP-1-associated DNA-repair proteins (as it presumably would 
in alternative NHEJ [25]).  However, this model does associate Ku80 with a PARP 
family member in a site-specific manner, suggesting a mechanism by which the reported 
PARP-1-Ku80 complex forms [28] and Ku80 becomes PARsylated [17] (Figure 1).   
We propose pADPr modification of Ku80, at the DSB specifically, may in fact 
serve as a mechanism for recruitment of DNA-PKcs and its subsequent activation, similar 
to PARP-1 automodification in the recruitment to SSB-repair proteins [25].  This model 
depicts the co-localization of PARP-1 and the Ku heterodimer at the DSB and the 
ensuing PARsylation of Ku80, providing a plausible basis for the ‘DNA-dependent’ 
nature of the DNA-dependent Protein Kinase; i.e., DNA-PK is activated upon recruitment 
and binding of DNA-PKcs to the pADPr-modified, DNA-bound Ku heterodimer. 
5.2.4 pADPr acts as a scaffold between DNA-PK protein components 
We propose that PARP-1, the ‘competitor’ with the Ku heterodimer for DSBs 
[21], co-localizes with the Ku heterodimer at the DSB and subsequently PARsylates 
Ku80.  The pADPr-modification of Ku80 provides a practical means of recruitment for 
  149     
 
DNA-PKcs.  The pADPr modification has been shown to be essential in non-covalent 
scaffolding between proteins [6], which requires a pADPr interacting motif [17].  
Interestingly, both Ku70 and DNA-PKcs have been shown to possess these motifs and 
are capable of forming complexes with PARsylated proteins [17].     
We speculate that pADPr provides the core scaffolding structure within the DNA-
PK holoenzyme and is necessary for stability and function of the enzyme in NHEJ-
mediated DNA-repair.  Consistent with our model, the pADPr chain extending from 
Ku80 (PARP-1-dependent) would serve as a platform for a strong non-covalent 
interaction with the pADPr-interacting motif(s) of DNA-PKcs.  Ku80 in a PARsylated 
form favors recruitment of pADPr-modified DNA-PKcs (with enhanced kinase activity 
[12]) to complete pADPr-dependent DNA-PK scaffolding; the pADPr chain extending 
from DNA-PKcs interacts with the Ku70 pADPr-interacting motif [16, 17] (Figure 1).   
5.2.5 pADPr modification in the activation, recruitment and stabilization of DNA-PK 
components  
Here, we propose to investigate pADPr-modification as a key feature of 
functional DNA-PK. The model we intend to test involves pADPr-modification of Ku80 
at DSBs specifically, perhaps by catalytic activity of PARP-1, co-localized to the DSB. 
The PARsylated heterodimer electrostatically recruits DNA-PKcs to the DSB site in a 
similar fashion as hypo-autoPARsylated PARP-1 recruits SSB-repair proteins (reviewed 
[8]). Next, the newly recruited DNA-PKcs protein interacts with the pADPr chain 
extending from Ku80 via its pADPr interaction motif.  However, the affinity of DNA-
PKcs for the Ku heterodimer is likely dependent on the PARsylated state of DNA-PKcs. 
DNA-PKcs recruited in PARsylated state will interact electrostatically (through the 
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pADPr chain) with the pADPr-interacting motif of Ku70.  In this model, pADPr 
modification is responsible for DNA-PKcs recruitment to the Ku heterodimer, as well as 
the stabilization of the DNA-PK holoenzyme where it acts as a scaffold between the 
subunits.  Further, DNA-PKcs may be recruited by Ku80-associated pADPr, but DNA-
PK scaffolding would be incomplete without pADPr associated DNA-PKcs. Thus, the 
selection of DNA-PKcs in a PARsylated, kinase active state is necessary to establish a 
stable, catalytically active DNA-PK complex (Figure 1). 
Corresponding to the model proposed above, deficiency in PARP-1 activity 
would result in failure to modify Ku80 via pADPr.  The consequences of this deficiency 
would in many ways mirror that of failed DNA-PKcs pADPr modification or DNA-PKcs 
deficiency.  Here, the inability to PARsylate Ku80 would deter DNA-PKcs recruitment 
and therefore fail to assemble the functional DNA-PK holoenzyme.  In the event DNA-
PKcs was recruited to the heterodimer by chance, the incomplete scaffolding of DNA-PK 
components would again result in a short lived DNA-PK complex.  This model provides 
a potential explanation as to why the DNA-PK holoenzyme does not localize to DSBs 
preassembled; PARP-1-dependent PARsylation of Ku80 at the DSB provides reasoning 
as to the why the recruitment of DNA-PKcs to the heterodimer is ‘DNA-dependent’.            
Our overall goal is to move forward from our initial observation of tankyrase 1-
dependent PARsylation of DNA-PKcs being required for proteasome resistance, to 
pADPr modification being critical for appropriate recruitment, scaffolding and activation 
of DNA-PK and ‘classic-NHEJ’. We aim to investigate the involvement of pADPr-
modified forms of DNA-PKcs in DNA-PK holoenzyme assembly and function. Further, 
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we aim to provide evidence of PARP-1 as a critical accessory protein to DNA-PK 
assembly. 
Under conditions in which DNA-PKcs is not recruited in a pADPr-modified form, 
DNA-PK holoenzyme scaffolding is incomplete, unstable and catalytically inactive.  
Further, we postulate dysfunction of PARP-1 would result in deficient DNA-PKcs 
recruitment.  However, in this case, successful binding of DNA-PKcs with the 
heterodimer despite lacking Ku80 pADPr modificaiton would result in a catalytically 
active but unstable holoenzyme.  Our model presented here poses a mechanism for DNA-
PK holoenzyme formation, stabilization and activation.  Deficiencies in PARsylating 
events would result in the shift from DNA-PK-mediated end-joining to PARP-1 mediated 
DSB-repair.  
5.3.0 PARP-1-mediated ‘alternative’ NHEJ or salvage pathway? 
We propose a potential model for PARP-1 acting as an accessory protein to the 
DNA-PK holoenzyme assembly which can potentially explain the findings of previous 
studies suggesting PARP-1 and DNA-PK function in conjunction with one another for 
efficient end-joining repair [26], not as competitors as speculated by others [21].  This 
relationship between PARP-1 and DNA-PK may also involve PARP-2, as PARP-2 has 
been historically recognized as a PARP with ‘redundant’ function to PARP-1 [29-31].   
In the absence of DNA-PKcs, Ku-mediated end-joining involving ligase IV is 
known to occur in a PARP-1 independent fashion [24, 32, 33].  Thus, although the 
mechanism of DSB-repair may differ, failure to recruit DNA-PKcs results in residual Ku-
mediated, Ligase IV/XRCC4-dependent end-joining.  Failure to resolve DSBs by DNA-
PK and/or Ligase IV dependent end-joining results in the initiation of PARP-1-mediated 
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alternative-NHEJ, involving several PARP-1 interacting single-stranded break (SSB) 
repair proteins [25].     
PARP-1 is known to interact with DNA for brief periods of time during its role in 
DNA-repair (SSB and DSB-repair).   PARP-1 readily binds single-strand breaks in a 
hypo-PARsylated form for the purpose of recruiting the required SSB-repair components, 
XRCC1 and Ligase III [8, 9, 34].  DNA-bound PARP-1 is stimulated to further auto-
PARsylate, resulting in hyper-PARsylated PARP-1 and release from the DNA through 
electrostatic repulsion [9, 35].  Considering DNA-bound PARP-1 stimulates the release 
of PARP-1, it is unlikely PARP-1 binding to the each side of the DSB is sustained for a 
long enough period of time to facilitate a true alternative NHEJ pathway.   
Second, PARP-1 access to the DNA break may not be entirely inhibited by the 
DNA-bound Ku heterodimer.  In fact, it has been postulated that PARP-1 functions 
concurrently with DNA-PK to achieve NHEJ [26].  The Ku heterodimer recognizes the 
chemistry of DSBs and translocates ~14bps upstream from the damage site [27].  Due to 
this, there is a degree of interference introduced by Ku that antagonizes PARP-1 
association with the DNA.  However, this does not necessarily mean PARP-1 is entirely 
blocked from the DNA-break.  Rather, the affinity of PARP-1 for the exposed DNA ends 
may be reduced, owing to steric hinderance resulting from Ku-bound DNA.  Further, the 
longer Ku70/80 is in association with DNA, the greater the chance for the heterodimer to 
dissociate from the DNA or translocate distal from the break and failure to form the 
DNA-PK holoenzyme.  
Lastly, we know the alternative method of NHEJ is employed in the event of Ku, 
Ligase IV and in some cases DNA-PKcs deficiencies [36-39].  Compared to ‘classical’, 
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DNA-PK-mediated NHEJ, ‘alternative’ NHEJ is slow and error-prone, resulting in 
translocations between chromosomes [40-42].  The combination of these alternative 
NHEJ characteristics results in an elevated frequency of chromosomal translocations [40] 
and thus, increased carcinogenic potential (reviewed in [40, 43]).  The question to be 
addressed is what drives the ‘switch’ from ‘classic’ to ‘alternate’ NHEJ pathways, and 
what contributes to the reduced fidelity of end-joining function in the latter pathway?  
Recent research proposes the machinery involved in ‘alternative’ NHEJ is comprised 
largely of SSB-repair proteins [25, 44, 45] and thus, we suspect PARP-1-mediated DSB 
repair may in fact be the result of SSB-repair events.   
5.4.0 PARP-1-mediated DSB-repair via alternative NHEJ 
5.4.1 Alternative NHEJ as DSB-salvage pathway mediated by SSB-repair events   
In vitro analysis has shown PARP-1 affinity for exposed DNA-ends is higher than 
that of DNA-PK, indicating broken DNA (double- or single-stranded) will 
‘preferentially’ bind PARP-1 over the DNA-PK holoenzyme [46].  However, inhibition 
of either PARP-1 or DNA-PKcs has been shown to decrease (not entirely diminish) DSB-
repair capability to a remarkably similar extent, suggesting PARP-1 and DNA-PK work 
in conjunction to rapidly repair DSBs [26, 47].  We suggest PARP-1 does not compete 
with the Ku heterodimer for DSBs [21] (DNA-PK verses PARP-1-mediated NHEJ) but 
rather, persists as an accessory protein to the DNA-PK holoenzyme.  Failure to assemble 
a functionally active DNA-PK holoenzyme results in PARP-1-mediated DSB-repair. 
We postulate PARP-1 and the Ku heterodimer interact at DSBs concurrently, 
allowing for PARP-1/2 mediated PARsylation of Ku80. Failure to recruit DNA-PKcs and 
activate the DNA-PK holoenzyme will ultimately favor PARP-1 association with the 
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DSB, independent of the Ku heterodimer resulting in the ‘switch’ to alternative NHEJ.  
PARP-1 binding to DNA inhibits association of the Ku heterodimer with the DSB and 
activates PARP-1 catalytic activity, subsequent automodification (hypoPARsylates) and 
the recruitment of SSB-repair machinery [44, 45].  In both alternative NHEJ and SSB-
repair, PARP-1 automodification recruits XRCC1 [34], Ligase III and DNA polymerase 
β (POL-β) [8], perhaps on each side of the DNA duplex to facilitate SSB-repair.  Thus, 
PARP-1-mediated DSB-repair requires time to recruit the necessary repair proteins and 
close proximity of the broken ends (Figure 2).  Our model provides an explanation for the 
error-prone nature of PARP-1-mediated DSB end-joining, which often results in 
translocation events between chromosomes [40, 48, 49].         
We explain the characteristics of PARP-1-dependent alternative NHEJ as the 
result of slower DSB-repair due to the restrictions of SSB-repair processes in repairing 
DSBs.  As time elapses following the induction of DSBs, PARP-1-mediated repair fails 
to end-join the originally paired DNA-strands, as they become increasingly far apart.  
Thus, the ends of the break can ‘drift’ toward an entirely different DSB, where PARP-1-
mediated SSB-repair events can end-join the proximal DNA-strands, resulting in a 
translocation event.  This explanation of the alternative-NHEJ process as a salvage 
pathway, using two independent SSB-repair events provides a potential explanation as to 
the reduced efficiency and error-prone nature of PARP-1-mediated DSB repair.         
5.5.0 DNA-PKcs pADPr-modified residue(s) 
Beyond the scope of PARP-1-mediated DSB-repair, it will be critical to establish 
the precise location/s of tankyrase 1-dependent DNA-PKcs pADPr modification.  
Identification of these pADPr modified residues in DNA-PKcs will be essential to 
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understanding DNA-PKcs deficiencies (protein level and/or function), telomere 
uncapping and impaired NHEJ capability.  As with our study investigating the impact of 
single-nucleotide polymorphisms (SNPs) within the murine Prkdc allele and telomere-
uncapping, a SNP in a critical domain/motif is capable of abolishing protein function 
[50].  Variant forms of DNA-PKcs resulting from SNPs and possibly influencing pADPr 
modification sites of DNA-PKcs directly or tankyrase 1 interacting motifs, would be 
crucial to developing biomarkers for IR sensitivity, estimating risk of carcinogenesis and 
even understanding accelerated aging.  The inability to PARsylate DNA-PKcs as the 
consequence of a SNP impacting tankyrase 1 interaction and/or pADPr accepting 
residues would result in critically low levels of DNA-PKcs, as it becomes a substrate for 
E3 ligase ubiquitination.     
Relevant to our model proposing pADPr-dependent DNA-PK activation, 
recruitment and scaffolding, variant forms of DNA-PKcs incapable of being PARsylated, 
would fail to form a stable, activated DNA-PK holoenzyme capable of performing DNA-
PK-mediated NHEJ function.  Hence, cellular IR sensitivity would be increased and 
background mutagenesis would further enhance carcinogenic risk.  Additionally, variant 
forms of tankyrase 1 resulting from SNPs in the TNKS allele would result in similar, if 
not identical phenotypes.  
5.6.0 Significance and Relevance to Cancer 
Identification of the mechanism by which the DNA-PK holoenzyme is assembled, 
stabilized and activated is of critical importance with respect to carcinogenesis.  
Carcinogenesis is characterized by the accumulation of mutations, genomic instability 
and inappropriate cell-cycle regulation.  Our proposed investigation would provide 
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valuable mechanistic insight into pADPr-dependent DNA-PK function and effective 
NHEJ.  According to our model, DNA-damage induced in a background where pADPr-
acceptor residues in DNA-PKcs and/or Ku80 are mutated would result in a significantly 
increased rate of mutagenesis due to inefficient ‘classical’ NHEJ.  The inability to 
assemble a catalytically active DNA-PK holoenzyme, as seen in Ku deficient cells, would 
result in PARP-1-mediated end-joining throughout the cell cycle [40].  This method of 
end-joining is slow, inefficient and error prone, resulting in increased translocation [40-
42].  Inherently, translocations between chromosomes has been shown to correlate with 
increased carcinogenic potential; often playing a role in oncogene activation.  The 
Philadelphia chromosome, a 9:22 translocation responsible for CML, provides a classic 
example (reviewed in [43]).  Our model would be the first to explain the shift from DNA-
PK-mediated NHEJ to PARP-1-mediated end-joining and the corresponding increase in 
translocation events and subsequent carcinogenic phenotypes as the result of mis-
regulated pADPr-dependent recruitment, scaffolding and activation of the DNA-PK 
holoenzyme. 
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6.1.0 Overview of Findings 
6.1.1 DNA-PKcs-dependent telomere end-capping requires the leucine zipper domain 
Our investigation of the two single-nucleotide polymorphisms (SNPs) residing in 
the Prkdc allele of the BALB/c mouse revealed that the leucine zipper domain is essential 
for effective telomere end-caping.  Consistent with our prior studies, we find the DNA-
PKcs-deficient BALB/c mouse experiences telomere uncapping and fusion events 
involving DSBs following IR exposure [1].  The BALB/c mouse harbors two Prkdc 
SNPs, one within the phosphatidylinositol-3-related-kinase (PIKK) (M3844V) domain 
and the other within the protein interacting leucine zipper motif (R2140C) [2].  Here, we 
investigated the DNA-PKcs SNPs responsible for BALB/c telomere dysfunction using 
the LEWES mouse, which contains only the Prkdc SNP within the PIKK domain 
(M3844V) [3].  The frequency of telomere-based fusions, both spontaneous and IR 
induced, in LEWES mirrored those observed in the control C57BL/6 mouse [3].  Based 
on these findings, we concluded that DNA-PKcs end-capping function relies on the 
leucine zipper motif rather than the catalytic kinase activity, perhaps suggesting an 
important new role for conformational changes in activating the kinase function.    
The transcriptional (mRNA) expression of the BALB/c Prkdc allele does not 
significantly differ from C57BL/6 Prkdc allele expression [4].  However, the level of 
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detectable DNA-PKcs protein is significantly less in the BALB/c cell line compared to 
that of C57BL/6.  Thus, the SNPs within the leucine zipper and PIKK domain of the 
Prkdc allele in the BALB/c mouse negatively impacts DNA-PKcs protein stability [2, 4].  
The SCID mouse shows a more dramatic DNA-PKcs deficiency and instability 
phenotypes [5] and unlike BALB/c, SCID contains a truncated form of the DNA-PKcs 
protein that results in lowered protein levels and a kinase null protein [6].  Interestingly, 
the BALB/c DNA-PKcs protein is not truncated and contains all functional domains but 
protein levels are reduced as the consequence of a posttranscriptional defect [2, 4, 7].  We 
sought to separate function of the BALB/c Prkdc SNPs present in the leucine zipper 
motif (R2140C) and PIKK domain (M3844V). 
Considering our evidence demonstrating DNA-PKcs protein stability dependence 
on tankyrase 1 poly(ADP-ribosyl)ation (PARsylation/pADPr) [8], we speculated that 
specific SNPs within the Prkdc allele might interfere with the ability to PARsylate DNA-
PKcs.  Although, we recognize that the tankyrase 1-DNA-PKcs relationship has not yet 
been investigated in the mouse model and that  tankyrases are known to play differing 
roles in the mouse compared to humans [9], if the relationship between tankyrase 1 and 
DNA-PKcs identified in human cell lines holds true in the mouse, then it is possible that 
the leucine zipper motif is critical for the association of DNA-PKcs with tankrase 1.  An 
inability to initiate docking between the two proteins as a consequence of SNPs in the 
leucine zipper domain could result in the inability to pADPr-modify DNA-PKcs and 
subsequent proteasome-mediated degradation, explaining the dramatically reduced level 
of detectable DNA-PKcs protein in the BALB/c mouse [2].  Further, telomeric end-
capping and DNA-PK-mediated NHEJ would be impaired as the consequence of the 
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inability for DNA-PKcs to accept pADPr.  This model would explain the observed 
sensitivity of BALB/c cells to IR, increased mutagenesis and telomere-uncapping [1, 2, 4, 
7, 10, 11].  Extrapolation of this model to the human, argues particular PRKDC 
polymorphisms in domains that are essential for tankyrase-1 binding and/or pADPr 
addition of the DNA-PKcs protein would result in robust genome and telomere instability 
phenotypes.                     
6.1.2 Tankyrase 1 depletion results in telomeric-recombination and genomic instability 
phenotypes 
We identified tankyrase 1 as a key player in maintaining genomic integrity by 
regulating stability of the DNA-repair protein DNA-PKcs.  Such a role for tankyrase 1 is 
novel in that the tankyrase subfamily of PARPs lack a DNA-binding domain, unlike the 
DNA-repair-associated PARPs 1 and 2 [12-14].  Initially identified and understood to be 
a regulator of telomere length, tankyrase 1 PARsylates the telomere-repeat binding factor 
1 (TRF1), releasing it from the telomere and providing access to telomerase [15, 16].  
Consistent with our initial hypothesis and supporting reports describing the necessity for 
tankyrase 1 in telomere stability [17], tankyrase 1 siRNA-mediated protein depletion 
resulted in elevated frequencies of cytogenetically visible telomere sister chromatid 
exchanges (T-SCEs) [8].  However, we did not observe increased frequencies of 
genomic-sister chromatid exchanges (G-SCE) above background under similar tankyrase 
1 knockdown conditions [8], suggesting the role of tankyrase 1 in regulating these 
recombination events is specific to the telomere.  Provided the well characterized role of 
tankyrase 1 in dissociating TRF1 from telomeric double-stranded DNA [15, 16], 
tankyrase 1 knockdown would result in the failure to dissociate TRF1, stalling the 
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replication fork progression through the telomere.  To circumnavigate the obstruction 
posed by TRF1, sister chromatid exchanges within the telomeric sequence would allow 
for short advancements, a ‘by-pass’ by the DNA-polymerase.   
n addition to the telomere-specific function of tankyrase 1 in terms of regulating 
sister chromatid exchanges, tankyrase 1 knockdown also resulted in an array of 
unanticipated genomic instability phenotypes.  First, the depletion of tankyrase 1 protein 
levels resulted in increased IR-sensitivity in multiple cell-types (over the mock 
transfected controls).  This finding suggested that the impact of tankyrase 1 depletion 
reaches beyond increased telomere-recombination (T-SCE) and may involve a role in 
DNA-repair.  In support of this, our analysis of mutation frequency in human 
lymphoblasts (WTK1) under tankyrase 1 knockdown conditions revealed elevated 
frequencies of thymidine kinase (TK) mutations.  Tankyrase 1 depletion also resulted in 
increased terminal deletions and telomere-based chromosome fusions following exposure 
to both low- and high- linear energy transfer (LET) radiation-types (over the siRNA 
mock transfection) [8].  Therefore, the depletion of tankyrase 1 protein resulted in a 
significant increase over the background of several genomic instability phenotypes. 
Western blot analysis of classical non-homologous end-joining (C-NHEJ) 
proteins Ku80 and DNA-PKcs following tankyrase 1 knockdown revealed a significant 
reduction in DNA-PKcs protein levels; however, levels of Ku80 were unaffected by 
tankyrase 1 protein depletion.  To investigate the underlying mechanism by which the 
DNA-PKcs protein was depleted, we determined the relative level of mRNA transcripts 
for tankyrase 1, tankyrase 2 and DNA-PKcs via qRT-PCR analysis.  As expected, 
tankyrase 1 mRNA levels were diminished whereas tankyrase 2 and DNA-PKcs 
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transcript levels were unaffected.  These findings demonstrated the specificity of the 
knockdown (tankyrase 1-specific), and that DNA-PKcs protein stability relies on 
tankyrase 1 at the protein level.  Further, the converse knockdown of DNA-PKcs showed 
that tankyrase 1 protein levels were unaffected.  Based on these findings, we concluded 
that DNA-PKcs protein stability is dependent on the catalytic activity of tankyrase 1.  We 
found that the depletion of tankyrase 1 leads to increased telomere recombination events 
and further, the depletion or catalytic inhibition of tankyrase 1 results in genomic and 
telomere instability phenotypes that emerge as a consequence of DNA-PKcs depletion. 
6.1.3 DNA-PKcs protein stability is dynamically regulated by tankyrase 1-dependent 
pADPr-modification and PARG activity  
Instability phenotypes emerging as the consequence of tankyrase 1 siRNA-
mediate depletion stems from the combination of telomere uncapping and DNA double-
stranded break (DSB)-repair deficiencies.  Most importantly, we identified the role of 
tankyrase 1 in DNA-repair associated genomic instability as one that is indirect in nature; 
i.e., DNA-PKcs protein stability is dependent on the tankyrase 1 protein.  Preliminary 
evidence also suggested that the relationship between tankryase 1 and DNA-PKcs was 
not stoichiometric in nature which would require the stable interaciton of tankyrase 1 
with DNA-PKcs, as Co-IP failed to demonstrate a stable complex between the two 
proteins.  In support or a transient interaction, we found that high concentrations of the 
broad-range PARP inhibitor 3-aminobenzamide (3-AB) (20 mM, more than that 
necessary to inhibit PARP-1 and PARP-2 [18, 19]) was most effective in the depletion of 
DNA-PKcs protein levels; suggesting the activity of a PARP family member other than 
PARP-1 and/or PARP-2 is responsible for DNA-PKcs protein stability.  
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To investigate further, we turned to small molecule inhibitors of tankyrase 1 and 
poly(ADP-ribose) glycohydrolase (PARG) enzymatic activity, XAV939 and ADP-HPD 
respectively.  We found that inhibition of tankyrase PARP catalytic activity resulted in 
the rapid and prominent reduction of DNA-PKcs protein levels.  This observation 
supported the concept that DNA-PKcs protein stability is dependent on tankyase 1 and 
more importantly, builds on the findings of the 3-AB studies suggesting tankyrase 1 
catalytic activity as a key factor in DNA-PKcs protein stability.  We concluded that the 
stability of DNA-PKcs is dependent on tankyrase 1 PARsylating activity specifically, 
rather than the simple presence of the tankyrase 1 protein alone.  Furthermore, the 
PARsylating activity of tankyrase 1 in DNA-PKcs protein stability does not appear to be 
redundant across PARP-family members; i.e., 3-AB and XAV939 studies indicated the 
activity of other PARPs do not contribute to the stability of DNA-PKcs.    
Additional studies, including western blot analysis (over-exposed) with 
fluorescent immunolabeling of DNA-PKcs, revealed high molecular weight forms of 
DNA-PKcs that failed to migrate with the dominant 470kD band.  Further electrophoretic 
separation of the 470kD DNA-PKcs protein band revealed that DNA-PKcs was highly 
heterogeneous with respect to molecular weight.  Lysates from cells treated with 
tankyrase and/or PARG inhibitors (XAV939 & ADP-HPD, respectively) demonstrated 
that the heterogeneity of DNA-PKcs molecular weight is dependent on tankyrase 1 
enzymatic modification (PARsylation).  Therefore, we concluded that DNA-PKcs was 
PARsylated via tankyrase 1, resulting in a proteasome-resistant form of DNA-PKcs, in 
what might arguably be a catalytically active form of DNA-PKcs [20].   
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In addition to identification of a mechanistic role for tankyrase 1 in DNA-PKcs 
stability, we clearly demonstrated the fundamental importance in maintaining the 
dynamic nature of the pADPr modification and thus, the appropriate regulation of the 
pADPr acceptor protein, DNA-PKcs.  In our model, the outcome of disrupting the critical 
dynamics of pADPr addition and removal proved to be detrimental from two separate 
approaches:  pADPr-dependent DNA-PKcs stability and appropriate tankyrase 1 
autoregulation.   
Beyond demonstrating the dependency of DNA-PKcs protein stability on 
tankyrase 1 PARsylation, XAV939 tankyrase inhibitor studies revealed the importance of 
the transient, dynamic nature of the pADPr-modification.  Inhibition of tankyrase 1 
enzymatic activity resulted in the depletion of DNA-PKcs over a short time course (<12 
hours) compared to the siRNA studies, in which maximum depletion of DNA-PKcs 
required approximately 24 hours.  Inhibition of the tankyrase PARP domain rapidly 
destabilized the DNA-PKcs protein despite the increase in intracellular tankyrase 1 
protein levels [8].  Provided PARG activity is rapid enough to dePARsylate all pADPr 
modified proteins in <60 seconds following PARP inhibition proteaome-wide [21, 22], 
we suspected that pADPr modification of DNA-PKcs was short-lived with a rapid turn 
over between 'PARsylated' and 'dePARsylaed' states.   
Inhibition of tankyrase 1 PARsylating activity forces the rapid PARG-mediated 
dePARsylation of DNA-PKcs, favoring proteasome-mediated degradation.  We do not 
suspect every monomer of DNA-PKcs to be PARsylated intracellularly but rather acts 
dynamically with a rapid on/off rate, supporting the concept that posttranslational 
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modifications (e.g., phosphorylation) with regulatory implications are generally transient 
and in nature [23, 24].  
Over the course of our investigation, we repeatedly illustrated that the regulation 
of DNA-PKcs protein stability is dependent on pADPr-addition by tankyrase 1 & 
removal by PARG [8].  Targeting of DNA-PKcs for proteasome-mediated degradation 
appears to depend on several factors, including the state of DNA-PKcs PARsylation in 
respect to time and space.  In order to be targeted for the proteasome, PARG activity 
against DNA-PKcs PARsylation and E3-Ligase acitivty must be close in time and space 
such that the respective DNA-PKcs protein unit exists in a completely dePARsylated state 
at the instantaneous moment of the encounter with an E3-Ligase.  PARsylated forms of 
DNA-PKcs that encounter an E3-Ligase therefore will have no consequence, illustrating 
the importance for the dynamics of pADPr addition and removal.  Changing the rate of 
DNA-PKcs PARsylation (siRNA knockdown and/or catalytic inhibition) resulted in an 
increased frequency of DNA-PKcs in a dePARsyalted form, available to modification by 
E3-Ligase and subsequent protein degradation by the proteasome.             
In studies investigating inhibition of PARG activity (ADP-HPD), we disrupted 
the ability for a PARsylated target to revert back to its original, unmodified state.  Due to 
the fact that pADPr additions are short-lived under normal conditions [25], inhibition of 
PARG abrogated the ability to use pADPr-protein modification in a transient, regulated 
fashion.  We found that PARG inhibition resulted in rapid DNA-PKcs depletion, 
mirroring the effect of tankyrase 1 siRNA-mediated knockdown and XAV939 inhibition, 
exposing the consequence of disrupting the appropriate regulation of pADPr 
automodification in regards to tankyrase 1.  Tankyrase 1 binds and PARsylates target 
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proteins in multimerized hetero- and homo-complexes of tankyrases 1 & 2 interacting 
through their sterile alpha motifs (SAM) [26, 27].  The subsequent event is 
autoPARsylation, which disrupts tankyrase-tankyrase SAM interactions and dissociates 
the automodified tankyrase from the tankyrase-complex [26].  Under normal cellular 
conditions, a considerable proportion of automodified tankyrase would be dePARsylated 
by the activity of PARG and maintain an active status.  Monomers of pADPr-modified 
tankyrase 1 that are not dePARsylated become substrates for ubiquitination and 
degradation [28].  Therefore, the addition of the PARG inhibitor (ADP-HPD) to cell 
culture results in the rapid accumulation of tankyrases in a PARsylated state, followed by 
ubiquitination and degradation.  As a consequence, tankyrase 1 protein levels are 
abolished over a short-time course, coupled with the concurrent loss of DNA-PKcs 
protein levels.  Though the mechanism of tankyrase 1 depletion differed, PARG 
inhibition resulted in loss of DNA-PKcs as the result of reduced tankyrase 1 levels, 
similar to DNA-PKcs depletion by siRNA knockdown of tankyrase 1.  
6.2.0 Implications of tankyrase 1-dependent pADPr modification of DNA-PKcs in 
carcinogenesis and aging 
Revealing tankyrase 1 as an important regulator of DNA-PKcs protein stability is 
informative regarding the array of possible instability phenotypes that would emerge as a 
consequence of polymorphic forms of either protein.  We have not yet determined the 
relevant protein interaction sites and specific residue(s) of DNA-PKcs that are 
PARsylated, which would provide insight into the domains of the PRKDC and TNKS 
alleles in which SNPs would result in defective protein variants, potentially impacting the 
intracellular roles of DNA-PKcs in end-capping and/or NHEJ.     
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Our analysis of DNA-PKcs protein domains that contribute to mammalian 
telomere end-capping suggested that the leucine zipper motif of DNA-PKcs, rather than 
the PIKK domain, is essential for this particular function.  It remains unclear what role 
each DNA-PKcs domain plays in NHEJ and downstream DNA-repair-dependent 
genomic stability.  For future investigations of DNA-PKcs pADPr-modification in the 
appropriate recruitment, scaffolding and activation in the DNA-PK holoenzyme, it will 
be important to consider the several functional domains of the PRKDC allele that could 
be influenced by SNPs.  We speculate the relevant domains may involve a combination 
of those necessary to facilitate protein interactions (leucine zipper motif), kinase function 
(PIKK domain) and pADPr-acceptor/interacting residues.  Additionally, SNPs in the 
TNKS allele that impact protein interactions (ankyrin-like repeat domains) may also 
affect the efficiency and consistency of tankyrase 1-mediated DNA-PKcs pADPr-
modification.  Interestingly, several SNPs in the human PRKDC allele have been 
associated with human cancers [29], supporting the possibility of disrupted tankyrase 1 
interaction and/or pADPr modification.  SNPs in the TNKS allele that correlate to various 
cancers have been identified, and involve telomere erosion. [30, 31].   
Identification of the mechanism by which DNA-PKcs is regulated [8] has 
important implications in respect to carcinogenesis and aging, both of which can be 
characterized by the accumulation of mutations paired with increasing genomic 
instability, and inappropriate cell-cycle regulation over time as the result of DNA-mis-
repair or chronic damage [32-34].  Mutations occurring in the PRKDC and/or TNKS 
alleles that disrupt the transient interaction between tankyrase 1 and DNA-PKcs and/or 
PARsylation of specific  DNA-PKcs residues would be expected to result in reduced 
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levels of DNA-PKcs, similar to the phenomenon seen in the SCID and BALB/c mouse 
[2, 6].  As a consequence, both telomere and genomic instability phenotypes would 
emerge, including increased mutation frequency and deficient DNA-PK-mediated NHEJ 
repair [8], which may further advance carcinogenic potential.  If a translocation event 
were to occur within a tumor suppressor gene resulting in the inactivation of the 
downstream proteins function, or the activation of a proto-oncogene, the risk of 
carcinogenic potential will become significantly elevated [32], corresponding with 
previous reports regarding the DNA-PKcs deficient BALB/c mouse [4, 7, 10]. 
The loss of DNA-PKcs would result in telomere uncapping [1, 5, 35, 36] and 
DSB-repair mediated by PARP-1 [37]. DSB-repair by the PARP-1-dependent alternative 
NHEJ pathway is characterized by slower end-joining processivity and an elevated 
frequency of translocation events [38], at least some of which could result from telomere-
DSB fusion events. 
Evidence from Maria Blasco and colleagues suggested that deficiencies of DNA-
PKcs, Ku80/86 or PARP-1 all contribute to accelerated aging phenotypes in mice with a 
telomerase negative background [39].  This study provides additional evidence 
supporting the findings of ours and others that suggest a DNA-PK NHEJ model that 
incorporates PARP-1 as an accessory protein to the holoenzyme [40].  In the study by 
Blasco and colleges, Ku80/86 and DNA-PKcs knockout mice were characterized by 
‘early-aging’ phenotypes compared to mice containing only telomerase deficiencies, 
suggesting that the loss of DNA-PK-mediated NHEJ accelerates aging phenotypes.  
Although PARP-1 knockout mice displayed early-aging phenotypes compared to 
controls, they did not pose accelerated aging phenotypes to the same extent observed in 
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Ku80/86 and DNA-PKcs deficient mice.  Regarding the classical NHEJ model, the loss 
of PARP-1 alone should not impact the effectiveness of DNA-PK-mediated NHEJ.  We 
propose the loss of PARP-1 contributes to the slight aging phenotypes observed by 
Blasco et al. as a consequence of failed PARP-1 dependent pADPr-modification of 
Ku80/86.  Pertaining to our proposed PARP-1-DNA-PK NHEJ model (Chapter 5), we 
speculated that failure of Ku80 pADPr modification (by PARP-1) would result in the 
inability to efficiently recruit and maintain the catalytically active pADPr-modified 
DNA-PKcs [20].   
Regulation of DNA-PKcs protein stability by tankyrase 1 catalytic PARP activity 
provides us with a novel approach to investigating cancer and aging phenotypes 
pertaining to deficient telomere end-capping and DNA-PK-mediated end-joining repair.  
We next seek to determine the functional attributes of pADPr-modification of DNA-PKcs 
in classical NHEJ.  We suspect the consequence of impaired DNA-PKcs pADPr-
modification (beyond protein destabilization and degradation) is likely to be one of 
increased mutagenesis and persistent chromosome instability, thereby facilitating 
carcinogenesis on the one hand, and limited cellular proliferation on the other, 
contributing to accelerated aging.   
There are many diseases characterized by premature aging phenotypes in 
childhood and juvenile cancer cases.  Most of these aging phenotypes have been 
attributed to deficiencies in DNA-repair and replication proteins such as ATM, BLM and 
WRN [41-45].  Fitting into this scheme is the inability to perform NHEJ in a DNA-PK-
dependent manner.  Inherited germ-line mutations in DNA-PKcs pADPr-acceptor 
residues, tankyrase 1 binding domains or tankyrase 1 catalytic function would result in an 
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individual with an elevated risk of the early onset of cancers and aging phenotypes in 
affected tissues.  Further, validation of our proposed PARP-1 associated DNA-PK model 
would suggest interference with non-covalent pADPr-interacting sites of DNA-PKcs and 
Ku70 as well as Ku80/86 pADPr accepting residue(s), would contribute to deficient end-
joining, perpetuating aging and carcinogenic phenotypes.  Cumulatively, our discovery of 
the mechanism underlying tankyrase-1-dependent DNA-PKcs regulation via 
PARsyaltion, coupled with the important implications of defects in either protein, 
provides valuable insight into an additional mechanism by which both accelerated aging 
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